
<html lang="en"     class="pb-page"  data-request-id="9dee15d8-05ab-417f-9a6d-47c0919ea8e3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b01840;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease" /></meta><meta name="dc.Creator" content="S. Barret  Kalindjian" /></meta><meta name="dc.Creator" content="Sanjay V.  Kadnur" /></meta><meta name="dc.Creator" content="Christopher A.  Hewson" /></meta><meta name="dc.Creator" content="Chandregowda  Venkateshappa" /></meta><meta name="dc.Creator" content="Suresh  Juluri" /></meta><meta name="dc.Creator" content="Rajendra  Kristam" /></meta><meta name="dc.Creator" content="Bheemashankar  Kulkarni" /></meta><meta name="dc.Creator" content="Zainuddin  Mohammed" /></meta><meta name="dc.Creator" content="Rohit  Saxena" /></meta><meta name="dc.Creator" content="Vellarkad N.  Viswanadhan" /></meta><meta name="dc.Creator" content="Jayashree  Aiyar" /></meta><meta name="dc.Creator" content="Donna  McVey" /></meta><meta name="dc.Description" content="Chemokine receptor 9 (CCR9), a cell surface chemokine receptor which belongs to the G protein-coupled receptor, 7-trans-membrane superfamily, is expressed on lymphocytes in the circulation and is t..." /></meta><meta name="Description" content="Chemokine receptor 9 (CCR9), a cell surface chemokine receptor which belongs to the G protein-coupled receptor, 7-trans-membrane superfamily, is expressed on lymphocytes in the circulation and is t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 17, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01840" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01840" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01840" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01840" /></link>
        
    
    

<title>A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01840" /></meta><meta property="og:title" content="A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0011.jpeg" /></meta><meta property="og:description" content="Chemokine receptor 9 (CCR9), a cell surface chemokine receptor which belongs to the G protein-coupled receptor, 7-trans-membrane superfamily, is expressed on lymphocytes in the circulation and is the key chemokine receptor that enables these cells to target the intestine. It has been proposed that CCR9 antagonism represents a means to prevent the aberrant immune response of inflammatory bowel disease in a localized and disease specific manner and one which is accessible to small molecule approaches. One possible reason why clinical studies with vercirnon, a prototype CCR9 antagonist, were not successful may be due to a relatively poor pharmacokinetic (PK) profile for the molecule. We wish to describe work aimed at producing new, orally active CCR9 antagonists based on the 1,3-dioxoisoindoline skeleton. This study led to a number of compounds that were potent in the nanomolar range and which, on optimization, resulted in several possible preclinical development candidates with excellent PK properties." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01840"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01840">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01840&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01840&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01840&amp;href=/doi/10.1021/acs.jmedchem.5b01840" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3098-3111</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01757" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01894" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S.+Barret++Kalindjian">S. Barret Kalindjian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sanjay+V.++Kadnur">Sanjay V. Kadnur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+A.++Hewson">Christopher A. Hewson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chandregowda++Venkateshappa">Chandregowda Venkateshappa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suresh++Juluri">Suresh Juluri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajendra++Kristam">Rajendra Kristam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bheemashankar++Kulkarni">Bheemashankar Kulkarni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zainuddin++Mohammed">Zainuddin Mohammed</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rohit++Saxena">Rohit Saxena</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vellarkad+N.++Viswanadhan">Vellarkad N. Viswanadhan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayashree++Aiyar">Jayashree Aiyar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donna++McVey">Donna McVey</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Norgine Ltd, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS, United Kingdom</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Jubilant Biosys Limited, #96, Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Jubilant Chemsys Limited, B-34 Sector-58, Noida 201301, India</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#4521282633203c052b2a37222c2b206b262a28"><span class="__cf_email__" data-cfemail="89ede4eaffecf0c9e7e6fbeee0e7eca7eae6e4">[emailÂ protected]</span></a>. Phone: +44 (0)1895 826600.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01840&amp;href=/doi/10.1021%2Facs.jmedchem.5b01840" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3098â3111</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 17, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 November 2015</li><li><span class="item_label"><b>Published</b> online</span>17 March 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01840" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01840</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3098%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DS.%2BBarret%2BKalindjian%252C%2BSanjay%2BV.%2BKadnur%252C%2BChristopher%2BA.%2BHewson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D7%26contentID%3Dacs.jmedchem.5b01840%26title%3DA%2BNew%2BSeries%2Bof%2BOrally%2BBioavailable%2BChemokine%2BReceptor%2B9%2B%2528CCR9%2529%2BAntagonists%253B%2BPossible%2BAgents%2Bfor%2Bthe%2BTreatment%2Bof%2BInflammatory%2BBowel%2BDisease%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3111%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01840"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1278</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01840" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;S.&quot;,&quot;last_name&quot;:&quot;Barret Kalindjian&quot;},{&quot;first_name&quot;:&quot;Sanjay&quot;,&quot;last_name&quot;:&quot;V. Kadnur&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;A. Hewson&quot;},{&quot;first_name&quot;:&quot;Chandregowda&quot;,&quot;last_name&quot;:&quot;Venkateshappa&quot;},{&quot;first_name&quot;:&quot;Suresh&quot;,&quot;last_name&quot;:&quot;Juluri&quot;},{&quot;first_name&quot;:&quot;Rajendra&quot;,&quot;last_name&quot;:&quot;Kristam&quot;},{&quot;first_name&quot;:&quot;Bheemashankar&quot;,&quot;last_name&quot;:&quot;Kulkarni&quot;},{&quot;first_name&quot;:&quot;Zainuddin&quot;,&quot;last_name&quot;:&quot;Mohammed&quot;},{&quot;first_name&quot;:&quot;Rohit&quot;,&quot;last_name&quot;:&quot;Saxena&quot;},{&quot;first_name&quot;:&quot;Vellarkad&quot;,&quot;last_name&quot;:&quot;N. Viswanadhan&quot;},{&quot;first_name&quot;:&quot;Jayashree&quot;,&quot;last_name&quot;:&quot;Aiyar&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;McVey&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3098-3111&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01840&quot;},&quot;abstract&quot;:&quot;Chemokine receptor 9 (CCR9), a cell surface chemokine receptor which belongs to the G protein-coupled receptor, 7-trans-membrane superfamily, is expressed on lymphocytes in the circulation and is the key chemokine receptor that enables these cells to target the intestine. It has been proposed that CCR9 antagonism represents a means to prevent the aberrant immune response of inflammatory bowel disease in a localized and disease specific manner and one which is accessible to small molecule approaches. One possible reason why clinical studies with vercirnon, a prototype CCR9 antagonist, were not successful may be due to a relatively poor pharmacokinetic (PK) profile for the molecule. We wish to describe work aimed at producing new, orally active CCR9 antagonists based on the 1,3-dioxoisoindoline skeleton. This study led to a number of compounds that were potent in the nanomolar range and which, on optimization, resulted in several possible preclinical development candidates with excellent PK properties.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01840&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01840" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01840&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01840" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01840&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01840" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01840&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01840&amp;href=/doi/10.1021/acs.jmedchem.5b01840" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01840" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01840" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01840%26sid%3Dliteratum%253Aachs%26pmid%3D26987013%26genre%3Darticle%26aulast%3DKalindjian%26date%3D2016%26atitle%3DA%2BNew%2BSeries%2Bof%2BOrally%2BBioavailable%2BChemokine%2BReceptor%2B9%2B%2528CCR9%2529%2BAntagonists%253B%2BPossible%2BAgents%2Bfor%2Bthe%2BTreatment%2Bof%2BInflammatory%2BBowel%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D7%26spage%3D3098%26epage%3D3111%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/jmcmar.2016.59.issue-7/20160414-01/jmcmar.2016.59.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Chemokine receptor 9 (CCR9), a cell surface chemokine receptor which belongs to the G protein-coupled receptor, 7-trans-membrane superfamily, is expressed on lymphocytes in the circulation and is the key chemokine receptor that enables these cells to target the intestine. It has been proposed that CCR9 antagonism represents a means to prevent the aberrant immune response of inflammatory bowel disease in a localized and disease specific manner and one which is accessible to small molecule approaches. One possible reason why clinical studies with vercirnon, a prototype CCR9 antagonist, were not successful may be due to a relatively poor pharmacokinetic (PK) profile for the molecule. We wish to describe work aimed at producing new, orally active CCR9 antagonists based on the 1,3-dioxoisoindoline skeleton. This study led to a number of compounds that were potent in the nanomolar range and which, on optimization, resulted in several possible preclinical development candidates with excellent PK properties.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract in which tissue damage and inflammation lead to long-term, often irreversible impairment of the structure and function of the gastrointestinal tract.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> While there are a number of therapeutic options for treating and maintaining remission in some patients with IBD, none of the currently available medicines provides a cure, and, overall, there remains a significant unmet medical need in this area.</div><div class="NLM_p">Chemokines are a family of structurally related small proteins released from a variety of different cells within the body.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> They have a primary ability to induce chemotaxis and thereby attract multiple cells of the immune system to sites of inflammation or as a part of normal immune function homeostasis. Examples of the types of cells attracted by chemokines include monocytes, T and B lymphocytes, dendritic cells, natural killer cells, eosinophils, basophils, and neutrophils. In addition, chemokines are also able to cause activation of leukocytes at the site of inflammation by a variety of means such as causing degranulation of granulocytes, generation of superoxide anions (oxidative burst), and up-regulation of integrins to cause extravasation.</div><div class="NLM_p">Chemokine receptor 9 (CCR9), a cell surface chemokine receptor which belongs to the G protein-coupled receptor (GPCR), 7-trans-membrane (7-TM) superfamily, is expressed on lymphocytes in the circulation and is the key chemokine receptor that enables these cells to target the intestine.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> CCR9 has only one identified ligand, thymus-expressed chemokine (TECK; also known as chemokine ligand 25 (CCL25)).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The primary site of CCL25 expression is in epithelial cells lining the intestinal lumen,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and CCR9-positive cells are enriched in both the small intestine and the colon, relative to the circulation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Disruption of the CCR9/CCL25 interaction by antibody and small molecule antagonists of CCR9 has been demonstrated to be effective in preventing the inflammation observed in small animal models of IBD.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a></div><div class="NLM_p">Consequently, it has been proposed that CCR9 antagonism represents a means to prevent the aberrant immune response of IBD in a more localized and disease-specific manner and one which is accessible to small molecule approaches. This is in contrast to the more systemic and generalized immunosuppression underpinning many of the currently used biological therapies, e.g., anti-tumor necrosis factorâÎ± therapy.</div><div class="NLM_p">As judged by the patent literature,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> a number of groups have been active in the exploration of structureâactivity relationships (SAR) for CCR9, and these efforts have been the subject of reviews.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Most prominent among these is the compound discovered by Chemocentryx and licensed by GlaxoSmithKline, <i>N</i>-{4-chloro-2-[(1-oxidopyridin-4-yl)carbonyl]phenyl}-4-(1,1-dimethylethyl) benzenesulfonamide (<b>1</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), also known variously as vercirnon, CCX-282, or GSK1605786.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This compound underwent successful Phase II clinical trials for Crohnâs disease<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> but ultimately demonstrated a lack of efficacy in the Phase III SHIELD trials.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> It was our conjecture that the reason for failure at Phase III was likely a combination of the patient population selected for study (who were more seriously ill than the Phase II population) and the relatively poor pharmacokinetic (PK) profile, which led to the use of a high, but apparently insufficient, dose of drug.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of vercirnon, compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We wish to report on some of the SAR studies underpinning a successful medicinal chemistry program which was aimed at producing an orally available CCR9 antagonist with a superior PK profile to compound <b>1</b>. Others, too, have recently reported on their efforts to improve on the properties of vercirnon.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p last">The program started by identifying the common features required by molecules to act as CCR9 antagonists by considering a number of reference templates from the available literature.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These groups were then introduced onto small, commonly utilized, mainly bicyclic or tricyclic scaffolds, attempting to mimic the steric and electronic chemical space that was a feature of the known ligands. This is effectively a privileged structure approach, a concept that has found substantial utility in discovering nonpeptide ligands for peptide hormone receptors.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Some 20 distinct series of compounds were devised and examples made, of which three were deemed to be of sufficient interest to investigate in more detail, and one of which, based on the 1,3-dioxoisoindoline skeleton, is presented in this paper. Our approach has given rise to a number of lead optimized molecules and a set of compounds from which a preclinical development candidate can be chosen.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> shows the preparation of 3-chloro-6-nitrophthalic anhydride (<b>4</b>) from 3-chlorophthalic anhydride (<b>2</b>). Compound <b>2</b> was nitrated in 74% yield by treatment for 12 h at room temperature with a mixture of nitric and sulfuric acids. The resulting phthalic acid (<b>3</b>) was then treated with acetic anhydride at a temperature of 120 Â°C for 18 h to produce the desired anhydride (<b>4</b>) in almost quantitative yield. This material was used in the preparation of compounds <b>11</b>â<b>16</b> and <b>19</b>â<b>71</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-Chloro-6-nitrophthalic Anhydride (<b>4</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HNO<sub>3</sub>/H<sub>2</sub>SO<sub>4</sub>, rt, 12 h, 74%. (b) Ac<sub>2</sub>O, 120 Â°C, 18 h, 99%.</p></p></figure><div class="NLM_p">The preparation of the compounds for testing followed the generic procedures illustrated in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The appropriate anhydride <b>i</b> was condensed with the amine <b>ii</b> to yield the imide <b>iii</b>. This reaction was performed by heating the reagents at a reflux in acetic acid for 18 h. When R<sub>3</sub> was hydrogen or methyl, reduction of the nitro group was carried out using hydrogen and 10% palladium on charcoal as a catalyst. The amine <b>iv</b> was reacted with the appropriate sulfonyl chloride in pyridine for 24 h at room temperature, to leave the requisite test compounds. Where R<sub>3</sub> was chloro, the nitro reduction reaction was carried out either using Raney nickel and hydrogen or, more usually, iron powder in acetic acid. Furthermore, the sulfonylation reaction required somewhat more forceful conditions. This step was carried out in one of two ways: a one-step process, using pyridine as solvent and heating at 125 Â°C for 24 h in the presence of a catalytic quantity of DMAP, or a two-step process. This was achieved by heating a pyridine solution to 90 Â°C for 8 h. This resulted in a mixture of the required compound and a bis-sulfonylated species. The second sulfonyl group was removed by stirring the mixture with 1 M tetra-<i>N</i>-butyl-ammonium fluoride in THF for 3 h at room temperature. Oxidation, as needed to produce pyridine-<i>N</i>-oxides, was achieved by stirring a dichloromethane solution of the substrate with meta-chloroperoxybenzoic acid at room temperature for 8 h. Conversion of an R<sub>3</sub> chloro group to the nitrile, as in compound <b>16</b>, was carried out by heating the substrate with a mixture of zinc cyanide, zinc dust, 1,1â²bis(diphenylphosphino)ferrocene, and tris(dibenzylideneacetone)dipalladium(0) in dimethylacetamide to 120 Â°C in a microwave for 2 h.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Reaction Scheme for the Synthesis of Compounds <b>5</b>â<b>71</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOAc, reflux, 18 h. (b) 10% Pd/C/H<sub>2</sub>, MeOH. (c) Fe, HOAc, 6 h or H<sub>2</sub>/Raney Ni, ethanol, 6 h. (d) Pyridine, rt, 24 h. (e) cat DMAP, pyridine 125 Â°C, 24 h or (1) Pyridine, 90 Â°C, 8 h; (2) 1 M TBAF in THF, rt, 3 h. (f) mCPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8 h. (g) Zn(CN)<sub>2</sub>, dppf, Pd<sub>2</sub>(dba)<sub>3</sub>, Zn dust, N<sub>2</sub>, DMA, 120 Â°C, 2 h, microwave.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Using the approach described in the <a class="ref internalNav" href="#sec1" aria-label="Introduction">Introduction</a> section, we have found that the 1,3-dioxoisoindoline skeleton represents an excellent template from which to prepare CCR9 antagonists.</div><div class="NLM_p">The initial assay strategy involved examining the ability of molecules to inhibit the ligand-dependent increase in intracellular Ca<sup>2+</sup> initiated through CCR9 interaction with its ligand, CCL25, using the Fluorescent Imaging Plate Reader (FLIPR) platform. This was carried out using MOLT-4 cells (ECACC Catalogue no.: 85011413), which is a cell line of human origin that endogenously expresses both CCR9A and CCR9B. Promising compounds were then examined in a cell line that overexpressed recombinant human CCR9A (Millipore) (CCR9 OE) and in a functional chemotaxis assay, also using MOLT-4 cells. In parallel, a series of tests were carried out in vitro to determine some of the ADME properties of molecules, in order to establish whether they had appropriate drug-like characteristics. PK in mice was used to establish oral bioavailability before the molecules were examined in recognized models of IBD in rodents.</div><div class="NLM_p">CCR9A and CCR9B receptors were first described in 2000.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, there have been no reports of any functional differences between them, and so we were not concerned strategically with selectivity in this program. In the event, a cell line expressing the CCR9B receptor was produced, and representative compounds tested in a calcium flux assay. No significant differences in the behavior of the ligands was seen (data not shown).</div><div class="NLM_p">In the first phase of the work, careful consideration of the reference templates showed that all the molecules contained an aryl-sulfonamide and that this was generally attached through a spacer to another aromatic ring. Optimally, this second aromatic ring was a pyridine moiety. With this putative pharmacophore established, a series of molecular alignments were carried out using molecular modeling tools to determine the best positions for substitution of the various skeletons under consideration. In this way, several 1,3-dioxoisoindoline molecules were designed and tested. Compound <b>5</b>, a 4-<sup><i>t</i></sup>butyl-substituted aryl sulfonamide and containing a pyridine ring attached at its 3-position, was found to possess submicromolar levels of CCR9 activity (<i>K</i><sub>i</sub> 479 nM).</div><div class="NLM_p">With this compound in hand, a number of close analogues were made in order to survey the initial SAR (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). It was found that other substituents could be introduced onto the aryl sulfonamide ring in place of a 4-<sup><i>t</i></sup>butyl group (e.g., compounds <b>6</b>â<b>9</b>) some of which, such as in compounds <b>7</b> and <b>8</b>, showed slightly improved primary potency in the MOLT-4 calcium flux assay. However, other data generated with these molecules in the CCR9 OE calcium flux and MOLT-4 chemotaxis assays (data not shown) showed unpredictable and wide discrepancies. This coupled with some stability concerns did not make the alternative substitutions attractive for further elaboration either initially or later in the program. The most important change made at this point was the introduction of a substituent into the 7-position of the 1,3-dioxoisoindoline ring. Methyl (compound <b>17</b>), cyano (compound <b>16</b>), and, especially, chloro (compound <b>11</b>) substituents improved the primary potency. However, larger groups in this position were generally detrimental. Molecular docking studies (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) into a model of the receptor suggest that the chloro group in compound <b>11</b> picked up a number of extra receptor residues, relative to the situation with compound <b>5</b>. There were interactions of both molecules with a number of side-chains, such as Tyr 126 and Ile 197, which help to form a hydrophobic pocket in which to accommodate the <sup><i>t</i></sup>butylphenyl group and with several polar amino acids on the receptor such as Lys 127, Lys 218, and Thr 199, which are thought to bind with the sulfonyl oxygen and pyridine nitrogen. However, contacts were seen with compound <b>11</b> alone (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b) between the chloro group and Ile 279, Phe 130, and Val 276. These extra interactions, none particularly dominant, may be giving rise to the approximate 20-fold enhancement in binding potency observed.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Overlay of two CCR9 antagonists, compounds <b>5</b> (pink) and <b>11</b> (cyan) docked into the binding pocket of a model of the CCR9 receptor. (b) Detail of the interactions of the chloro atom in compound <b>11</b> with residues in the binding pocket responsible for the enhanced affinity of this molecule. All distances quoted are in angstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. FLIPR Data Obtained for Compounds <b>5</b>â<b>18</b> in MOLT-4 Cells: Initial Survey<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">B</th><th class="colsep0 rowsep0" align="center" char=".">MOLT-4 <i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>5</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">479</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">2713</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>7</b></td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">123</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>8</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">206</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">1322</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>10</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">618</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">N<sup>+</sup>-O<sup>â</sup></td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">N<sup>+</sup>-O<sup>â</sup></td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>15</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">189</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">456</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values quoted are geometric means obtained from at least two separate experiments. For <i>n</i> = 2 individual replicates are within 3-fold and for <i>n</i> â¥ 3, SEM does not exceed 0.2 log units. The assay was carried out as outlined in the <a class="ref internalNav" href="#sec4" aria-label="Experimental">Experimental</a> section. Compound <b>1</b>, used as a reference, produced a <i>K</i><sub>i</sub> of 1.1 nM.</p></div></div></div><div class="NLM_p">Two other SAR trends were noted in this initial study. First, compounds such as <b>5</b> and <b>11</b>, where the pyridine ring is attached directly to the 1,3-dioxoisoindoline ring, are of similar potencies to analogues such as <b>10</b> and <b>13</b>, where there is a single carbon linker. Comparing <b>13</b> to <b>15</b>, which has a two carbon linker, sees the longer chain start to become less potent. Hence, it was decided to concentrate future efforts on directly linked and C<sub>1</sub>-bridged molecules. Second, compounds were prepared (<b>12</b> and <b>14</b>) where the pyridine nitrogen had been oxidized to a pyridine N-oxide moiety. This change led to compounds with similar potency to the parent pyridines and with generally equivalent or superior ADME-related properties such as solubility. On this basis and in future studies, a significant number of pyridine N-oxides were prepared from some of the more interesting pyridine compounds, in an attempt to fine-tune drug-like properties in the evolving series.</div><div class="NLM_p"><a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> shows a comparison of the binding modes of compounds <b>12</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <i>n</i> = 0) and <b>14</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <i>n</i> = 1), predicted by docking in the CCR9 receptor model and potentially demonstrates how the receptor can accommodate both directly linked and one carbon-separated compounds within its active site. The <sup><i>t</i></sup>butylphenylsulfonamide portions from the two molecules overlay in close proximity, but the space occupied by the 1,3-dioxoisoindoline ring in each molecule is subtly different. First, these rings are not quite coplanar. Second and more obviously, one molecule appears to be significantly rotated around an axis, perpendicular to the plane of the ring, relative to the other. These changes allow the extra carbon atom in the linker of compound <b>14</b> to be accommodated, while simultaneously permitting the pyridine rings in both the molecules to fit to about the same depth within the aromatic binding pocket. This model suggests that the mouth of the binding pocket is of sufficient size to permit its access from two different approach vectors.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Alternate views of the overlay of two CCR9 antagonists, compounds <b>12</b> (cyan) and <b>14</b> (green) docked into the binding pocket of a model of the CCR9 receptor. All distances quoted are in angstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As mentioned above, alterations to the substituent or the substitution pattern of the aryl group attached to the sulfonamide were ultimately unproductive. The next step was to examine structure activity dependencies for changes around the pyridine ring, with this group either attached directly to the 1,3-dioxoisoindoline ring or with a one carbon atom separation. For both groups of compounds reported here, the rest of the molecule was held constant, with a 4-<sup><i>t</i></sup>butylphenylsulfonamide group in the 4-position and a chloro group substitution in the 7-position of the 1,3-dioxoisoindoline ring.</div><div class="NLM_p">Looking first at compounds with a direct attachment between the pyridine and the 1,3-dioxoisoindoline rings (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), a series of pyridines, attached at the 3-position and substituted in the 5-position with a modest variety of groups, were prepared. Among these, data from compounds <b>19</b>â<b>22</b>, suggested that as long as a substituent was not too large, there was little preference for either modestly electron-donating or -withdrawing substituents for this combination. Thus, it was decided to probe further substitutional dependencies with a combination of methyl, methoxy, ethoxy, and nitrile groups with halo groups used additionally, if the chemistry readily permitted. This strategy allowed compounds to retain a molecular weight close to a notional limit of approximately 500.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. FLIPR Data Obtained in MOLT-4 Cells for Compounds <b>19</b>â<b>54</b> Directly Linking the Pyridine to the 1,3-Dioxoisoindoline Skeleton<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center">A</th><th class="colsep0 rowsep0" align="center">B</th><th class="colsep0 rowsep0" align="center">C</th><th class="colsep0 rowsep0" align="center">D</th><th class="colsep0 rowsep0" align="center">E</th><th class="colsep0 rowsep0" align="center" char=".">MOLT-4 <i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OEt</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>21</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-CN</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>23</b></td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>24</b></td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">N<sup>+</sup>-O<sup>â</sup></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>26</b></td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">N<sup>+</sup>-O<sup>â</sup></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b></td><td class="colsep0 rowsep0" align="left">C-F</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>28</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>29</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>30</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>31</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>32</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OEt</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>34</b></td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="left">C-CN</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>36</b></td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>37</b></td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>38</b></td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>39</b></td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>40</b></td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="char" char=".">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>41</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>42</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">C-Et</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>43</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>44</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>45</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>46</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-CN</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-CN</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>50</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>51</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>52</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>53</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>54</b></td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values quoted are geometric means obtained from at least two separate experiments. For <i>n</i> = 2 individual replicates are within 3-fold and for <i>n</i> â¥ 3, SEM does not exceed 0.2 log units. The assay was carried out as outlined in the <a class="ref internalNav" href="#sec4" aria-label="Experimental">Experimental</a> section. Compound <b>1</b>, used as a reference, produced a <i>K</i><sub>i</sub> of 1.1 nM.</p></div></div></div><div class="NLM_p">Continuing the exploration of the pyridines attached at the 3-position, substituents were introduced into the 2-position, ortho to both the nitrogen group and the attachment point of the pyridine. Of the molecules examined, it was found that the methyl (<b>23</b>, 3 nM), methoxy (<b>25</b>, 3 nM) and fluoro (<b>27</b>, 7 nM)) derivatives provided excellent primary activity, in the nanomolar range. Pyridine N-oxides corresponding to compounds <b>23</b> (compound <b>24</b>) and <b>25</b> (compound <b>26</b>) maintained these levels of potency. Several compounds (e.g., <b>28</b>â<b>30</b>) were prepared with substitutions at the 6-position of the pyridine, but the potency was found to be reduced relative to the molecules substituted at the 2-position. Finally, monosubstitutions in the 4-position were considered. Here, again, by substituting ortho to the point of attachment, compounds <b>31</b>â<b>33</b> all showed potency in the nanomolar range (7, 2, and 9 nM, respectively).</div><div class="NLM_p">Although only a relatively small effect, in the 3-pyridine direct linked series, ortho substitution to the point of attachment was found to be optimal. This is presumably due to the substituent acting to slow down any torsional movements of the two rings and hence reinforcing conformations, whereby the pyridine nitrogen is in position to interact with its conjugate partner, Lys 218, on the receptor.</div><div class="NLM_p">Further analogues were prepared with additional substituents on the 3-pyridine ring (compounds <b>34</b>â<b>42</b>). Although two compounds, <b>38</b> (8 nM) and <b>39</b> (5 nM), where two methoxy and two methyl groups, respectively, flanked the pyridine nitrogen, gave potency in the nanomolar range, none exceeded the results obtained with analogous mono 2- or 6-substituted materials.</div><div class="NLM_p">The unsubstituted analogues with the point of attachment in the 2-position (<b>43</b>) and the 4-position (<b>53</b>) of the pyridine were prepared, and both were found to be modestly more potent than compound <b>11</b>, the equivalent 3-pyridine. A number of substituents were introduced to compound <b>43</b>, but in general this was found to be a detrimental tactic for the 2-attached pyridines, and, with the exception of the 6-methyl derivative (<b>48</b>), which was equipotent with the parent, a several fold loss of potency was observed (compounds <b>44</b>â<b>47</b>, <b>49</b>â<b>52</b>). A similar pattern (data not shown) was observed with the 4-position attached pyridine analogs, with only the introduction of a 3-methyl group (<b>54</b>) leading to materially enhanced potency.</div><div class="NLM_p">It is likely, given the relative lack of dependence of activity on the nature or position of substitution on the pyridine ring, that the role of these groups, providing that they are relatively small, is to effect the precise conformation of the ring relative to the isoindoline, rather than to interact directly with the receptor.</div><div class="NLM_p">Analogues (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) were also prepared of the prototype, C<sub>1</sub>-bridged molecule (<b>13</b>, 22 nM). The 2-attached pyridine compound (<b>55</b>) maintained a similar potency, whereas the 4-attached pyridine analogue (<b>69</b>) improved primary activity by about 3-fold (8 nM). N-oxide formation of <b>55</b> and <b>13</b> resulted in compounds <b>56</b> and <b>14</b>, respectively, both slightly more active than the corresponding parent in the primary assay. The pyridine N-oxide of <b>69</b> (compound <b>70</b>) is of note, as it loses activity by about 4-fold relative to the pyridine itself, an unusual observation for this normally very conservative modification.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. FLIPR Data Obtained in MOLT-4 Cells for Compounds <b>55</b>â<b>71</b> with a One Carbon Atom Spacer between the Pyridine to the 1,3-Dioxoisoindoline Skeleton<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center">A</th><th class="colsep0 rowsep0" align="center">B</th><th class="colsep0 rowsep0" align="center">C</th><th class="colsep0 rowsep0" align="center">D</th><th class="colsep0 rowsep0" align="center">E</th><th class="colsep0 rowsep0" align="center" char=".">MOLT-4 <i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>55</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="left">N<sup>+</sup>-O<sup>â</sup></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>57</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>58</b></td><td class="colsep0 rowsep0" align="left">N<sup>+</sup>-O<sup>â</sup></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-F</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>61</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-CN</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>62</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>63</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>64</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>65</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N<sup>+</sup>-O<sup>â</sup></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>66</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>67</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">123</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>68</b></td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>69</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>70</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N<sup>+</sup>-O<sup>â</sup></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>71</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">C-OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">108</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values quoted are geometric means obtained from at least two separate experiments. For <i>n</i> = 2 individual replicates are within 3-fold and for <i>n</i> â¥ 3, SEM does not exceed 0.2 log units. The assay was carried out as outlined in the <a class="ref internalNav" href="#sec4" aria-label="Experimental">Experimental</a> section. Compound <b>1</b>, used as a reference, produced a <i>K</i><sub>i</sub> of 1.1 nM.</p></div></div></div><div class="NLM_p">In contrast to the compounds in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, where substitution in the ortho position to the point of attachment was generally beneficial to potency, all the compounds with a single carbon-atom linker did not improve with substituents added. Indeed, with one exception, potency was significantly reduced on introduction of the candidate substituents, especially when the sterically most demanding methoxy groups were used. The exception is compound <b>59</b> where the small, fluorine substituent had been introduced and where potency was slightly improved. As would be expected, the extra carbon in the linker between the pyridine and the 1,3-dioxoisoindoline rings allowed the pyridine a greater locus in which to move, which probably takes it to the extremes of the binding pocket. Extra substituents with any significant steric demand would be difficult to accommodate in such a situation.</div><div class="NLM_p">Given the relatively flat SAR, we were in the fortunate position of having many compounds to progress through our screening cascade and examine for drug-like properties. A considerable number of compounds were progressed for further in vitro assessment, some of which are shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. The most promising compounds showed a good congruence in potency between the two FLIPR-based assays and the functional chemotaxis measured in MOLT-4 cells. In our hands, this last assay was too variable to be considered as a reliable primary data source, but was used to give confidence that compounds could elicit a functional response. Examining these results, alongside information on solubility, metabolic stability as measured in microsomes (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) and general selectivity considerations allowed for a group of compounds to be identified as candidates for PK studies, the data for some of which are reported in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. The excellent PK profiles obtained in mice with the compounds based on the 1,3-dioxoisoindoline skeleton were in contrast to the data obtained with compound <b>1</b>, which in our hands gave a very poor exposure following oral dosing and a short half-life along with relatively rapid clearance when administered intravenously (iv).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. FLIPR and Chemotaxis Data Obtained Respectively in CCR9 Overexpressing Cells (CCR9 OE) and MOLT-4 Cells for Selected Compounds<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center" char=".">FLIPR CCR9 OE <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">MOLT-4 chemotaxis <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">357</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">>300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>69</b></td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Values quoted are geometric means obtained from at least two separate experiments. The assays were carried out as outlined in the <a class="ref internalNav" href="#sec4" aria-label="Experimental">Experimental</a> section.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">For <i>n</i> = 2, individual replicates are within 4-fold, and for <i>n</i> â¥ 3, SEM does not exceed 0.3 log units. Compound <b>1</b>, used as a reference, produced a <i>K</i><sub>i</sub> of 3.7 nM in this assay.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">For <i>n</i> â¥ 3, SEM does not exceed 0.5 log units. Compound <b>1</b>, used as a reference, produced a <i>K</i><sub>i</sub> of 10.0 nM in this assay.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. ADME and PK Data for Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center" char=".">solubility pH 7.4 (Î¼M)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">human liver microsomes % remaining<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse liver microsomes % remaining<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse iv <i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">clearance (mL/min/kg)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse AUC po (ngÂ·h/mL)<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse F<sub>abs</sub> (%)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="char" char=".">340</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">126</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td><td class="colsep0 rowsep0" align="char" char=".">3.92</td><td class="colsep0 rowsep0" align="char" char=".">13892</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">3.26</td><td class="colsep0 rowsep0" align="char" char=".">2.60</td><td class="colsep0 rowsep0" align="char" char=".">46837</td><td class="colsep0 rowsep0" align="char" char=".">73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">114</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">1.28</td><td class="colsep0 rowsep0" align="char" char=".">4.69</td><td class="colsep0 rowsep0" align="char" char=".">16230</td><td class="colsep0 rowsep0" align="char" char=".">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">5.37</td><td class="colsep0 rowsep0" align="char" char=".">1.73</td><td class="colsep0 rowsep0" align="char" char=".">23998</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td><td class="colsep0 rowsep0" align="char" char=".">6.86</td><td class="colsep0 rowsep0" align="char" char=".">35594</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char=".">1.32</td><td class="colsep0 rowsep0" align="char" char=".">2.34</td><td class="colsep0 rowsep0" align="char" char=".">67859</td><td class="colsep0 rowsep0" align="char" char=".">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">1.05</td><td class="colsep0 rowsep0" align="char" char=".">2.57</td><td class="colsep0 rowsep0" align="char" char=".">35999</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Solubility of test compounds in pH7.4 buffer. Mean based on three replicates.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Human liver microsomes incubated with the test compound at 37 Â°C. The data are the mean of 3 replicates. Compound disappearance monitored over 30 min period. SEM is <10% of the mean values.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Mouse liver microsomes incubated with the test compound at 37 Â°C. The data are the mean of 3 replicates. Compound disappearance monitored over 30 min period. SEM is <10% of the mean values.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Data derived by consideration of mean elimination half-life (rate of elimination of compound from plasma) following 1 mg/kg iv dosing to 12 mice (vehicle: 5% DMSO, 5% solutol: absolute alcohol (1:1, v/v) and 90% of normal saline). Data fitted with Pharsight WinNonLin version 5.2.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Data derived by comparison of plasma concentration of test compound vs time AUCs following 10 mg/kg po dosing to 12 mice (vehicle: Tween-80 and 0.5% methyl cellulose). Data fitted with Pharsight WinNonLin version 5.2.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Data derived by comparison of plasma concentration of test compound vs time AUCs following 1 mg/kg iv and 10 mg/kg po dosing to 12 mice.</p></div></div></div><div class="NLM_p">On the basis of the overall in vitro profile and PK studies, a number of compounds were examined following oral administration in various in vivo models of IBD. Thus, for example, data gathered for three of these molecules in an acute dextran sulfate sodium (DSS)-induced colitis model study in mice are presented in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. The same molecules were also used in a chronic study as shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Behavior of compounds <b>14</b>, <b>24</b>, <b>56</b> in the chronic DSS-induced colitis mouse model showing: (a) change in body weight with time; composite changes in (b) disease activity index (DAI); (c) fecal consistency; and (d) hemoccult score.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Dose Dependency Studies of Compounds <b>14</b>, <b>24</b>, and <b>56</b> in the Acute DSS-Induced Colitis Model in Mice<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center" char=".">3 (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">10 (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">30 (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">100 (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">21<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">31<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">58<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">41<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">51<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">86<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">32<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">33<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">51<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Data quoted is the percentage reduction in the disease activity index relative to a vehicle-treated disease control, following twice daily oral dosing of the dose shown. Studies were conducted as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental">Experimental</a> section using 12 animals in each group and including nondisease and vehicle-treated disease control groups.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last"><i>p</i> < 0.05  versus disease control in one way ANOVA followed by Dunnettâs test.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last"><i>p</i> < 0.01  versus disease control in one way ANOVA followed by Dunnettâs test.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last"><i>p</i> < 0.001 versus disease control in one way ANOVA followed by Dunnettâs test.</p></div></div></div><div class="NLM_p">Attempts to use compound <b>1</b> as a reference material in the oral studies failed, and so this was compared (50 mg/kg) with compound <b>14</b> (30 mg/kg). Both compounds were dosed subcutaneously (sc), twice daily using an acute DSS-induced colitis protocol, whereby the compounds were dosed for 10 days, with 2.25% (w/v) DSS being introduced into drinking water for the first 5 days of the study. The results were assessed using a disease activity index (DAI) score, which is a composite of observations made on body weight, hemoccult, and stool consistency and by comparison with vehicle and DSS treated animals as well as untreated (no DSS) animals. Even using the sc route, the percentage reduction in DAI for compound <b>1</b> did not reach statistical significance (17%), although there was a clear effect on some of the individual parameters. Compound <b>14</b> (24% reduction in DAI) showed significance at the 95% confidence level.</div><div class="NLM_p">The same acute model was used to carry out dose dependency studies for the most promising compounds. The data summarized in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> shows that there was a good doseâresponse relationship for the compounds examined, with significant reduction in DAI noted at lower doses of 10 and 30 mg/kg and highly significant results at the highest dose used. Compound <b>24</b> at the top dose of 100 mg/kg provided excellent protection against the induced colitis.</div><div class="NLM_p">In the chronic model, compounds were dosed throughout the 30 day duration of the experiment with three spells of 1.75% (w/v) DSS administration in drinking water; from days 1 to 5, 11 to 15, and 21 to 25. As can be seen in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, all three test compounds showed substantial protection against the cycles of DSS-induced colitis, DAI showing significant or highly significant improvements.</div><div class="NLM_p last">In conclusion, we have developed and optimized a series of CCR9 antagonists based on a 1,3-dioxoisoindoline skeleton. These molecules are highly potent at the receptor and have excellent PK properties, resulting in highly significant data being obtained in well-recognized models of IBD. Several of these molecules are potential, preclinical candidates.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Molecular Modeling Methodology</h3><div class="NLM_p last">A homology model of the CCR9 receptor was initially built using the bovine rhodopsin structure as the template, selected based on a template search that involved sequence-based BLAST<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> as well as fold-recognition-based FFAS searches.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> During the later stages of this study when experimental coordinates of the CCR5 structure complexed with an antagonist, maraviroc, were released (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS">4MBS</a>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> this structure was found to be suitable to develop a more refined homology model of the CCR9 receptor. The sequence of CCR5 was compared to that of CCR9, and the homology was found to be good enough to proceed showing a similarity of 53%, an identity of 33.2% with gaps of 6.2%. A multiple sequence alignment of all members of chemokine family (CCR1 to CCR10 and CXCR1 to CXCR7) using the PROMALS3D Web server<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was performed to ensure that the specific conserved motifs of class A GPCRs were aligned properly across the family. The pairwise sequence alignment between CCR9 and CCR5 was extracted and used to build the homology model using the Prime module of the Schrodinger software suite.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> After refining the model, it was checked for robustness using Ramachandran plots: core region: 90.4%, allowed region: 7.8%, generously allowed region: 1.8%, and disallowed region: 0.0%. The model was further refined by rigid and induced-fit docking using reference compounds and later some compounds from the 1,3-dioxoisoindoline series.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General</h3><div class="NLM_p">Analytical thin-layer chromatography (TLC) was performed on Merck silica gel 60 F<sub>254</sub> aluminum-backed plates. Compounds were visualized by ultraviolet (UV) light and/or stained either with iodine, potassium permanganate, or ninhydrin solution. Flash column chromatography was performed on silica gel (100â200 mesh). <sup>1</sup>H nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance-400 MHz spectrometer with a BBO (broad band observe) and BBFO (broad band fluorine observe) probe. Chemical shifts (Î´) are expressed in parts per million (ppm) downfield by reference to tetramethylsilane as the internal standard. Splitting patterns are designated as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) and bs (broad singlet). Coupling constants (<i>J</i>) are given in hertz (Hz). Purity assessment for final compounds was based on the following three LCMS methods using the electrospray ionization (ESI) technique. Method 1 consisted of the following: Acquity BEH C-18 column 2.10 mm Ã 100 mm, 1.70 Î¼m. Mobile phase; A, 5 mM ammonium acetate in water; B, acetonitrile; gradient, 90% A to 10% A in 8 min with 10 min run time and a flow rate of 0.3 mL/min. Method 2 consisted of the following: Acquity HSS-T3 column 2.10 mm Ã 100 mm, 1.8 Î¼m. Mobile phase; A, 0.1% TFA in water; B, acetonitrile; gradient, 90% A to 10% A in 8 min with 10 min run time and a flow rate of 0.3 mL/min. Method 3 consisted of the following: Zorbax HD C18 column 2.10 mm Ã 50 mm, 1.8 Î¼m. Mobile phase; A, 0.01% acetic acid in 95% water and methanol; B, 0.01% acetic acid in 5% water and methanol; gradient, 100% A to 100% B in 4 min with 5 min run time and a flow rate of 0.3 mL/min. The method used for each individual compound is shown in parentheses after retention time information.</div><div class="NLM_p last">All experimental procedures involving animals were reviewed locally by the Institutional Animal Ethics Committee (IAEC) of Jubilant Biosys Limited, Bangalore, India and assessed for safety and humane usage.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of Test Compounds</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 3-Chloro-6-nitrophthalic acid (<b>3</b>)</h4><div class="NLM_p last">To a stirred solution of nitric acid and sulfuric acid (172 mL:439 mL) at 0 Â°C was added 3-chlorophthalic anhydride (<b>2</b>, 250.0 g, 1.37 mol) in small portions. The reaction mixture was stirred at room temperature for 12 h and then cooled to 0 Â°C. This was followed by the addition of crushed ice. The solid which precipitated out was filtered to afford the title compound as a white solid (250.0 g; 74% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 14.34 (bs, 2H), 8.16â8.13 (d, <i>J</i> = 8.8 Hz, 1H), 7.93â7.91 (d, <i>J</i> = 8.8 Hz, 1H). MS (M â 1): 244.0.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 3-Chloro-6-nitrophthalic anhydride (<b>4</b>)</h4><div class="NLM_p last">A stirred solution of 3-chloro-6-nitrophthalic acid <b>(3</b>, 250.0 g, 1.02 mol) in acetic anhydride (3.5 L) was heated at 120 Â°C for 18h. The reaction mixture was cooled and concentrated under reduced pressure. The crude solid obtained was washed with hexane and triturated with 20% diethyl ether in hexane to afford the title compound as an off-white solid (230g; 99% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 8.48â8.46 (d, <i>J</i> = 8.8 Hz, 1H), 8.30â8.27 (d, <i>J</i> = 8.8 Hz, 1H). MS (M + 1): 228.0.</div></div><div id="sec4_3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(2-(pyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>5</b>)</h4><div class="NLM_p">A general method for the preparation of compounds <b>5</b>â<b>10</b> using the appropriate amines and arylsulfonyl chlorides is illustrated by the preparation of <b>5</b>.</div><div id="sec4_3_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Step A</h5><div class="NLM_p last">To a stirred solution of 3-nitrophthalic anhydride (2.0 g, 10.36 mmol) in acetic acid (28 mL) was added 3-aminopyridine(0.37 g, 3.88 mmol), and the reaction mixture heated to a reflux for 18 h. The reaction was cooled to room temperature, and the acetic acid was removed under reduced pressure to obtain a crude product. This material was suspended in ethanol (5 mL), cooled, and filtered to leave crude 4-nitro-2-(pyridin-3-yl)isoindoline-1,3-dione as a white solid (2.5 g). MS (M + 1): 270.1. This was used without further purification in the next step.</div></div><div id="sec4_3_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Step B</h5><div class="NLM_p last">To a solution of crude 4-nitro-2-(pyridin-3-yl)isoindoline-1,3-dione (2.0 g) in methanol (100 mL) under nitrogen atmosphere was added 10% Pd/C (0.1 g). The reaction mixture was purged with hydrogen and stirred under hydrogen balloon pressure for 18 h at room temperature, whereupon the reaction mixture was filtered through a Celite bed under a nitrogen atmosphere, and the solvent evaporated under reduced pressure to afford crude compound, 4-amino-2-(pyridin-3-yl) isoindoline-1,3-dione, as a yellow solid (0.8 g). MS (M + 1): 240.1. The crude material was carried forward to next step without purification.</div></div><div id="sec4_3_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Step C</h5><div class="NLM_p last">A mixture of crude 4-amino-2-(pyridin-3-yl) isoindoline-1, 3-dione (100 mg) and pyridine (2 mL) was cooled to 0 Â°C. <i>tert</i>-Butylbenzenesulfonyl chloride (274 mg, 1.18 mmol) was added, and the mixture stirred for 24 h at room temperature. The reaction mixture was concentrated, and to the residue obtained was added a saturated solution of ammonium chloride and extracted with dichloromethane. The organic layer was washed with brine solution and dried over anhydrous sodium sulfate. This was filtered, and the organic solvent was evaporated under reduced pressure to obtain crude compound. The crude material was purified using preparative TLC with 100% ethyl acetate as mobile phase to leave 4-(<i>tert</i>-butyl)-<i>N</i>-(2-(pyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide as a light-yellow solid (<b>5</b>; 30 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 11.28 (bs, 1H), 8.59â8.56 (m, 2H), 7.83 (d, <i>J</i> = 8.0 Hz, 2H), 7.76 (d, <i>J</i> = 8.0 Hz, 2H), 7.54â7.58 (m, 4H), 7.43 (bs, 1H), 1.24 (s, 9H). MS (M â 1): 434.2. (LCMS purity 98.14%, Rt = 6.12 min (1)).</div></div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-(Trifluoromethyl)-<i>N</i>-(2-(pyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>6</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 8.74 (s, 1H), 8.63 (d, <i>J</i> = 4.4 Hz, 1H), 8.15 (s, 1H), 8.07 (d, <i>J</i> = 8.0 Hz, 1H), 7.87 (t, <i>J</i> = 8.0 Hz, 2H), 7.80 (d, <i>J</i> = 8.4 Hz, 1H), 7.68 (t, <i>J</i> = 7.2 Hz, 2H), 7.53 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (q, <i>J</i> = 4.8 Hz, 1H). MS (M + 1): 448.1 (LCMS purity 99.99%, Rt = 2.32 min (3)).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-(Trifluoromethoxy)-<i>N</i>-(2-(pyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>7</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 11.42 (s, 1H), 8.59 (m, 2H), 8.0 (d, <i>J</i> = 8.8 Hz, 2H), 7.88 (d, <i>J</i> = 8.4 Hz, 1H), 7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.60 (d, <i>J</i> = 7.2 Hz, 3H), 7.54 (m, 2H). MS (M + 1): 464.1 (LCMS purity 99.99%, Rt = 2.37 min (3)).</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-(Trifluoromethyl)-4-chloro-<i>N</i>-(2-(pyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>8</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.62 (bs, 1H), 8.64â8.60 (m, 2H), 8.42â8.42 (m, 1H), 8.37â8.34 (m, 1H), 7.86â7.78 (m, 3H), 7.76â7.73 (m, 1H), 7.65â7.63 (m, 1H), 7.61â7.58 (m, 1H). MS (M + 1): 482.0 (LCMS purity 98.48%, Rt = 2.46 min (3)).</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-(Trifluoromethyl)-4-fluoro-<i>N</i>-(2-(pyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>9</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 11.47 (bs, 1H), 8.60 (s, 1H), 8.59 (d, <i>J</i> = 4.4 Hz, 1H), 8.22 (s, 1H), 8.11 (d, <i>J</i> = 7.6 Hz, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.89 (d, <i>J</i> = 7.6 Hz, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 1H), 7.56 (m, 3H). MS (M + 1): 466.1 (LCMS purity 96.15%, Rt = 5.52 min (1)).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(2-(pyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>10</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.82 (bs, 1H), 8.58 (s, 1H), 8.51 (d, <i>J</i> = 4.0 Hz, 1H), 7.89 (d, <i>J</i> = 8.8 Hz, 2H), 7.71â7.78 (m, 2H), 7.59 (d, <i>J</i> = 8.4 Hz, 3H), 7.54 (d, <i>J</i> = 7.2 Hz, 1H), 7.39â7.42 (m, 1H), 4.76 (s, 2H), 1.24 (s, 9H). MS (M + 1): 450.2. (LCMS Purity 98.25%, Rt = 2.56 min (3)).</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(pyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>11</b>)</h4><div class="NLM_p">4-Chloro-7-nitro-2-(pyridin-3-yl)isoindoline-1,3-dione was prepared from compound <b>4</b> and 3-aminopyridine as described in <a class="ref internalNav" href="#sec4_3_2_2" aria-label="Step A">Step A</a>. To a solution of this material (4.5 g, 14.8 mmol) in ethanol (100 mL) under nitrogen atmosphere was added Raney nickel. The reaction mixture was purged with hydrogen and stirred under hydrogen balloon pressure for 6 h at room temperature. The reaction mass was filtered through a Celite bed under a nitrogen atmosphere, and the solvent evaporated under reduced pressure to afford compound 4-amino-7-chloro-2-(pyridin-3-yl)isoindoline-1,3-dione as a yellow solid (1.3 g, 32%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 8.65 (s, 1H), 8.61â8.59 (d, <i>J</i> = 4.8 Hz, 1H), 7.90â7.87 (d, <i>J</i> = 4.8 Hz, 1H), 7.59â7.56 (m, 1H), 7.50â7.48 (m, 1H), 7.08â7.04 (m, 1H), 6.74â6.60 (m, 2H). MS (M + 1): 274.0.</div><div class="NLM_p last">A mixture of the intermediate amino compound (300 mg, 1.09 mmol) and pyridine (3 mL) was cooled to 0 Â°C and <i>tert</i>-butylbenzenesulfonyl chloride (1.01 g, 4.1 mmol) was added together with a catalytic quantity of DMAP. The reaction mixture was stirred for 24 h at 125 Â°C. The reaction mixture was concentrated, and to the resultant residue water was added and extracted with dichloromethane. The organic layer was washed with brine solution, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and the organic solvent was evaporated under reduced pressure to obtain the crude compound. This was purified by preparative HPLC to afford the title compound as a light yellow solid (170 mg, 33%) <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.0 (bs, 1H), 8.60 (m, 2H), 7.86â7.83 (m, 3H), 7.66â7.64 (m, 2H), 7.59â7.56 (m, 3H), 1.27 (s, 9H). MS (M + 1): 470.2 (LCMS Purity 97.52%, Rt = 6.17 min (1)).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-(4-(4-(<i>tert</i>-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)pyridine 1-Oxide (<b>12</b>)</h4><div class="NLM_p">To a stirred solution of compound <b>11</b> (0.16 g, 0.34 mmol) in dichloromethane (5 mL) was added metachloroperoxybenzoic acid (0.059 g, 0.34 mmol). The reaction was stirred at room temperature for 8 h, whereupon the solvent was concentrated under reduced pressure, and the residue diluted with water. The aqueous layer was extracted with dichloromethane. The combined organic layers were washed sequentially with sodium bicarbonate and brine, then dried over anhydrous sodium sulfate, filtered, and concentrated under vacuum to leave the crude compound which was triturated with hexane ether (1:1) mixture followed by prep TLC purification using 5% methanol in dichloromethane to afford the title compound (60 mg, 36%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.06 (bs, 1H), 8.33â8.31 (m, 2H), 7.94â7.92 (m, 2H), 7.83â7.81 (m, 1H), 7.69â7.57 (m, 4H), 7.45â7.43 (d, <i>J = </i> 8.0 Hz, 1H), 1.27 (s, 9H). MS (M + 1): 486.1. (LCMS purity 96.97%, Rt = 5.34 min (1)).</div><div class="NLM_p last">The same general method used to synthesize compound <b>12</b> was used to prepare all the pyridine 1-oxides (compounds <b>14</b>, <b>24</b>, <b>26</b>, <b>56</b>, <b>58</b>, <b>65</b>, and <b>70</b>) described below, from their equivalent pyridines.</div></div><div id="sec4_3_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(pyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>13</b>)</h4><div class="NLM_p">Other compounds where R<sub>3</sub> is chloro or CN were all prepared using the general condition <a class="ref internalNav" href="#sec4_3_2_2" aria-label="Step A">Step A</a> above by reacting compound <b>4</b> with the appropriate amines and the following procedures: <a class="ref internalNav" href="#sec4_3_9_2" aria-label="Step D">Step D</a> instead of <a class="ref internalNav" href="#sec4_3_2_3" aria-label="Step B">Step B</a> and <a class="ref internalNav" href="#sec4_3_9_3" aria-label="Step E">Step E</a> instead of <a class="ref internalNav" href="#sec4_3_2_4" aria-label="Step C">Step C</a>. This is illustrated by the synthesis of <b>13</b>. The resulting pyridine compounds were further modified as required.</div><div id="sec4_3_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> General Synthesis Step D</h5><div class="NLM_p last">4-Chloro-7-nitro-2-(pyridin-3-ylmethyl)isoindoline-1,3-dione was prepared from compound <b>4</b> and 3-aminomethylpyridine as described in <a class="ref internalNav" href="#sec4_3_2_1" aria-label="Step A">Step A</a>. To a solution of this material (120 g, 0.378 mol) in acetic acid (1.9 L) cooled to 10 Â°C was added iron powder (120 g, 2.14 mol) portion wise over 3 h. The reaction mixture was stirred for 6 h at room temperature and then filtered through a Celite bed. The filtrate was neutralized with sodium bicarbonate solution, and the resulting aqueous layer was extracted with ethyl acetate. The organic solvent was dried, filtered, and evaporated under reduced pressure to obtain the crude compound. This material was further purified by trituration using acetonitrile and ethyl acetate to afford 4-amino-7-chloro-2-(pyridin-3-ylmethyl)isoindoline-1,3-dione as a brown solid (70 g, 64% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 8.55 (s, 1H), 8.48 (m, 1H), 7.70â7.68 (d, <i>J</i> = 7.6 Hz, 1H), 7.41â7.39 (d, <i>J</i> = 8.8 Hz, 1H), 7.35 (m, 1H), 7.0â6.98 (d, <i>J</i> = 8.8 Hz, 1H), 6.63 (bs, 2H), 4.72 (s, 2H). MS (M + 1): 288.1 (LCMS purity 95.99%).</div></div><div id="sec4_3_9_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> General Synthesis Step E</h5><div class="NLM_p last">A mixture of 4-amino-7-chloro-2-(pyridin-3-ylmethyl)isoindoline-1,3-dione (70 g, 0.243 mol) in pyridine (1.22 L) was cooled to 0 Â°C, and 4-(<i>tert</i>-butyl) benzenesulfonyl chloride (169 g, 0.731 mol) was added. The reaction mixture was stirred at 80 Â°C for 12 h, whereupon it was cooled and concentrated under reduced pressure. The reaction mixture was diluted with water, and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with brine solution, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure. To this residual material was added 1 M TBAF in THF solution (1.1 L), and the resulting solution was stirred for 4 h at room temperature. The reaction mixture was concentrated and diluted with ethyl acetate, and the organic layer was washed successively with saturated ammonium chloride and water, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude compound was purified by column chromatography using 25% ethyl acetate in hexane to afford 4-(<i>tert</i>-butyl)-<i>N</i>-(7-chloro-2-(pyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>13</b>; 52 g, 45%), as an off white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.92 (bs, 1H), 8.57 (s, 1H), 8.50 (s, 1H),7.92â7.90 (d, <i>J</i> = 8 Hz, 2H), 7.75â7.73 (d, <i>J</i> = 9.2 Hz, 2H), 7.62â7.58 (m, 3H), 7.38â7.35 (m, 1H), 4.74 (s, 2H), 1.26 (s, 9H). MS (M + 1): 484.1. (LCMS purity 97.90%, Rt = 6.38 min(1)).</div></div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-((4-(4-(<i>tert</i>-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)methyl)-pyridine 1-Oxide (<b>14</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.93 (bs, 1H), 8.26 (s, 1H), 8.14â8.12 (d, <i>J</i> = 6 Hz, 1H), 7.93â7.91 (d, <i>J</i> = 8 Hz, 2H),7.75â7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.63â7.58 (m, 3H), 7.38â7.34 (t, <i>J</i> = 6.8 Hz, 1H), 7.29â7.27(d, <i>J</i> = 9.2 Hz, 1H), 4.69 (s, 2H), 1.26 (s, 9H). MS (M + 1): 500.1. (LCMS purity 98.73%, Rt = 5.47 min(1)).</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-(pyridin-3-yl)ethyl)-1,3-dioxoisoindolin-4-yl)benzene- sulfonamide (<b>15</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.91 (bs, 1H), 8.41â8.37 (m, 2H), 7.89â7.86 (d, <i>J</i> = 8.4 Hz, 2H), 7.73â7.71 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.58 (m, 4H), 7.30â7.29 (d, <i>J</i> = 5.2 Hz, 1H), 3.77â3.74 (t, <i>J</i> = 6.4 Hz, 2H), 2.90â2.87 (t, <i>J</i> = 6.4 Hz, 2H), 1.26 (s, 9H). MS (M + 1): 498.4. (LCMS purity 99.62%, Rt = 6.22 min (1)).</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-cyano-1,3-dioxo-2-(pyridin-3-ylmethyl)isoindolin-4-yl)benzenesulfonamide (<b>16</b>)</h4><div class="NLM_p">To a stirred solution of compound <b>13</b> (0.15 g, 0.31 mmol) in dimethylacetamide (4 mL) was added zinc II cyanide (0.073 g, 62 mmol) under nitrogen followed by addition of 1,1â²-bis (diphenylphosphino)ferrocene (0.034 g, 0.062 mmol) and Pd<sub>2</sub>(dba)<sub>3</sub> (0.43 g, 0.046 mmol). To the reaction mixture was added zinc dust (0.005 g), and the reaction mixture was purged under nitrogen for 30 min. The reaction was heated at 120 Â°C for 2 h in microwave. The reaction mixture was cooled, filtered, and concentrated under reduced pressure. The crude residue was purified by column chromatography using 4% methanol in dichloromethane to afford the title compound (0.02g, 13.6% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 8.70 (s, 1H), 8.61â8.60 (d, <i>J</i> = 4.4 Hz, 1H), 8.11â8.09 (d, <i>J</i> = 8.8 Hz, 1H), 8.03â7.99 (m, 3H), 7.70â7.64 (m, 3H), 7.58â7.55 (m, 1H), 4.84 (s, 2H), 1.27 (s, 9H). MS (M + 1): 475.5. (LCMS purity 99.77%, Rt = 5.15 min) (1).</div><div class="NLM_p last">Compounds <b>17</b>and <b>18</b> were prepared utilizing the general method illustrated by the synthesis of compound <b>5</b>, using 3-methyl-6-nitrophthalic anhydride, the appropriate amines and <i>tert</i>-butylbenzenesulfonyl chloride.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-methyl-2-(pyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>17</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.76 (bs, 1H), 8.63â8.59 (m, 2H), 7.89â8.83 (m, 3H), 7.63â7.57 (m, 5H), 2.55 (s, 3 H), 1.26 (s, 9 H). MS (M + 1): 450.2. (LCMS purity 99.71%, Rt = 4.26 min (1)).</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-methyl-2-(pyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>18</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.72 (bs, 1H), 8.53.-8.48 (m, 2H), 7.87â7.85 (d, <i>J</i> = 8 Hz, 2H), 7.70â7.68 (d, <i>J</i> = 7.6 Hz, 1H), 7.59â7.57 (d, <i>J</i> = 8 Hz, 2H), 7.52â7.51(m, 2H), 7.35 (m, 1H), 4.72 (s, 2H), 3.32 (s, 3H), 1.25 (s, 9H). MS (M + 1): 464.2. (LCMS purity 98.68%, Rt = 6.62 min (1)).</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-methoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>19</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.03 (bs, 1H), 8.39â8.38 (d, <i>J</i> = 2.4 Hz, 1H), 8.22â8.21 (d, <i>J</i> = 1.6 Hz, 1H), 7.94â7.92 (d, <i>J</i> = 8.4 Hz, 2H), 7.84â7.82 (d, <i>J</i> = 9.2 Hz, 1H), 7.69â7.63 (m, 3H), 7.50â7.48 (m, 1H), 3.85 (s, 3H), 1.25 (s, 9H). MS (M â 1): 498.2. (LCMS purity 98.37%, Rt = 6.20 min (1)).</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-ethoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>20</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.02 (bs, 1H), 8.36 (s, 1H), 8.19 (s, 1H), 7.93â7.91 (m, 2H), 7.84â7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.69â7.63 (m, 3H), 7.46 (s, 1H), 4.15â4.10 (q, <i>J</i> = 6.8 Hz, 2H), 1.38â1.34 (t, <i>J</i> = 6.8 Hz, 3H), 1.27 (s, 9H). MS (M + 1): 514.5. (LCMS purity 98.16%, Rt = 6.28 min (1)).</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-methylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>21</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.97 (bs, 1H), 8.49 (s, 1H), 8.40 (s, 1H), 7.93â7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.84â7.82 (d, <i>J</i> = 9.2 Hz, 1H), 7.69â7.63 (m, 4H), 2.37 (s, 3H), 1.27 (s, 9H). MS (M + 1): 484.2. (LCMS purity 96.68%, Rt = 6.22 min (1)).</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-cyanopyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>22</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.09 (bs, 1H), 9.12â9.11 (d, <i>J</i> = 1.6 Hz, 1H), 8.93â8.92 (d, <i>J</i> = 2 Hz, 1H), 8.38â8.09 (m, 1H), 7.94â7.92 (d, <i>J</i> = 8.8 Hz, 2H), 7.88â7.86 (d, <i>J</i> = 8.8 Hz, 1H), 7.71â7.69 (d, <i>J</i> = 8.8 Hz, 1H), 7.65â7.63 (d, <i>J</i> = 8.8 Hz, 2H), 1.27 (s, 9H). MS (M + 1): 495.1. (LCMS purity 99.87%, Rt = 5.98 min (1)).</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-methylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>23</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.00 (bs, 1H), 8.57â8.56 (d, <i>J</i> = 3.6 Hz, 1H),7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.83â7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.78â7.76 (d, <i>J</i> = 7.2 Hz, 1H), 7.70â7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.61 (d, <i>J</i> = 8.4 Hz, 2H), 7.43â7.39 (m, 1H), 2.31 (s, 3H), 1.27 (s, 9H). MS (M + 1): 484.0. (LCMS purity 99.02%, Rt = 6.06 min (1)).</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(4-(4-(<i>tert</i>-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)-2-methyl-pyridine 1-Oxide (<b>24</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.04 (bs, 1H), 8.45â8.43 (d, <i>J</i> = 5.6 Hz, 1H), 7.93â7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.85â7.83 (d, <i>J</i> = 8.8 Hz, 1H), 7.69â7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.8 Hz, 2H),7.47â7.40 (m, 2H), 2.20 (s, 3H), 1.27 (s, 9 H). MS (M + 1): 500.3. (LCMS purity 99.45%, Rt = 5.40 min (1)).</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-methoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>25</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO- d6): Î´ 10.09 (bs, 1H), 8.33â8.31 (m, 1H), 7.94â7.92 (d, <i>J</i> = 8.4 Hz, 2H), 7.82â7.80 (m, 2H), 7.67â7.63 (m, 3H), 7.21â7.18 (m, 1H), 3.84 (s, 3H), 1.28 (s, 9H). MS (M + 1): 500.3. (LCMS purity 99.56%, Rt = 6.40 min (1)).</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-(4-(4-(<i>tert</i>-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)-2-methoxy-pyridine 1-Oxide (<b>26</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.14 (bs, 1H), 8.42â8.41 (d, <i>J</i> = 6.4 Hz, 1H), 7.93â7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.85â7.84 (d, <i>J</i> = 7.2 Hz, 1H), 7.69â7.62 (m, 3H), 7.47â7.45 (d, <i>J</i> = 8 Hz, 1H), 7.37 (m, 1H), 3.98 (s, 3H), 1.27 (s, 9H). MS (M + 1): 516.3. (LCMS purity 98.38%, Rt = 5.36 min (1)).</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-fluoropyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>27</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.10 (bs, 1H), 8.39â8.38 (d, <i>J</i> = 2.8 Hz, 1H), 8.12â8.10 (m, 1H), 7.91â7.89 (d, <i>J</i> = 8.4 Hz, 2H), 7.87â7.84 (d, <i>J</i> = 9.2 Hz, 1H),7.72â7.69 (m, 1H), 7.63â7.58 (m, 3H), 1.27 (s, 9H). MS (M â 1): 486.0. (LCMS purity 99.36%, Rt = 6.20 min (1)).</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(6-methylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>28</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´9.97 (bs, 1H), 8.46â8.45 (d, <i>J</i> = 2 Hz, 1H), 7.93â7.91 (d, <i>J</i> = 8.4 Hz, 2H),7.82â7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.72â7.62 (m, 4H), 7.44â7.42 (d, <i>J</i> = 8 Hz, 1H), 2.53 (s, 3H), 1.27 (s, 9H). MS (M + 1): 484.1. (LCMS purity 98.42%, Rt = 6.21 min (1)).</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(6-methoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>29</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.97 (bs, 1H), 8.19â8.18 (s, 1H), 7.94â7.92 (d, <i>J</i> = 8.8 Hz, 2H), 7.82â7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.75â7.72 (dd, <i>J</i> = 2.8, 2.4 Hz, 1H), 7.68â7.63 (m, 3H), 7.0â6.98 (d, <i>J</i> = 8.8 Hz, 1H), 3.90 (s, 3H), 1.27 (s, 9H). MS (M + 1): 500.4. (LCMS purity 99.12%, Rt = 6.50 min(1)).</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(6-fluoropyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>30</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.03 (bs, 1H), 8.29 (s, 1H), 8.07â8.04 (m, 1H), 7.94â7.92 (d, <i>J</i> = 8.8 Hz, 2H),7.84â7.82 (d, <i>J</i> = 8.4 Hz, 1H), 7.69â7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.65â7.63 (d, <i>J</i> = 8 Hz, 2H), 7.43â7.40 (m, 1 H), 2H), 1.27 (s, 9H). MS (M + 1): 488.0. (LCMS purity 98.06%, Rt = 6.30 min(1)).</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-methylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>31</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.02 (bs, 1H), 8.53â8.52 (d, <i>J</i> = 5.2 Hz, 1H), 8.47 (s, 1H), 7.92â7.90 (d, <i>J</i> = 8.8 Hz, 2H), 7.85â7.83 (d, <i>J</i> = 8.8 Hz, 1H), 7.70â7.68 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.8 Hz, 2H),7.47â7.46 (d, <i>J</i> = 5.6 Hz, 1H), 2.16 (s, 3H), 1.27 (s, 9H). MS (M + 1): 484.1. (LCMS purity 99.08%, Rt = 6.13 min(1)).</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-methoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>32</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.09 (bs, 1H), 8.59â8.57 (d, <i>J</i> = 6 Hz, 1H), 8.39 (s, 1H), 7.93â7.91 (m, 2H), 7.85â7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.67â7.62 (m, 3H). 7.31â7.30 (d, <i>J</i> = 5.6 Hz, 1H), 3.84 (s, 3H), 1.28 (s, 9H). MS (M + 1): 500.4. (LCMS purity 99.04%, Rt = 5.91 min(1)).</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-ethoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>33</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.09 (bs, 1H), 8.55â8.54 (d, <i>J</i> = 5.6 Hz, 1H), 8.38 (s, 1H), 7.93â7.91 (d, <i>J</i> = 8.8 Hz, 2H), 7.85â7.83 (d, <i>J</i> = 8.8 Hz, 1H), 7.69â7.67 (d, <i>J</i> = 9.2 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.8 Hz, 2H), 7.30â7.28 (d, <i>J</i> = 6.0 Hz, 1H), 4.19â4.14 (q, <i>J</i> = 6.8 Hz, 2H), 1.27 (s, 9H), 1.22â1.18 (t, <i>J</i> = 6.8 Hz, 3H). MS (M + 1): 514.3. (LCMS purity 99.57%, Rt = 6.15 min(1)).</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2,5-dimethylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>34</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.99 (bs, 1H), 8.41 (s, 1H), 7.91â7.89 (d, <i>J</i> = 8.4 Hz, 2H), 7.84â7.82 (d, <i>J</i> = 8.9 Hz, 1H), 7.69â7.67 (d, <i>J</i> = 8.9 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.5 Hz, 2H), 7.58 (s, 1H), 2.30 (s, 3H), 2.25 (s, 3H), 1.27 (s, 9H). MS (M + 1): 498.4. (LCMS purity 98.84%, Rt = 6.31 min(1)).</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-cyano-5-methylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>35</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.20 (bs, 1H), 8.75 (s, 1H), 7.99 (s, 1H), 7.93â7.88 (m, 3H), 7.72â7.70 (d, <i>J</i> = 8.9 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.5 Hz, 2H), 2.43 (s, 3H), 1.27 (s, 9H). MS (M + 1): 509.3. (LCMS purity 95.40%, Rt = 6.17 min(1)).</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-methoxy-5-methylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>36</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.04 (bs, 1H), 8.14 (s, 1H), 7.93â7.91 (d, <i>J</i> = 8.5 Hz, 2H), 7.84â7.26 (d, <i>J</i> = 8.8 Hz, 1H), 7.67â7.62 (m, 4H), 3.80 (s, 3H), 2.27 (s, 3H), 1.28 (s, 9H). MS (M + 1): 514.4. (LCMS purity 98.58%, Rt = 6.65 min(1)).</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-methyl-6-methoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>37</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (bs, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.83â7.81 (d, <i>J</i> = 8.4 Hz, 1H), 7.68â7.57 (m, 4H), 6.80â6.78 (d, <i>J</i> = 8.4 Hz, 1H), 3.88 (s, 3H), 2.20 (s, 3H), 1.27 (s, 9H).). MS (M + 1): 514.3. (LCMS purity 97.64%, Rt = 6.64 min(1)).</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2,6-dimethoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>38</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.04 (bs, 1H), 7.94â7.92 (d, <i>J</i> = 8.4 Hz, 2H), 7.83â7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.68â7.62 (m, 4H), 6.55â6.53 (d, <i>J</i> = 8.4 Hz, 1H), 3.92 (s, 3H), 3.84 (s, 3H), 1.28 (s, 9H). MS (M + 1): 530.1. (LCMS purity 97.32%, Rt = 6.74 min(1)).</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2,6-dimethylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>39</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.99 (bs, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.83â7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.69â7.66 (d, <i>J</i> = 9.2 Hz, 1H), 7.64â7.62 (m, 3H),7.26â7.24 (d, <i>J</i> = 8 Hz, 1H), 2.48 (s, 3H), 2.24 (s, 3H), 1.27 (s, 9H). MS (M + 1): 498.1. (LCMS purity 99.02%, Rt = 6.22 min(1)).</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-methoxy-4-methylpyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>40</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.12 (bs, 1H), 8.18â8.16 (d, <i>J</i> = 5.2 Hz, 1H), 7.92â7.89 (d, <i>J</i> = 8.4 Hz, 2H), 7.87â7.85 (d, <i>J</i> = 8.4 Hz, 1H), 7.69â7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.63â7.61 (d, <i>J</i> = 8.4 Hz, 2H), 7.08â7.07 (d, <i>J</i> = 5.2 Hz, 1H), 3.78 (s, 3H), 2.12 (s, 3 H), 1.27 (s, 9H). MS (M + 1): 514.3. (LCMS purity 98.28%, Rt = 6.52 min(1)).</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-methyl-5-methoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>41</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.01 (bs, 1H),8.38 (s, 1H), 8.16 (s, 1H),7.91â7.89 (d, <i>J</i> = 8.4 Hz, 2H), 7.83â7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.69â7.58 (m, 3H), 3.97 (s, 3H),1.97 (s, 3H), 1.27 (s, 9H). MS (M + 1): 514.3. (LCMS purity 97.43%, Rt = 6.21 min(1)).</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-ethyl-5-methoxypyridin-3-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>42</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.04 (bs, 1H), 8.42 (s, 1H), 8.16 (s, 1H), 7.93â7.91 (d, <i>J</i> = 8.5, 2H), 7.85â7.83 (d, <i>J</i> = 8.9 Hz 1H), 7.69â7.67 (d, <i>J</i> = 8.9 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.9 Hz, 2H), 3.98 (s, 3H), 2.43â2.41 (q, <i>J</i> = 8.8 Hz, 2H), 1.27 (s, 9H), 0.97â0.93 (t, <i>J</i> = 7.2 Hz, 3H). MS (M + 1): 528.4. (LCMS purity 97.26%, Rt = 6.46 min(1)).</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(pyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>43</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (bs, 1H), 8.64â8.63 (d, <i>J</i> = 4.4 Hz, 1H), 8.06â8.02 (m, 1H), 7.93â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.84â7.82 (d, <i>J</i> = 9.2 Hz, 1H), 7.69â7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.4 Hz, 2H), 7.55â7.49 (m, 2H), 1.27 (s, 9H). MS (M + 1): 470.0. (LCMS purity 97.71%, Rt = 6.12 min(1)).</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(3-methoxypyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>44</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.10 (bs, 1H), 8.20â8.19 (d, <i>J</i> = 4 Hz, 1H), 7.91â7.84 (m, 3H), 7.76â7.74 (d, <i>J</i> = 8 Hz, 1H), 7.68â7.66 (d, <i>J</i> = 8.4 Hz, 1H), 7.64â7.59 (m, 3H), 3.80 (s, 3H), 1.27 (s, 9H). MS (M + 1): 500.1. (LCMS purity 98.26%, Rt = 6.27 min(1)).</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-methylpyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>45</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.97 (bs, 1H), 8.48â8.47 (d, <i>J</i> = 4.8 Hz, 1H), 7.91â7.89 (d, <i>J</i> = 8.4 Hz, 2H), 7.84â7.82 (d, <i>J</i> = 8.4 Hz, 1H), 7.69â7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.4 Hz, 2H), 7.38â7.36 (d, <i>J</i> = 4.8 Hz, 1H), 7.32 (s, 1H), 2.40 (s, 3H), 1.27 (s, 9H). MS (M + 1): 484.1. (LCMS purity 97.84%, Rt = 6.29 min(1)).</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-cyanopyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>46</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.07 (bs, 1H), 8.93â8.91 (d, <i>J</i> = 4.8 Hz, 1H), 8.04â8.03 (d, <i>J</i> = 4.8 Hz, 1H), 7.95â7.90 (m, 3H), 7.87â7.85 (d, <i>J</i> = 8.8 Hz, 1H), 7.70â7.68 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.4 Hz, 2H), 1.27 (s, 9H). MS (M + 1): 495.1. (LCMS purity 96.34%, Rt = 6.17 min(1)).</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-methylpyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>47</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.97 (bs, 1H), 8.46 (s, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.86â7.81 (m, 2H), 7.68â7.66 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.4 Hz, 2H), 7.39â7.36 (d, <i>J</i> = 8 Hz, 1H), 2.38 (s, 3H), 1.27 (s, 9H). MS (M + 1): 484.1. (LCMS purity 99.58%, Rt = 6.32 min(1)).</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(6-methylpyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>48</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (bs, 1H), 7.93â7.91 (m, 3H), 7.83â7.81 (d, <i>J</i> = 8.4 Hz, 1H), 7.68â7.66 (d, <i>J</i> = 8.4 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.4 Hz, 2H), 7.40â7.39 (d, <i>J</i> = 7.2 Hz, 1H), 7.30â7.28 (d, <i>J</i> = 7.2 Hz, 1H), 2.45 (s, 3H), 1.27 (s, 9H). MS (M + 1): 484.1. (LCMS purity 99.87%, Rt = 6.32 min(1)).</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(6-cyanopyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>49</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.07 (bs, 1H), 8.35â8.31 (m, 1H), 8.20â8.18 (d, <i>J</i> = 7.2 Hz, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.86â7.84 (d, 8.4 Hz, 2H), 7.70â7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.8 Hz, 2H), 1.27 (s, 9H). MS (M + 1): 495.1. (LCMS purity 99.47%, Rt = 6.24 min(1)).</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-fluoropyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>50</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (bs, 1H), 8.66 (m, 1H), 8.01â7.74 (m, 4H), 7.69â7.53 (m, 4H), 1.27 (s, 9H). MS (M + 1): 488.0. (LCMS purity 98.21%, Rt = 6.27 min(1)).</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-fluoropyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>51</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.05 (bs, 1H), 8.71â8.67 (m, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.86â7.84 (d, <i>J</i> = 8.8 Hz, 1H), 7.70â7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.62 (d, <i>J</i> = 8.4 Hz, 2H), 7.54â7.51 (m, 1H), 7.48â7.45 (m, 1H), 1.27 (s, 9H). MS (M + 1): 488.3. (LCMS purity 99.27%, Rt = 6.18 min(1)).</div></div><div id="sec4_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-methoxy-6-methylpyridin-2-yl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>52</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.94 (bs, 1H), 9.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.82â7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.68â7.62 (m, 3H), 7.56â7.54 (s, 1H), 7.32â7.29 (d, <i>J</i> = 8.6 Hz, 1H), 3.89 (s, 3H), 2.36 (s, 3H), 1.27 (s, 9H). MS (M + 1): 514.4. (LCMS purity 97.80%, Rt = 6.49 min(1)).</div></div><div id="sec4_3_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(pyridin-4-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>53</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.03 (bs, 1H), 8.74â8.73 (d, <i>J</i> = 4.8 Hz, 2H), 7.94â7.92 (d, <i>J</i> = 8.4 Hz, 2H), 7.84â7.82 (d, <i>J</i> = 9.2, 1H), 7.69â7.63 (m,3H),7.50â7.49 (d, <i>J</i> = 5.2, 2H), 1.27 (s, 9H). MS (M + 1): 470.3. (LCMS purity 99.76%, Rt = 6.01 min(1)).</div></div><div id="sec4_3_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(3-methylpyridin-4-yl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>54</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.03 (bs, 1H), 8.64 (s, 1H), 8.56â8.55 (d, <i>J</i> = 5.2 Hz, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H),7.85â7.82 (d, <i>J</i> = 9.2 Hz, 1H), 7.70â7.67 (d, <i>J</i> = 8.8 Hz, 1H),7.64â7.62 (d, <i>J</i> = 8.4 Hz, 2H),7.39â7.37 (d, <i>J</i> = 5.2 Hz, 1H), 2.14 (s, 3H), 1.27 (s, 9H). MS (M + 1): 484.3. (LCMS purity 99.45%, Rt = 6.03 min(1)).</div></div><div id="sec4_3_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(pyridin-2-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzene-sulfonamide (<b>55</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.00 (bs, 1H), 8.43â8.42 (d, <i>J</i> = 4 Hz, 1H), 7.93â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.79â7.75 (m, 2H), 7.63â7.61 (m, 3H), 7.42â7.40 (d, <i>J</i> = 8 Hz, 1H), 7.29â7.26 (m, 1H), 4.84 (s, 2H), 1.27 (s, 9H). MS (M + 1): 484.1. (LCMS purity 99.45%, Rt = 6.36 min(1)).</div></div><div id="sec4_3_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-((4-(4-(<i>tert</i>-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)methyl)-pyridine 1-Oxide (<b>56</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.97 (bs, 1H), 8.34â8.32 (d, <i>J</i> = 6.4 Hz, 1H), 7.95â7.93 (d, <i>J</i> = 8.4 Hz, 2H), 7.78â7.76 (d, <i>J</i> = 8.8 Hz, 1H), 7.64â7.61 (m, 3H), 7.51â7.49 (d, <i>J</i> = 7.2 Hz, 1H),7.42â7.39 (m, 1H), 7.31â7.28 (m, 1H), 4.77 (s, 2H), 1.27 (s, 9H). MS (M + 1): 500.0. (LCMS purity 99.22%, Rt = 5.51 min (1)).</div></div><div id="sec4_3_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-methylpyridin-2-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>57</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (bs, 1H), 8.26 (s, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H),7.78â7.76 (d, <i>J</i> = 8.8 Hz, 1H), 7.62â7.60 (m, 3H), 7.59â7.57 (d, <i>J</i> = 8 Hz, 1H), 7.30â7.29 (d, <i>J</i> = 7.6 Hz, 1H),4.79 (s, 2H), 2.24 (s, 3H), 1.26 (s, 9H). MS (M + 1): 498.3. (LCMS purity 99.72%, Rt = 6.52 min(1)).</div></div><div id="sec4_3_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-((4-(4-(<i>tert</i>-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)methyl)-5-methylpyridine 1-Oxide (<b>58</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.97 (bs, 1H), 8.23 (s, 1H), 7.91â7.89 (d, <i>J</i> = 7.8 Hz, 2H), 7.70 (s, 1H), 7.61â7.59 (d, <i>J</i> = 7.6 Hz, 3H), 7.35â7.34 (d, <i>J</i> = 6.6 Hz, 1H), 7.15â7.13 (d, <i>J</i> = 7.7 Hz, 1H), 4.73 (s, 2H), 2.24 (s, 3H), 1.27 (s, 9H). MS (M + 1): 514.4 (LCMS purity 98.04%, Rt = 5.72 min (1)).</div></div><div id="sec4_3_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(3-fluoropyridin-2-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>59</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.07 (bs, 1H), 8.28â8.26 (d, <i>J</i> = 4.4 Hz, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.80â7.73 (m, 2H), 7.63â7.70 (m, 3H), 7.43â7.41 (m, 1H), 4.93 (s, 2H), 1.27 (s, 9H). MS (M + 1): 502.2. (LCMS purity 98.77%, Rt = 6.51 min(1)).</div></div><div id="sec4_3_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(6-methylpyridin-2-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>60</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.90 (bs, 1H), 7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.78â7.75 (d, <i>J</i> = 9.2 Hz, 1H), 7.63â7.57 (m, 4H), 7.14â7.13 (d, <i>J</i> = 6 Hz, 2H), 4.76 (s, 2H), 2.37 (s, 3H), 1.26 (s, 9H). MS (M + 1): 498.3. (LCMS purity 97.29%, Rt = 6.20 min(2)).</div></div><div id="sec4_3_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-cyanopyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>61</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.92 (bs, 1H), 8.94 (s, 1H), 8.88 (s, 1H), 8.30 (s, 1H), 7.94â7.92 (d, <i>J</i> = 8.2 Hz, 2H), 7.75â7.73 (d, <i>J</i> = 8.8 Hz, 1H), 7.63â7.59 (m, 3H), 4.82 (s, 2H), 1.26 (s, 9H). MS (M + 1): 509.1. (LCMS purity 99.14%, Rt = 6.92 min(1)).</div></div><div id="sec4_3_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-methylpyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>62</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.95 (bs, 1H), 8.36â8.36 (d, <i>J</i> = 1.6 Hz, 2H), 7.92â7.90 (d, <i>J</i> = 8.6 Hz, 2H), 7.74â7.72 (d, <i>J</i> = 8.9 Hz, 1H), 7.62â7.60 (m, 3H), 7.54 (s, 1H), 4.69 (s, 2H), 2.26 (s, 3H), 1.26 (s, 9H). MS (M + 1): 498.4. (LCMS purity 99.50%, Rt = 6.39 min(1)).</div></div><div id="sec4_3_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(5-methoxypyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>63</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.93 (bs, 1H), 8.40 (s, 1H), 8.34 (s, 1H), 7.93â7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.76â7.74 (d, <i>J</i> = 9.2 Hz, 1H), 7.70 (m, 1H), 7.63â7.61 (m, 3H), 4.81 (s, 2H), 3.88 (s, 3H), 1.26 (s, 9H). MS (M + 1): 514.1. (LCMS purity 99.02%, Rt = 6.30 min(1)).</div></div><div id="sec4_3_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(4-methylpyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>64</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (bs, 1H), 8.41 (s, 1H), 8.35â8.33 (d, <i>J</i> = 5.2 Hz, 1H), 7.91â7.89 (d, <i>J</i> = 8.4 Hz, 2H), 7.74â7.72 (d, <i>J</i> = 9.2 Hz, 1H), 7.62â7.58 (m, 3H), 7.22â7.21 (d, <i>J</i> = 4.8 Hz, 1H), 4.72 (s, 2H), 2.36 (s, 3H), 1.26 (s, 9H). MS (M + 1): 498.4. (LCMS purity 99.26%, Rt = 6.29 min(1)).</div></div><div id="sec4_3_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 3-((4-(4-(<i>tert</i>-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)methyl)-4-methylpyridine 1-Oxide (<b>65</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.93 (bs, 1H), 8.14 (s, 1H), 8.05â8.03 (d, <i>J</i> = 6.8 Hz, 1H), 7.93â7.91 (d, <i>J</i> = 8.8 Hz, 2H), 7.74â7.72 (d, <i>J</i> = 8.8 Hz, 1H), 7.63â7.58 (m, 3H), 7.25â7.23 (d, <i>J</i> = 6.8 Hz, 1H), 4.65 (s, 2H), 2.31 (s, 3H), 1.26 (s, 9H). MS (M + 1): 514.1 (LCMS purity 98.22%, Rt = 5.50 min (1)).</div></div><div id="sec4_3_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(6-methylpyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>66</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.94 (bs, 1H), 8.41 (s, 1H), 7.90â7.88 (d, <i>J</i> = 8.8 Hz, 2H), 7.73â7.71 (d, <i>J</i> = 8.8 Hz, 1H), 7.61â7.57 (m, 4H), 7.21â7.19 (d, <i>J</i> = 8 Hz, 1H),4.68 (s, 2H), 2.42 (s, 3H), 1.26 (s, 9H). MS (M + 1): 498.1. (LCMS purity 99.77%, Rt = 6.34 min(1)).</div></div><div id="sec4_3_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(6-methoxypyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>67</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´9.91 (bs, 1H), 8.13 (s, 1H), 7.90â7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.76â7.71 (m, 1H), 7.65â7.57 (m, 4H), 6.78â6.76 (d, <i>J</i> = 8.4 Hz, 1H), 4.64 (s, 2H), 3.81 (s, 3H), 1.25 (s, 9H). MS (M + 1): 514.1. (LCMS purity 99.34%, Rt = 4.76 min(2)).</div></div><div id="sec4_3_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-methoxypyridin-3-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>68</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.94 (bs, 1H), 8.09 (m, 1H),7.92â7.90 (d, <i>J</i> = 8.4 Hz, 2H),7.76â7.74 (d, <i>J</i> = 8.4 Hz, 1H), 7.63â7.60 (m, 3H), 7.56â7.55 (d, <i>J</i> = 6.4 Hz, 1H), 6.93â6.90 (m, 1H), 4.62 (s, 2H), 3.88 (s, 3H), 1.26 (s, 9H). MS (M + 1): 514.3. (LCMS purity 98.46%, Rt = 6.71 min(1)).</div></div><div id="sec4_3_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(pyridin-4-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>69</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (bs, 1H), 8.51â8.50 (d, <i>J</i> = 5.2 Hz, 2H), 7.93â7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.77â7.74 (d, <i>J</i> = 8.8 Hz, 1H), 7.63â7.59 (m, 3H), 7.33â7.32 (d, <i>J</i> = 5.2 Hz, 2H), 4.74 (s, 2 H), 1.27 (s, 9H). MS (M + 1): 484.1. (LCMS purity 95.90%, Rt = 6.16 min(1)).</div></div><div id="sec4_3_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 4-((4-(4-(<i>tert</i>-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)methyl)- pyridine 1-Oxide (<b>70</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.94 (bs, 1H), 8.16â8.14 (d, <i>J</i> = 6.8 Hz, 2H), 7.93â7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.76â7.74 (d, <i>J</i> = 8.8 Hz, 1H), 7.63â7.58 (m, 3H), 7.37â7.35 (d, <i>J</i> = 6.8 Hz, 2H), 4.68 (s, 2H), 1.26 (s, 9H). MS (M + 1): 500.0. (LCMS purity 95.09%, Rt = 5.35 min (1)).</div></div><div id="sec4_3_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 4-(<i>tert</i>-Butyl)-<i>N</i>-(7-chloro-2-(2-methoxypyridin-4-ylmethyl)-1,3-dioxoisoindolin-4-yl)benzenesulfonamide (<b>71</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.93 (bs, 1H), 8.10â8.08 (d, <i>J</i> = 5.2 Hz, 1H), 7.92â7.90 (m, 2H), 7.76â7.74 (d, <i>J</i> = 8.8 Hz, 1H), 7.62â7.59 (m, 3H), 6.92â6.90 (d, <i>J</i> = 5.2 Hz, 1H), 6.74 (s, 1H), 4.68 (s, 2H), 3.81 (s, 3H), 1.26 (s, 9H). MS (M + 1): 514.3. (LCMS purity 99.73%, Rt = 6.60 min(1)).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> FLIPRAssay Methodology</h3><div class="NLM_p last">MOLT-4 cells (100,000 cells/well) or CCR9A overexpressing cells (25,000 cells/well) were incubated in 50 Î¼L of assay buffer (1Ã HBSS, 20 mM HEPES) for MOLT4 cells and DMEM (Life Technologies, Grand Island, NY) plus 10% FBS media for CCR9A overexpression cells in Corning 96-well black clear bottom cell culture plates (Corning, Corning, NY) at 37 Â°C/5% CO<sub>2</sub> for an overnight period (CCR9A overexpressing cells) or for 2 h (MOLT4 cells). The plates were loaded with Fluo-4 NW calcium dye (Molecular Probes, Eugene, Oregon) and kept at 37 Â°C/5% CO<sub>2</sub> for 60 min and then at room temperature for 30 min. Cells were then incubated with test compound for 1 h, prior to stimulation with CCL25(Peprotech, Rocky Hill, NJ) at a typical EC80 concentration for CCR9A overexpression cells or a typical EC50 concentration for MOLT4 cells. The increase in intracellular calcium levels was measured with a FLIPR instrument (Molecular Devices, Sunny Vale, CA). The potency of the compounds as CCR9 antagonists was calculated as an IC<sub>50</sub> using GraphPad Prism software (variable slope four parameter) (GraphPad Software. Inc., LA Jolla, CA). The <i>K</i><sub>i</sub> of the test compounds were determined from the IC<sub>50</sub> values.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> MOLT-4 Chemotaxis Methodology</h3><div class="NLM_p">A functional chemotaxis assay studied the inhibition of CCL25-CCR9-mediated migration of MOLT-4 cells using the ChemoTx plate system (30 Î¼L lower well volume, 25 mm<sup>2</sup> filter area, 5 Î¼m pore size from Neuro Probe, Inc., Gaithersburg, MD, USA) and cells incubated in RPMI-1640 (Sigma, St. Louis, MO), 2 mM glutamine, 10% (v/v) fetal bovine serum (FBS), and 1% (v/v) Penstrep. Cells were seeded into the upper well at a density of 150,000 cells per well, pre-incubating with test compound for 30 min at 37 Â°C/5% CO<sub>2</sub>, followed by addition of 2 nM of CCL25 to the lower well and a further 2 h incubation at 37 Â°C/5% CO<sub>2</sub>. Cells migrating across the permeable membrane into the lower chamber were quantified using 5 Î¼L of 7Ã CyQUANT dye (Molecular Probes, Eugene, Oregon on an Envision 2103 multilabel reader (PerkinElmer, Waltham, MA). The potency of the test compounds as a CCR9 antagonists was calculated as an IC<sub>50</sub> using GraphPad Prism software (variable slope four parameter). The <i>K</i><sub>i</sub> of each compound was determined from the IC<sub>50</sub> values.</div><div class="NLM_p last">Compound <b>1</b> was included as a standard in these in vitro assays, and its behavior was in accordance with reported data.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Data was corrected for <i>K</i><sub>i</sub> using information from CCL25 doseâresponse curves, generated within each experiment.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Acute Mouse Model of DSS-Induced Colitis</h3><div class="NLM_p last">To assess the efficacy of compounds in a mouse (male, C57BL/6 mice) model of acute DSS-induced colitis, the disease was induced through administration of 2.25% (w/v) DSS in drinking water from days 1 to 5. The test compounds were administered from days 1 to 10 (po, bid, in 0.5% (w/v) methyl cellulose and 0.25% (v/v) Tween-80). A vehicle only control group (+DSS) and a nondisease group (âDSS) were also included. Group sizes of 12 mice were used.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Chronic Mouse Model of DSS-Induced Colitis</h3><div class="NLM_p last">To assess the behavior of compounds in a chronic DSS colitis model in mice (Male C57BL/6 mice), the disease was induced by administration of 1.75% DSS (w/v) in three cycles (days 1â5, 11â15, and 21â25) in drinking water. The test compounds were dosed from days 1â30 (po, bid, 0.5% methyl cellulose (0.5% (w/v)) and 0.25% (v/v) Tween-80), and the animals were sacrificed on day 31. A vehicle only control group (+DSS) and a nondisease group (âDSS) were also included. Groups consisted of 12â18 animals. DAI is calculated as reported in literature.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Statistical Analysis</h3><div class="NLM_p last">Data was analyzed using Two way ANOVA followed by Bonferroni test and One way ANOVA followed by Dunnettâs test in Graphpad Prism software.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d39e5977-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01840">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01840" class="ext-link">10.1021/acs.jmedchem.5b01840</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental details and data (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01840/suppl_file/jm5b01840_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Compound data (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01840/suppl_file/jm5b01840_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01840/suppl_file/jm5b01840_si_001.pdf">jm5b01840_si_001.pdf (877.91 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01840/suppl_file/jm5b01840_si_002.csv">jm5b01840_si_002.csv (5.93 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01840" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna McVey</span> - <span class="hlFld-Affiliation affiliation">Norgine
Ltd, Norgine House, Widewater
Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS, United Kingdom</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f2969f9184978bb29c9d80959b9c97dc919d9f"><span class="__cf_email__" data-cfemail="87e3eae4f1e2fec7e9e8f5e0eee9e2a9e4e8ea">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">S. Barret Kalindjian</span> - <span class="hlFld-Affiliation affiliation">Norgine
Ltd, Norgine House, Widewater
Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanjay V. Kadnur</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Biosys Limited, #96,
Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher A. Hewson</span> - <span class="hlFld-Affiliation affiliation">Norgine
Ltd, Norgine House, Widewater
Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chandregowda Venkateshappa</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Biosys Limited, #96,
Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suresh Juluri</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Biosys Limited, #96,
Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajendra Kristam</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Biosys Limited, #96,
Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bheemashankar Kulkarni</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Biosys Limited, #96,
Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zainuddin Mohammed</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Biosys Limited, #96,
Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rohit Saxena</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Chemsys Limited, B-34
Sector-58, Noida 201301, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vellarkad N. Viswanadhan</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Biosys Limited, #96,
Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayashree Aiyar</span> - <span class="hlFld-Affiliation affiliation">Jubilant
Biosys Limited, #96,
Industrial Suburb, Second Stage, Yeshwanthpur, Bangalore 560022, India</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The work described herein was funded by Norgine.  Drs S. Barret Kalindjian, Christopher A. Hewson and Donna McVey were employees of Norgine.  Drs Sanjay V. Kadnur, Venkateshappa Chandregowda, Suresh Juluri, Rajendra Kristam, Bheemashankar Kulkarni, Zainuddin Mohammed, Rohit Saxena, Vellarkad N. Viswanadhan, and Jayashree Aiyar were contractors to Norgine.<br /></br></div></li></ul></div><div class="ack" id="ACK-d39e5974-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Vishal Mane is thanked for his contributions to the in vivo work. Ian Cox, Jim McCormack, and Christine Reynet are thanked for helpful discussions throughout the project. The work described herein was funded by Norgine.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i98" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i98"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i99" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i99"> Abbreviations Used</h2><tr><td class="NLM_term">7-TM</td><td class="NLM_def"><p class="first last">seven transmembrane</p></td></tr><tr><td class="NLM_term">BBFO</td><td class="NLM_def"><p class="first last">broad band fluorine observe</p></td></tr><tr><td class="NLM_term">BBO</td><td class="NLM_def"><p class="first last">broad band observe</p></td></tr><tr><td class="NLM_term">BLAST</td><td class="NLM_def"><p class="first last">basic local alignment search tool</p></td></tr><tr><td class="NLM_term">CCL25</td><td class="NLM_def"><p class="first last">chemokine ligand 25</p></td></tr><tr><td class="NLM_term">DAI</td><td class="NLM_def"><p class="first last">disease activity index</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last">dimethylacetamide</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DPPF</td><td class="NLM_def"><p class="first last">1,1â² bis(diphenylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term">DSS</td><td class="NLM_def"><p class="first last">dextran sulfate sodium</p></td></tr><tr><td class="NLM_term">FFAS</td><td class="NLM_def"><p class="first last">fold and function assignment</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">IBD</td><td class="NLM_def"><p class="first last">inflammatory bowel disease</p></td></tr><tr><td class="NLM_term">MCPBA</td><td class="NLM_def"><p class="first last">meta-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetra-<i>N</i>-butyl-ammonium fluoride</p></td></tr><tr><td class="NLM_term">TECK</td><td class="NLM_def"><p class="first last">thymus-expressed chemokine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bouma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strober, W.</span><span> </span><span class="NLM_article-title">The immunological and genetic basis of inflammatory bowel disease</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">â</span> <span class="NLM_lpage">533</span><span class="refDoi">Â DOI: 10.1038/nri1132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1038%2Fnri1132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=12876555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Smtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=521-533&author=G.+Boumaauthor=W.+Strober&title=The+immunological+and+genetic+basis+of+inflammatory+bowel+disease&doi=10.1038%2Fnri1132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The immunological and genetic basis of inflammatory bowel disease</span></div><div class="casAuthors">Bouma, Gerd; Strober, Warren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">521-533</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract.  Enormous progress has been made recently in understanding the pathogenesis of these diseases.  Through the study of patients and mouse models, it has emerged that Crohn's disease is driven by the prodn. of interleukin-12 (IL-12) and interferon-Î³ (IFN-Î³), whereas ulcerative colitis is probably driven by the prodn. of IL-13.  A second area of progress is in the identification of specific genetic abnormalities that are responsible for disease.  The most important finding is the identification of mutations in the gene that encodes NOD2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.  Here, the authors discuss these recent findings and the implications for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP2kHY2gtjPrVg90H21EOLACvtfcHk0lhuAMLUYoVSDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Smtr4%253D&md5=3cff8673e11d7751397eb6e91c465658</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnri1132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1132%26sid%3Dliteratum%253Aachs%26aulast%3DBouma%26aufirst%3DG.%26aulast%3DStrober%26aufirst%3DW.%26atitle%3DThe%2520immunological%2520and%2520genetic%2520basis%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D521%26epage%3D533%26doi%3D10.1038%2Fnri1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Vinader, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afarinkia, K.</span><span> </span><span class="NLM_article-title">A beginnerâs guide to chemokines</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">â</span> <span class="NLM_lpage">852</span><span class="refDoi">Â DOI: 10.4155/fmc.12.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.4155%2Ffmc.12.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=22571610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms12iu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=845-852&author=V.+Vinaderauthor=K.+Afarinkia&title=A+beginner%E2%80%99s+guide+to+chemokines&doi=10.4155%2Ffmc.12.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A beginner's guide to chemokines</span></div><div class="casAuthors">Vinader, Victoria; Afarinkia, Kamyar</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">845-852</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">This review provides an overview of chemokines and their receptors, with an emphasis on general features and nomenclature along with a short summary of their properties and functions.  It is intended as an introduction to the subject and a ref. point for those wishing to learn key facts about chemokines and their role in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-o0O4DbOtaLVg90H21EOLACvtfcHk0lhuAMLUYoVSDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms12iu7s%253D&md5=2ce32997d86223951812525e0558c5db</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.49%26sid%3Dliteratum%253Aachs%26aulast%3DVinader%26aufirst%3DV.%26aulast%3DAfarinkia%26aufirst%3DK.%26atitle%3DA%2520beginner%25E2%2580%2599s%2520guide%2520to%2520chemokines%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D845%26epage%3D852%26doi%3D10.4155%2Ffmc.12.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zabel, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agace, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassam, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zovko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponath, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, D. P.</span><span> </span><span class="NLM_article-title">Human G protein-coupled receptor GPR-9â6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine mediated chemotaxis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">â</span> <span class="NLM_lpage">1256</span><span class="refDoi">Â DOI: 10.1084/jem.190.9.1241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1084%2Fjem.190.9.1241" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1999&pages=1241-1256&author=B.+A.+Zabelauthor=W.+W.+Agaceauthor=J.+J.+Campbellauthor=H.+M.+Heathauthor=D.+Parentauthor=A.+I.+Robertsauthor=E.+C.+Ebertauthor=N.+Kassamauthor=S.+Qinauthor=M.+Zovkoauthor=G.+J.+La+Rosaauthor=L.+L.+Yangauthor=D.+Solerauthor=E.+C.+Butcherauthor=P.+D.+Ponathauthor=C.+M.+Parkerauthor=D.+P.+Andrew&title=Human+G+protein-coupled+receptor+GPR-9%E2%80%936%2FCC+chemokine+receptor+9+is+selectively+expressed+on+intestinal+homing+T+lymphocytes%2C+mucosal+lymphocytes%2C+and+thymocytes+and+is+required+for+thymus-expressed+chemokine+mediated+chemotaxis&doi=10.1084%2Fjem.190.9.1241"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1084%2Fjem.190.9.1241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.190.9.1241%26sid%3Dliteratum%253Aachs%26aulast%3DZabel%26aufirst%3DB.%2BA.%26aulast%3DAgace%26aufirst%3DW.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BJ.%26aulast%3DHeath%26aufirst%3DH.%2BM.%26aulast%3DParent%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DA.%2BI.%26aulast%3DEbert%26aufirst%3DE.%2BC.%26aulast%3DKassam%26aufirst%3DN.%26aulast%3DQin%26aufirst%3DS.%26aulast%3DZovko%26aufirst%3DM.%26aulast%3DLa%2BRosa%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DL.%2BL.%26aulast%3DSoler%26aufirst%3DD.%26aulast%3DButcher%26aufirst%3DE.%2BC.%26aulast%3DPonath%26aufirst%3DP.%2BD.%26aulast%3DParker%26aufirst%3DC.%2BM.%26aulast%3DAndrew%26aufirst%3DD.%2BP.%26atitle%3DHuman%2520G%2520protein-coupled%2520receptor%2520GPR-9%25E2%2580%25936%252FCC%2520chemokine%2520receptor%25209%2520is%2520selectively%2520expressed%2520on%2520intestinal%2520homing%2520T%2520lymphocytes%252C%2520mucosal%2520lymphocytes%252C%2520and%2520thymocytes%2520and%2520is%2520required%2520for%2520thymus-expressed%2520chemokine%2520mediated%2520chemotaxis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1999%26volume%3D190%26spage%3D1241%26epage%3D1256%26doi%3D10.1084%2Fjem.190.9.1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zaballos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GutiÃ©rrez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ArdavÃ­n, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¡rquez, G.</span><span> </span><span class="NLM_article-title">Cutting edge: Identification of the orphan chemokine receptor GPR-9â6 as CCR9, the receptor for the chemokine CCL25</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">5671</span><span class="NLM_x">â</span> <span class="NLM_lpage">5675</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=5671-5675&author=A.+Zaballosauthor=J.+Guti%C3%A9rrezauthor=R.+Varonaauthor=C.+Ardav%C3%ADnauthor=G.+M%C3%A1rquez&title=Cutting+edge%3A+Identification+of+the+orphan+chemokine+receptor+GPR-9%E2%80%936+as+CCR9%2C+the+receptor+for+the+chemokine+CCL25"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZaballos%26aufirst%3DA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DJ.%26aulast%3DVarona%26aufirst%3DR.%26aulast%3DArdav%25C3%25ADn%26aufirst%3DC.%26aulast%3DM%25C3%25A1rquez%26aufirst%3DG.%26atitle%3DCutting%2520edge%253A%2520Identification%2520of%2520the%2520orphan%2520chemokine%2520receptor%2520GPR-9%25E2%2580%25936%2520as%2520CCR9%252C%2520the%2520receptor%2520for%2520the%2520chemokine%2520CCL25%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D5671%26epage%3D5675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kunkel, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haraldsen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisvert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vierra, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardlaw, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agace, W. W.</span><span> </span><span class="NLM_article-title">Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of the tissue-specific chemokines as an organizing principle in regional immunity</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">761</span><span class="NLM_x">â</span> <span class="NLM_lpage">768</span><span class="refDoi">Â DOI: 10.1084/jem.192.5.761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1084%2Fjem.192.5.761" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2000&pages=761-768&issue=5&author=E.+J.+Kunkelauthor=J.+J.+Campbellauthor=G.+Haraldsenauthor=J.+Panauthor=J.+Boisvertauthor=A.+I.+Robertsauthor=E.+C.+Ebertauthor=M.+A.+Vierraauthor=S.+B.+Goodmanauthor=M.+C.+Genoveseauthor=A.+J.+Wardlawauthor=H.+B.+Greenbergauthor=C.+M.+Parkerauthor=E.+C.+Butcherauthor=D.+P.+Andrewauthor=W.+W.+Agace&title=Lymphocyte+CC+chemokine+receptor+9+and+epithelial+thymus-expressed+chemokine+%28TECK%29+expression+distinguish+the+small+intestinal+immune+compartment%3A+Epithelial+expression+of+the+tissue-specific+chemokines+as+an+organizing+principle+in+regional+immunity&doi=10.1084%2Fjem.192.5.761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1084%2Fjem.192.5.761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.192.5.761%26sid%3Dliteratum%253Aachs%26aulast%3DKunkel%26aufirst%3DE.%2BJ.%26aulast%3DCampbell%26aufirst%3DJ.%2BJ.%26aulast%3DHaraldsen%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DBoisvert%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DA.%2BI.%26aulast%3DEbert%26aufirst%3DE.%2BC.%26aulast%3DVierra%26aufirst%3DM.%2BA.%26aulast%3DGoodman%26aufirst%3DS.%2BB.%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DWardlaw%26aufirst%3DA.%2BJ.%26aulast%3DGreenberg%26aufirst%3DH.%2BB.%26aulast%3DParker%26aufirst%3DC.%2BM.%26aulast%3DButcher%26aufirst%3DE.%2BC.%26aulast%3DAndrew%26aufirst%3DD.%2BP.%26aulast%3DAgace%26aufirst%3DW.%2BW.%26atitle%3DLymphocyte%2520CC%2520chemokine%2520receptor%25209%2520and%2520epithelial%2520thymus-expressed%2520chemokine%2520%2528TECK%2529%2520expression%2520distinguish%2520the%2520small%2520intestinal%2520immune%2520compartment%253A%2520Epithelial%2520expression%2520of%2520the%2520tissue-specific%2520chemokines%2520as%2520an%2520organizing%2520principle%2520in%2520regional%2520immunity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D192%26issue%3D5%26spage%3D761%26epage%3D768%26doi%3D10.1084%2Fjem.192.5.761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Papadakis, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prehn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouroumalis, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deem, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breaverman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponath, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodge, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targan, S. R.</span><span> </span><span class="NLM_article-title">CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohnâs disease</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">â</span> <span class="NLM_lpage">254</span><span class="refDoi">Â DOI: 10.1053/gast.2001.27154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1053%2Fgast.2001.27154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=11487533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVymsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2001&pages=246-254&author=K.+A.+Papadakisauthor=J.+Prehnauthor=S.+T.+Morenoauthor=L.+Chengauthor=E.+A.+Kouroumalisauthor=R.+Deemauthor=T.+Breavermanauthor=P.+D.+Ponathauthor=D.+P.+Andrewauthor=P.+H.+Greenauthor=M.+R.+Hodgeauthor=S.+W.+Binderauthor=S.+R.+Targan&title=CCR9-positive+lymphocytes+and+thymus-expressed+chemokine+distinguish+small+bowel+from+colonic+Crohn%E2%80%99s+disease&doi=10.1053%2Fgast.2001.27154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic crohn's disease</span></div><div class="casAuthors">Papadakis, Konstantinos A.; Prehn, John; Moreno, Sofia T.; Cheng, Lorna; Kouroumalis, Elias A.; Deem, Richard; Breaverman, Tim; Ponath, Paul D.; Andrew, David P.; Green, Peter H. R.; Hodge, Martin R.; Binder, Scott W.; Targan, Stephan R.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-254</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">Thymus-expressed chemokine (TECK or CCL25) is selectively expressed in the small bowel (SB), where lamina propria lymphocytes (LPL) and intraepithelial leukocyte expressing the cognate chemokine receptor CCR9 predominate.  The authors characterize the role of TECK and CCR9-expressing lymphocytes in small intestinal Crohn's disease.  CCR9 expression on lymphocytes from lamina propria, mesenteric lymph node, and peripheral blood was analyzed by flow cytometry and by Northern blotting for LPL.  TECK expression was analyzed in inflamed SB and colon by reverse-transcription polymerase chain reaction and immunohistochem.  The fraction of CCR9+ T cells in inflamed SB was significantly lower than in uninvolved SB mucosa.  In contrast, in peripheral blood lymphocytes, CCR9+ lymphocytes were markedly elevated in patients with small bowel Crohn's or celiac disease, but not in patients with purely colonic Crohn's.  Also, TECK expression is altered in inflamed small bowel, being intensely expressed in a patchy distribution in crypt epithelial cells in proximity to lymphocytic infiltrates.  TECK is not expressed in either normal or inflamed colon.  In SB immune-mediated diseases, there is repartitioning of CCR9+ lymphocytes between SB and blood and an altered pattern of TECK expression in SB Crohn's.  The TECK/CCR9 ligand/receptor pair may play an important role in the pathogenesis of SB Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou0eBnCrPhEbVg90H21EOLACvtfcHk0lgGZRjVkRGfcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVymsrk%253D&md5=4ee10b0d66c39b9df5f8659349309da4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1053%2Fgast.2001.27154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fgast.2001.27154%26sid%3Dliteratum%253Aachs%26aulast%3DPapadakis%26aufirst%3DK.%2BA.%26aulast%3DPrehn%26aufirst%3DJ.%26aulast%3DMoreno%26aufirst%3DS.%2BT.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DKouroumalis%26aufirst%3DE.%2BA.%26aulast%3DDeem%26aufirst%3DR.%26aulast%3DBreaverman%26aufirst%3DT.%26aulast%3DPonath%26aufirst%3DP.%2BD.%26aulast%3DAndrew%26aufirst%3DD.%2BP.%26aulast%3DGreen%26aufirst%3DP.%2BH.%26aulast%3DHodge%26aufirst%3DM.%2BR.%26aulast%3DBinder%26aufirst%3DS.%2BW.%26aulast%3DTargan%26aufirst%3DS.%2BR.%26atitle%3DCCR9-positive%2520lymphocytes%2520and%2520thymus-expressed%2520chemokine%2520distinguish%2520small%2520bowel%2520from%2520colonic%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DGastroenterology%26date%3D2001%26volume%3D121%26spage%3D246%26epage%3D254%26doi%3D10.1053%2Fgast.2001.27154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Rivera-Nieves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivashkina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cominelli, F.</span><span> </span><span class="NLM_article-title">Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">1518</span><span class="NLM_x">â</span> <span class="NLM_lpage">1529</span><span class="refDoi">Â DOI: 10.1053/j.gastro.2006.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1053%2Fj.gastro.2006.08.031" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=1518-1529&author=J.+Rivera-Nievesauthor=J.+Hoauthor=G.+Bamiasauthor=N.+Ivashkinaauthor=K.+Leyauthor=M.+Oppermannauthor=F.+Cominelli&title=Antibody+blockade+of+CCL25%2FCCR9+ameliorates+early+but+not+late+chronic+murine+ileitis&doi=10.1053%2Fj.gastro.2006.08.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2006.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2006.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DRivera-Nieves%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DJ.%26aulast%3DBamias%26aufirst%3DG.%26aulast%3DIvashkina%26aufirst%3DN.%26aulast%3DLey%26aufirst%3DK.%26aulast%3DOppermann%26aufirst%3DM.%26aulast%3DCominelli%26aufirst%3DF.%26atitle%3DAntibody%2520blockade%2520of%2520CCL25%252FCCR9%2520ameliorates%2520early%2520but%2520not%2520late%2520chronic%2520murine%2520ileitis%26jtitle%3DGastroenterology%26date%3D2006%26volume%3D131%26spage%3D1518%26epage%3D1529%26doi%3D10.1053%2Fj.gastro.2006.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Walters, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumgart, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairaghi, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertl, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penfold, M. E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungashe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schall, T. J.</span><span> </span><span class="NLM_article-title">Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for the treatment of inflammatory bowel disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">â</span> <span class="NLM_lpage">69</span><span class="refDoi">Â DOI: 10.1124/jpet.110.169714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1124%2Fjpet.110.169714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=20660125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gisr3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=61-69&author=M.+J.+Waltersauthor=Y.+Wangauthor=N.+Laiauthor=T.+Baumgartauthor=B.+N.+Zhaoauthor=D.+J.+Dairaghiauthor=P.+Bekkerauthor=L.+S.+Ertlauthor=M.+E.+T.+Penfoldauthor=J.+C.+Jaenauthor=S.+Keshavauthor=E.+Wendtauthor=A.+Pennellauthor=S.+Ungasheauthor=Z.+Weiauthor=J.+K.+Wrightauthor=T.+J.+Schall&title=Characterization+of+CCX282-B%2C+an+orally+bioavailable+antagonist+of+the+CCR9+chemokine+receptor%2C+for+the+treatment+of+inflammatory+bowel+disease&doi=10.1124%2Fjpet.110.169714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease</span></div><div class="casAuthors">Walters, Matthew J.; Wang, Yu; Lai, Nu; Baumgart, Trageen; Zhao, Bin N.; Dairaghi, Daniel J.; Bekker, Pirow; Ertl, Linda S.; Penfold, Mark E. T.; Jaen, Juan C.; Keshav, Satish; Wendt, Emily; Pennell, Andrew; Ungashe, Solomon; Wei, Zheng; Wright, J. J. Kim; Schall, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-69</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The chemokine system represents a diverse group of G protein-coupled receptors responsible for orchestrating cell recruitment under both homeostatic and inflammatory conditions.  Chemokine receptor 9 (CCR9) is a chemokine receptor known to be central for migration of immune cells into the intestine.  Its only ligand, CCL25, is expressed at the mucosal surface of the intestine and is known to be elevated in intestinal inflammation.  To date, there are no reports of small-mol. antagonists targeting CCR9.  We report, for the first time, the discovery of a small mol., CCX282-B, which is an orally bioavailable, selective, and potent antagonist of human CCR9.  CCX282-B inhibited CCR9-mediated Ca2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, resp.  In the presence of 100% human serum, CCX282-B inhibited CCR9-mediated chemotaxis with an IC50 of 33 nM, and the addn. of Î±1-acid glycoprotein did not affect its potency.  CCX282-B inhibited chemotaxis of primary CCR9-expressing cells to CCL25 with an IC50 of 6.8 nM.  CCX282-B was an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, resp.  CCX282-B also inhibited mouse and rat CCR9-mediated chemotaxis.  Inhibition of CCR9 with CCX282-B results in normalization of Crohn's disease such as histopathol. assocd. with the TNFÎARE mice.  Anal. of the plasma level of drug assocd. with this improvement provides an understanding of the pharmacokinetic/pharmacodynamic relationship for CCR9 antagonists in the treatment of intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAvKRxhmslqLVg90H21EOLACvtfcHk0lg3JNPoQuHXcA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gisr3I&md5=0d7903a7e25721ede33196f8e32f0e87</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.169714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.169714%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DN.%26aulast%3DBaumgart%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DB.%2BN.%26aulast%3DDairaghi%26aufirst%3DD.%2BJ.%26aulast%3DBekker%26aufirst%3DP.%26aulast%3DErtl%26aufirst%3DL.%2BS.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DKeshav%26aufirst%3DS.%26aulast%3DWendt%26aufirst%3DE.%26aulast%3DPennell%26aufirst%3DA.%26aulast%3DUngashe%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DWright%26aufirst%3DJ.%2BK.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26atitle%3DCharacterization%2520of%2520CCX282-B%252C%2520an%2520orally%2520bioavailable%2520antagonist%2520of%2520the%2520CCR9%2520chemokine%2520receptor%252C%2520for%2520the%2520treatment%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D61%26epage%3D69%26doi%3D10.1124%2Fjpet.110.169714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Carballido Herrera, J. M.; Jaksche, H.; Lehr, P.; Werner, G.; Winiski, A.</span><span> </span><span class="NLM_article-title">Inhibitors of CCR9 activity</span>. Patent WO 2007/071441, June 28,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+M.+Carballido+Herrera&author=H.+Jaksche&author=P.+Lehr&author=G.+Werner&author=A.+Winiski&title=Inhibitors+of+CCR9+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarballido%2BHerrera%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520CCR9%2520activity%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ungashe, S.; Wei, Z.; Wright, J. J.; Pennell, A.</span><span> </span><span class="NLM_article-title">Aryl sulfonamides</span>. Patent WO 2004/046092, July 15,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Ungashe&author=Z.+Wei&author=J.+J.+Wright&author=A.+Pennell&title=Aryl+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUngashe%26aufirst%3DS.%26atitle%3DAryl%2520sulfonamides%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Charvat, T. T.; Hu, C.; Melikian, A.; Novack, A.; Pennell, A. M. K.; Powers, J.; Punna, S.; Sullivan, E. J.; Thomas, W. D.; Ungashe, S.; Zhang, P.</span><span> </span><span class="NLM_article-title"><i>N</i>-(2-(Hetaryl)aryl)arylsulfonamides and <i>N</i>-(2-(Hetaryl)hetaryl)arylsulfonamides</span>. Patent WO 2009/038847, March 26,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+T.+Charvat&author=C.+Hu&author=A.+Melikian&author=A.+Novack&author=A.+M.+K.+Pennell&author=J.+Powers&author=S.+Punna&author=E.+J.+Sullivan&author=W.+D.+Thomas&author=S.+Ungashe&author=P.+Zhang&title=N-%282-%28Hetaryl%29aryl%29arylsulfonamides+and+N-%282-%28Hetaryl%29hetaryl%29arylsulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCharvat%26aufirst%3DT.%2BT.%26atitle%3DN-%25282-%2528Hetaryl%2529aryl%2529arylsulfonamides%2520and%2520N-%25282-%2528Hetaryl%2529hetaryl%2529arylsulfonamides%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ugashe, S.; Wei, Z.; Wright, J. J.; Pennell, A.</span><span> </span><span class="NLM_article-title">Aryl sulfonamides</span>. US Patent US 2004/0171654, September 2,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Ugashe&author=Z.+Wei&author=J.+J.+Wright&author=A.+Pennell&title=Aryl+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUgashe%26aufirst%3DS.%26atitle%3DAryl%2520sulfonamides%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Fleming, P.; Harriman, G. C. B.; Shi, Z.; Chen, S.</span><span> </span><span class="NLM_article-title">CCR9 inhibitors and methods of use thereof</span>. Patent WO2003/099773, December 4,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=P.+Fleming&author=G.+C.+B.+Harriman&author=Z.+Shi&author=S.+Chen&title=CCR9+inhibitors+and+methods+of+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DP.%26atitle%3DCCR9%2520inhibitors%2520and%2520methods%2520of%2520use%2520thereof%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Anderson, E. C.; Biediger, R. J.; Chen, J.; Dupre, B.; Lory, P.; Market, R. V.; Monk, K. A.; Savage, M. M.; Tennyson, R.; Young, B. M.</span><span> </span><span class="NLM_article-title">Modulators of CCR9 receptor and methods of use thereof</span>. US Patent US 2010/0029753, February 4,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+C.+Anderson&author=R.+J.+Biediger&author=J.+Chen&author=B.+Dupre&author=P.+Lory&author=R.+V.+Market&author=K.+A.+Monk&author=M.+M.+Savage&author=R.+Tennyson&author=B.+M.+Young&title=Modulators+of+CCR9+receptor+and+methods+of+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DE.%2BC.%26atitle%3DModulators%2520of%2520CCR9%2520receptor%2520and%2520methods%2520of%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Koenecke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FÃ¶rster, R.</span><span> </span><span class="NLM_article-title">CCR9 and inflammatory bowel disease</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">306</span><span class="refDoi">Â DOI: 10.1517/14728220902762928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1517%2F14728220902762928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=19236152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFKnu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=297-306&author=C.+Koeneckeauthor=R.+F%C3%B6rster&title=CCR9+and+inflammatory+bowel+disease&doi=10.1517%2F14728220902762928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">CCR9 and inflammatory bowel disease</span></div><div class="casAuthors">Koenecke, Christian; Foerster, Reinhold</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-306</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The pathol. features of inflammatory bowel disease (IBD) are assocd. with leukocyte cell infiltrates, which contribute to disease progression and persistence by prodn. of proinflammatory mediators.  Recruiting leukocytes to the gut involves local expression of chemokines that interact with receptors on the leukocytes' surface.  Specific antagonists may interfere with leukocyte recruitment to the intestine.  The chemokine receptor CCR9 is one of the key mols. in leukocyte homing to gut mucosa.  CCR9 antagonists have been shown to retard progression in patients with IBD.  Objective: To discuss CCR9 as a potential target for the treatment of IBD.  Methods: A literature review.  Results/conclusions: The therapeutic effects of CCR9 antagonists, in combination with established therapies, should be evaluated in an attempt to slow down leukocyte recruitment at early stages of IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0aD_iKz66KLVg90H21EOLACvtfcHk0lg3JNPoQuHXcA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFKnu78%253D&md5=2ccb6dbb178cdfb68badf503a7f1dc8f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F14728220902762928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902762928%26sid%3Dliteratum%253Aachs%26aulast%3DKoenecke%26aufirst%3DC.%26aulast%3DF%25C3%25B6rster%26aufirst%3DR.%26atitle%3DCCR9%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D297%26epage%3D306%26doi%3D10.1517%2F14728220902762928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Proudfoot, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span> </span><span class="NLM_article-title">Anti-chemokine small molecule drugs: a promising future?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">â</span> <span class="NLM_lpage">355</span><span class="refDoi">Â DOI: 10.1517/13543780903535867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1517%2F13543780903535867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=20113217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFKmsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=345-355&author=A.+E.+Proudfootauthor=C.+A.+Powerauthor=M.+K.+Schwarz&title=Anti-chemokine+small+molecule+drugs%3A+a+promising+future%3F&doi=10.1517%2F13543780903535867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-chemokine small molecule drugs: a promising future?</span></div><div class="casAuthors">Proudfoot, Amanda E. I.; Power, Christine A.; Schwarz, Matthias K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-355</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Chemokines have principally been assocd. with inflammation due to their role in the control of leukocyte migration, but just over a decade ago chemokine receptors were also identified as playing a pivotal role in the entry of the HIV virus into cells.  Chemokines activate seven transmembrane G protein-coupled receptors, making them extremely attractive therapeutic targets for the pharmaceutical industry.Areas covered in this review: Although there are now a large no. of mols. targeting chemokines and chemokine receptors including neutralizing antibodies in clin. trials for inflammatory diseases, the results to date have not always been pos., which has been disappointing for the field.  These failures have often been attributed to redundancy in the chemokine system.  However, other difficulties have been encountered in drug discovery processes targeting the chemokine system, and these will be addressed in this review.What the reader will gain: In this review, the reader will get an insight into the hurdles that have to be overcome, learn about some of the pitfalls that may explain the lack of success, and get a glimpse of the outlook for the future.Take home message: In 2007, the FDA approved maraviroc, an inhibitor of CCR5 for the prevention of HIV infection, the first triumph for a small-mol. drug acting on the chemokine system.  The time to market, 11 years from discovery of CCR5, was fast by industry stds.  A second small-mol. drug, a CXCR4 antagonist for hematopoietic stem cell mobilization, was approved by the FDA at the end of 2008.  The results of a Phase III trial with a CCR9 inhibitor for Crohn's disease are also promising.  This could herald the first success for a chemokine receptor antagonist as an anti-inflammatory therapeutic and confirms the importance of chemokine receptors as a target class for anti-inflammatory and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotTjTl2LXpmrVg90H21EOLACvtfcHk0lgDtpOmchctWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFKmsrw%253D&md5=1e9fcb9e17420219e301a0308e92c133</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543780903535867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780903535867%26sid%3Dliteratum%253Aachs%26aulast%3DProudfoot%26aufirst%3DA.%2BE.%26aulast%3DPower%26aufirst%3DC.%2BA.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26atitle%3DAnti-chemokine%2520small%2520molecule%2520drugs%253A%2520a%2520promising%2520future%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D345%26epage%3D355%26doi%3D10.1517%2F13543780903535867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Keshav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VaÅÃ¡sek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niv, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petryka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howaldt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bafutto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¡cz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetzel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinisch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">KarlÃ©n, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schall, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker, P.</span><span> </span><span class="NLM_article-title">Prospective randomized oral-therapy evaluation in Crohnâs disease trial-1 PROTECT-1 study group</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">e60094</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0060094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1371%2Fjournal.pone.0060094" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e60094&issue=3&author=S.+Keshavauthor=T.+Va%C5%88%C3%A1sekauthor=Y.+Nivauthor=R.+Petrykaauthor=S.+Howaldtauthor=M.+Bafuttoauthor=I.+R%C3%A1czauthor=D.+Hetzelauthor=O.+H.+Nielsenauthor=S.+Vermeireauthor=W.+Reinischauthor=P.+Karl%C3%A9nauthor=S.+Schreiberauthor=T.+J.+Schallauthor=P.+Bekker&title=Prospective+randomized+oral-therapy+evaluation+in+Crohn%E2%80%99s+disease+trial-1+PROTECT-1+study+group&doi=10.1371%2Fjournal.pone.0060094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0060094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0060094%26sid%3Dliteratum%253Aachs%26aulast%3DKeshav%26aufirst%3DS.%26aulast%3DVa%25C5%2588%25C3%25A1sek%26aufirst%3DT.%26aulast%3DNiv%26aufirst%3DY.%26aulast%3DPetryka%26aufirst%3DR.%26aulast%3DHowaldt%26aufirst%3DS.%26aulast%3DBafutto%26aufirst%3DM.%26aulast%3DR%25C3%25A1cz%26aufirst%3DI.%26aulast%3DHetzel%26aufirst%3DD.%26aulast%3DNielsen%26aufirst%3DO.%2BH.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DReinisch%26aufirst%3DW.%26aulast%3DKarl%25C3%25A9n%26aufirst%3DP.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26aulast%3DBekker%26aufirst%3DP.%26atitle%3DProspective%2520randomized%2520oral-therapy%2520evaluation%2520in%2520Crohn%25E2%2580%2599s%2520disease%2520trial-1%2520PROTECT-1%2520study%2520group%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D3%26spage%3De60094%26doi%3D10.1371%2Fjournal.pone.0060094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wendt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshav, S.</span><span> </span><span class="NLM_article-title">CCR9 antagonism: potential in the treatment of inflammatory bowel disease</span> <span class="citation_source-journal">Clin. Exp. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">130</span><span class="refDoi">Â DOI: 10.2147/CEG.S48305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.2147%2FCEG.S48305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=25897254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A280%3ADC%252BC2MjmsFyjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=119-130&author=E.+Wendtauthor=S.+Keshav&title=CCR9+antagonism%3A+potential+in+the+treatment+of+inflammatory+bowel+disease&doi=10.2147%2FCEG.S48305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease</span></div><div class="casAuthors">Wendt Emily; Keshav Satish</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental gastroenterology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammatory Bowel Disease (IBD), mainly comprising Crohn's disease (CD) and ulcerative colitis (UC), is a chronic condition that primarily affects the intestine and is characterized by leukocytic infiltration.  Blocking the migration of leukocytes from the circulation is therefore a reasonable therapeutic goal.  Recent clinical trials using this approach have shown promise, with the monoclonal antibody to Î±4Î²7 integrin, vedolizumab, and previously with the monoclonal antibody to the Î±4 subunit, natalizumab.  Directly targeting the subset of Î±4Î²7 expressing cells that co-express CC chemokine receptor 9 (CCR9), using the orally administered antagonist, CCX282-B, also known as vercirnon, has also been evaluated in Phase II and III trials that have produced mixed results.  Although CCX282-B showed efficacy in inducing response in active CD in early studies, this was not confirmed in a Phase III study.  CCX282-B was also more effective than placebo in maintaining remission, and this result has yet to be confirmed in Phase III.  The efficacy of blocking CCR9 in UC, where vedolizumab was effective, has not been tested.  The prospect of targeting CCR9 in IBD remains attractive.  Much of the local accumulation of inflammatory cells in the intestine arises from migration rather than local proliferation and genetic and pharmacological targeting of CCR9 or its ligand in preclinical models that mimic UC and CD ameliorate inflammation in some cases.  Furthermore, binding of chemokine ligands to receptor is a critical step in activating integrin binding, so there is a potential for synergistic action between integrin and chemokine antagonists.  CCR9 is expressed on a smaller proportion of circulating cells than Î±4Î²7 integrin, which may offer greater specificity of effect, particularly in long term use.  Furthermore, while Î±4Î²7 is widely expressed on T and B cell subsets, CCR9 is mainly expressed on effector memory Th1 cells.  Indications for the use of intestine-specific integrin and chemokine receptor targeting may also extend beyond IBD, to include, for example, postoperative ileus, and primary sclerosing cholangitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzG8G4Bs2UKUEgZCMqtRBifW6udTcc2eaGh7jSNQkcOrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjmsFyjsQ%253D%253D&md5=96b5219e57fb1e39a99c06030b042fa9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2147%2FCEG.S48305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCEG.S48305%26sid%3Dliteratum%253Aachs%26aulast%3DWendt%26aufirst%3DE.%26aulast%3DKeshav%26aufirst%3DS.%26atitle%3DCCR9%2520antagonism%253A%2520potential%2520in%2520the%2520treatment%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DClin.%2520Exp.%2520Gastroenterol.%26date%3D2015%26volume%3D8%26spage%3D119%26epage%3D130%26doi%3D10.2147%2FCEG.S48305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Feagan, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandborn, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâHaens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorak, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrance, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurgensen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. J.</span><span> </span><span class="NLM_article-title">Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohnâs disease</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span><span class="NLM_x">â</span> <span class="NLM_lpage">1181</span><span class="refDoi">Â DOI: 10.1111/apt.13398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1111%2Fapt.13398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=26400458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Ohu73J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=1170-1181&author=B.+G.+Feaganauthor=W.+J.+Sandbornauthor=G.+D%E2%80%99Haensauthor=S.+D.+Leeauthor=M.+Allezauthor=R.+N.+Fedorakauthor=U.+Seidlerauthor=S.+Vermeireauthor=I.+C.+Lawranceauthor=A.+C.+Maroneyauthor=C.+H.+Jurgensenauthor=A.+Heathauthor=D.+J.+Chang&title=Randomised+clinical+trial%3A+vercirnon%2C+an+oral+CCR9+antagonist%2C+vs.+placebo+as+induction+therapy+in+active+Crohn%E2%80%99s+disease&doi=10.1111%2Fapt.13398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease</span></div><div class="casAuthors">Feagan, B. G.; Sandborn, W. J.; D'Haens, G.; Lee, S. D.; Allez, M.; Fedorak, R. N.; Seidler, U.; Vermeire, S.; Lawrance, I. C.; Maroney, A. C.; Jurgensen, C. H.; Heath, A.; Chang, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1170-1181</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Background : Many patients with active Crohn's disease do not adequately respond to therapies, highlighting the need for new treatments.  Aims : To conduct a randomised, double-blind, placebo-controlled phase 3 study to assess the efficacy and safety of vercirnon, an oral inhibitor of CC chemokine receptor-9, for the treatment of patients with moderately-to-severely active Crohn's disease.  Methods : Patients with a Crohn's Disease Activity Index (CDAI) of 220-450, plus evidence of active disease (endoscopically confirmed or elevation of both C-reactive protein and faecal calprotectin), who had failed corticosteroid or immunosuppressant therapy were enrolled.  Patients were equally randomised to receive placebo, vercirnon 500 mg once daily or vercirnon 500 mg twice daily.  The primary endpoint was clin. response, defined as a 100-point decrease in CDAI from baseline to week 12.  Results : Six hundred and eight patients were randomised.  Patient characteristics and baseline demographics were similar among the groups.  The proportions of patients achieving a clin. response were 25.1%, 27.6% and 27.2% for placebo, once daily and twice daily resp.; treatment differences were not significant (2.5%; 95% confidence interval, CI -6.1% to 11.0%, P = 0.546 for once daily vs. placebo, and 2.1%; 95% CI -6.5% to 10.7%, P = 0.648 for twice daily vs. placebo).  Adverse events were reported in 69.8%, 73.3% and 78.1% with serious adverse events in 8.9%, 5.9%, and 6.0% of patients in the placebo, once-daily and twice-daily groups, resp.  Conclusions : We did not demonstrate efficacy of vercirnon as an induction therapy in patients with moderately-to-severely active Crohn's disease; its effect in maintenance therapy was not addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDpjdHoZsB-rVg90H21EOLACvtfcHk0lgbsrkcvQtg_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Ohu73J&md5=d7fbb83bdae34f08d4fa289646efc7d0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fapt.13398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fapt.13398%26sid%3Dliteratum%253Aachs%26aulast%3DFeagan%26aufirst%3DB.%2BG.%26aulast%3DSandborn%26aufirst%3DW.%2BJ.%26aulast%3DD%25E2%2580%2599Haens%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DS.%2BD.%26aulast%3DAllez%26aufirst%3DM.%26aulast%3DFedorak%26aufirst%3DR.%2BN.%26aulast%3DSeidler%26aufirst%3DU.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DLawrance%26aufirst%3DI.%2BC.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DJurgensen%26aufirst%3DC.%2BH.%26aulast%3DHeath%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DD.%2BJ.%26atitle%3DRandomised%2520clinical%2520trial%253A%2520vercirnon%252C%2520an%2520oral%2520CCR9%2520antagonist%252C%2520vs.%2520placebo%2520as%2520induction%2520therapy%2520in%2520active%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2015%26volume%3D42%26spage%3D1170%26epage%3D1181%26doi%3D10.1111%2Fapt.13398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stucka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varoglu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandonnet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, B.</span><span> </span><span class="NLM_article-title">Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3661</span><span class="NLM_x">â</span> <span class="NLM_lpage">3664</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.06.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1016%2Fj.bmcl.2015.06.046" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3661-3664&author=J.+Zhangauthor=J.+Romeroauthor=A.+Chanauthor=J.+Gossauthor=S.+Stuckaauthor=J.+Crossauthor=B.+Chamberlainauthor=M.+Varogluauthor=H.+Chandonnetauthor=D.+Ryanauthor=B.+Lippa&title=Biarylsulfonamide+CCR9+inhibitors+for+inflammatory+bowel+disease&doi=10.1016%2Fj.bmcl.2015.06.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.046%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DGoss%26aufirst%3DJ.%26aulast%3DStucka%26aufirst%3DS.%26aulast%3DCross%26aufirst%3DJ.%26aulast%3DChamberlain%26aufirst%3DB.%26aulast%3DVaroglu%26aufirst%3DM.%26aulast%3DChandonnet%26aufirst%3DH.%26aulast%3DRyan%26aufirst%3DD.%26aulast%3DLippa%26aufirst%3DB.%26atitle%3DBiarylsulfonamide%2520CCR9%2520inhibitors%2520for%2520inflammatory%2520bowel%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3661%26epage%3D3664%26doi%3D10.1016%2Fj.bmcl.2015.06.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitter, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotti, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerino, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirshfield, J.</span><span> </span><span class="NLM_article-title">Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2235</span><span class="NLM_x">â</span> <span class="NLM_lpage">2246</span><span class="refDoi">Â DOI: 10.1021/jm00120a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00120a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADyaL1cXmtVCgurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=2235-2246&author=B.+E.+Evansauthor=K.+E.+Rittleauthor=M.+G.+Bockauthor=R.+M.+DiPardoauthor=R.+M.+Freidingerauthor=W.+L.+Whitterauthor=G.+F.+Lundellauthor=D.+F.+Veberauthor=P.+S.+Andersonauthor=R.+S.+L.+Changauthor=V.+J.+Lottiauthor=D.+J.+Cerinoauthor=T.+B.+Chenauthor=P.+J.+Klingauthor=K.+A.+Kunkelauthor=J.+P.+Springerauthor=J.+Hirshfield&title=Methods+for+drug+discovery%3A+development+of+potent%2C+selective%2C+orally+effective+cholecystokinin+antagonists&doi=10.1021%2Fjm00120a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for drug discovery:  development of potent, selective, orally effective cholecystokinin antagonists</span></div><div class="casAuthors">Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2235-46</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">3-(Acylamino)-5-phenyl-2H-1,4-benzodiazepines) (I, X = H or F; R1 = H, Me, CH2CO2Et, CH2CO2H; R2 = acylamino, indolylalkyl, heterocyclic contg. groups, substituted benzoyl, etc.), antagonists of the peptide hormone cholecystokinin (CCK), are described.  Developed by reasoned modification of the known anxiolytic benzodiazepines, these compds. provide highly potent, orally effective ligands selective for peripheral (CCK-A) receptors, with binding affinities approaching or equaling that of the natural ligand CCK-8.  The distinction between CCK-A receptors on the one hand and CNS (CCK-B), gastrin, and central benzodiazepine receptors on the other is demonstrated by using the structure-activity profiles of the new compds.  Details of the binding of these agents to CCK-A receptors are examd., and the method of development of these compds. is discussed in terms of its relevance to the general problem of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF3uSMSNckhrVg90H21EOLACvtfcHk0lgbsrkcvQtg_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmtVCgurs%253D&md5=783be926d2512ab8f67c8786afcf0276</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm00120a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00120a002%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DWhitter%26aufirst%3DW.%2BL.%26aulast%3DLundell%26aufirst%3DG.%2BF.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DLotti%26aufirst%3DV.%2BJ.%26aulast%3DCerino%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DKling%26aufirst%3DP.%2BJ.%26aulast%3DKunkel%26aufirst%3DK.%2BA.%26aulast%3DSpringer%26aufirst%3DJ.%2BP.%26aulast%3DHirshfield%26aufirst%3DJ.%26atitle%3DMethods%2520for%2520drug%2520discovery%253A%2520development%2520of%2520potent%252C%2520selective%252C%2520orally%2520effective%2520cholecystokinin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D2235%26epage%3D2246%26doi%3D10.1021%2Fjm00120a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peden, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaitseva, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, J. M.</span><span> </span><span class="NLM_article-title">CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">â</span> <span class="NLM_lpage">1305</span><span class="refDoi">Â DOI: 10.4049/jimmunol.164.3.1293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.4049%2Fjimmunol.164.3.1293" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=1293-1305&author=C.+R.+Yuauthor=K.+W.+Pedenauthor=M.+B.+Zaitsevaauthor=H.+Goldingauthor=J.+M.+Farber&title=CCR9A+and+CCR9B%3A+two+receptors+for+the+chemokine+CCL25%2FTECK%2FCk+beta-15+that+differ+in+their+sensitivities+to+ligand&doi=10.4049%2Fjimmunol.164.3.1293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.164.3.1293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.164.3.1293%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.%2BR.%26aulast%3DPeden%26aufirst%3DK.%2BW.%26aulast%3DZaitseva%26aufirst%3DM.%2BB.%26aulast%3DGolding%26aufirst%3DH.%26aulast%3DFarber%26aufirst%3DJ.%2BM.%26atitle%3DCCR9A%2520and%2520CCR9B%253A%2520two%2520receptors%2520for%2520the%2520chemokine%2520CCL25%252FTECK%252FCk%2520beta-15%2520that%2520differ%2520in%2520their%2520sensitivities%2520to%2520ligand%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D1293%26epage%3D1305%26doi%3D10.4049%2Fjimmunol.164.3.1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Altschul, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipman, D. J.</span><span> </span><span class="NLM_article-title">Basic local alignment search tool</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">â</span> <span class="NLM_lpage">410</span><span class="refDoi">Â DOI: 10.1016/S0022-2836(05)80360-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1016%2FS0022-2836%2805%2980360-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=2231712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=1990&pages=403-410&author=S.+F.+Altschulauthor=W.+Gishauthor=W.+Millerauthor=E.+W.+Myersauthor=D.+J.+Lipman&title=Basic+local+alignment+search+tool&doi=10.1016%2FS0022-2836%2805%2980360-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Basic local alignment search tool</span></div><div class="casAuthors">Altschul, Stephen F.; Gish, Warren; Miller, Webb; Myers, Eugene W.; Lipman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">403-10</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">A new approach to rapid sequence comparison, basic local alignment search tool (BLAST), directly approximates alignments that optimize a measure of local similarity, the maximal segment pair (MSP) score.  Recent math. results on the stochastic properties of MSP scores allow an anal. of the performance of this method as well as the statistical significance of alignments it generates.  The basic algorithm is simple and robust; it can be implemented in a no. of ways and applied in a variety of contexts including straightforward DNA and protein sequence database searches, motif searches, gene identification searches, and in the anal. of multiple regions of similarity in long DNA sequences.  In addn. to its flexibility and tractability to math. anal., BLAST is an order of magnitude faster than existing sequence comparison tools of comparable sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEHw-q53MfLVg90H21EOLACvtfcHk0ljSJFvlPmgMBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D&md5=009d2323eb82f0549356880e1101db16</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2805%2980360-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252805%252980360-2%26sid%3Dliteratum%253Aachs%26aulast%3DAltschul%26aufirst%3DS.%2BF.%26aulast%3DGish%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DMyers%26aufirst%3DE.%2BW.%26aulast%3DLipman%26aufirst%3DD.%2BJ.%26atitle%3DBasic%2520local%2520alignment%2520search%2520tool%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1990%26volume%3D215%26spage%3D403%26epage%3D410%26doi%3D10.1016%2FS0022-2836%2805%2980360-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jaroszewski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychlewski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godzik, A.</span><span> </span><span class="NLM_article-title">FFAS03: a server for profile-profile sequence alignments</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">W284</span><span class="NLM_x">â</span> <span class="NLM_lpage">W288</span><span class="refDoi">Â DOI: 10.1093/nar/gki418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1093%2Fnar%2Fgki418" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=W284-W288&author=L.+Jaroszewskiauthor=L.+Rychlewskiauthor=Z.+Liauthor=W.+Liauthor=A.+Godzik&title=FFAS03%3A+a+server+for+profile-profile+sequence+alignments&doi=10.1093%2Fnar%2Fgki418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgki418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgki418%26sid%3Dliteratum%253Aachs%26aulast%3DJaroszewski%26aufirst%3DL.%26aulast%3DRychlewski%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGodzik%26aufirst%3DA.%26atitle%3DFFAS03%253A%2520a%2520server%2520for%2520profile-profile%2520sequence%2520alignments%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3DW284%26epage%3DW288%26doi%3D10.1093%2Fnar%2Fgki418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span> </span><span class="NLM_article-title">Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">1387</span><span class="NLM_x">â</span> <span class="NLM_lpage">1390</span><span class="refDoi">Â DOI: 10.1126/science.1241475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1126%2Fscience.1241475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=24030490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=1387-1390&author=Q.+Tanauthor=Y.+Zhuauthor=J.+Liauthor=Z.+Chenauthor=G.+W.+Hanauthor=I.+Kufarevaauthor=T.+Liauthor=L.+Maauthor=G.+Fenaltiauthor=J.+Liauthor=W.+Zhangauthor=X.+Xieauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=H.+Liuauthor=R.+C.+Stevensauthor=Q.+Zhaoauthor=B.+Wu&title=Structure+of+the+CCR5+chemokine+receptor-HIV+entry+inhibitor+maraviroc+complex&doi=10.1126%2Fscience.1241475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex</span></div><div class="casAuthors">Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">1387-1390</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry.  Here we report the 2.7 angstrom-resoln. crystal structure of human CCR5 bound to the marketed HIV drug maraviroc.  The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry.  A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity.  These high-resoln. insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5VKeO5Hmb7Vg90H21EOLACvtfcHk0ljSJFvlPmgMBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ&md5=730ee5644a2a144cd49cd0e9a15eba2e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241475%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure%2520of%2520the%2520CCR5%2520chemokine%2520receptor-HIV%2520entry%2520inhibitor%2520maraviroc%2520complex%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D1387%26epage%3D1390%26doi%3D10.1126%2Fscience.1241475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grishin, N. V.</span><span> </span><span class="NLM_article-title">PROMALS3D: a tool for multiple sequence and structure alignment</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2295</span><span class="NLM_x">â</span> <span class="NLM_lpage">2300</span><span class="refDoi">Â DOI: 10.1093/nar/gkn072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1093%2Fnar%2Fgkn072" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2295-2300&author=J.+Peiauthor=B.+H.+Kimauthor=N.+V.+Grishin&title=PROMALS3D%3A+a+tool+for+multiple+sequence+and+structure+alignment&doi=10.1093%2Fnar%2Fgkn072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkn072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkn072%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26atitle%3DPROMALS3D%253A%2520a%2520tool%2520for%2520multiple%2520sequence%2520and%2520structure%2520alignment%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3D2295%26epage%3D2300%26doi%3D10.1093%2Fnar%2Fgkn072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span> </span><span class="NLM_article-title">Force field validation using protein side chain prediction</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">11673</span><span class="NLM_x">â</span> <span class="NLM_lpage">11680</span><span class="refDoi">Â DOI: 10.1021/jp021564n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp021564n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVOisrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2002&pages=11673-11680&author=M.+P.+Jacobsonauthor=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=C.+S.+Rapp&title=Force+field+validation+using+protein+side+chain+prediction&doi=10.1021%2Fjp021564n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Force Field Validation Using Protein Side Chain Prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Kaminski, George A.; Friesner, Richard A.; Rapp, Chaya S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11673-11680</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-6106</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prediction of protein side chain conformations is used to evaluate the accuracy of force field parameters.  Specifically, new torsional parameters have recently been reported for the OPLS-AA force field, which achieved substantially better accuracy with respect to high level gas-phase quantum chem. calcns. [J. Phys. Chem. B 2001, 105, 6474].  Here we demonstrate that these new parameters also lead to qual. improved side chain prediction accuracy.  The primary emphasis is on the prediction of single side chain conformations, with the rest of the protein held fixed at the native configuration.  Errors due to incomplete sampling can thus be essentially eliminated, using a combination of rotamer search and energy minimization.  In addn., the protein environment is modeled realistically using implicit solvation and an explicit representation of crystal packing effects.  Aided by the development of new algorithms, these calcns. have been performed with modest computational requirements (a cluster of PCs) on a database of 36 proteins (â¼5000 total residues).  The side chain prediction tests that we employ are quite general and can be used to evaluate nonbonded or solvation parameters as well.  As such, they provide a useful complement to decoy studies for force field validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJvh-DVauJrVg90H21EOLACvtfcHk0lhi2aYaXTlhlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVOisrw%253D&md5=1cc23c97485ac031d3f2524f672370a4</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjp021564n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp021564n%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26atitle%3DForce%2520field%2520validation%2520using%2520protein%2520side%2520chain%2520prediction%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2002%26volume%3D106%26spage%3D11673%26epage%3D11680%26doi%3D10.1021%2Fjp021564n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pincus, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">A Hierarchical approach to all-atom protein loop prediction</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">â</span> <span class="NLM_lpage">367</span><span class="refDoi">Â DOI: 10.1002/prot.10613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1002%2Fprot.10613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=15048827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=351-367&author=M.+P.+Jacobsonauthor=D.+L.+Pincusauthor=C.+S.+Rappauthor=T.+J.+F.+Dayauthor=B.+Honigauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=A+Hierarchical+approach+to+all-atom+protein+loop+prediction&doi=10.1002%2Fprot.10613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">A hierarchical approach to all-atom protein loop prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Pincus, David L.; Rapp, Chaya S.; Day, Tyler J. F.; Honig, Barry; Shaw, David E.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The application of all-atom force fields (and explicit or implicit solvent models) to protein homol.-modeling tasks such as side-chain and loop prediction remains challenging both because of the expense of the individual energy calcns. and because of the difficulty of sampling the rugged all-atom energy surface.  Here the authors address this challenge for the problem of loop prediction through the development of numerous new algorithms, with an emphasis on multiscale and hierarchical techniques.  As a first step in evaluating the performance of the authors' loop prediction algorithm, the authors have applied it to the problem of reconstructing loops in native structures; the authors also explicitly include crystal packing to provide a fair comparison with crystal structures.  In brief, large nos. of loops are generated by using a dihedral angle-based buildup procedure followed by iterative cycles of clustering, side-chain optimization, and complete energy minimization of selected loop structures.  The authors evaluate this method by the largest test set yet used for validation of a loop prediction method, with a total of 833 loops ranging from 4 to 12 residues in length.  Av./median backbone root-mean-square deviations (RMSDs) to the native structures (superimposing the body of the protein, not the loop itself) are 0.42/0.24 Ã for 5 residue loops, 1.00/0.44 Ã for 8 residue loops, and 2.47/1.83 Ã for 11 residue loops.  Median RMSDs are substantially lower than the avs. because of a small no. of outliers; the causes of these failures are examd. in some detail, and many can be attributed to errors in assignment of protonation states of titratable residues, omission of ligands from the simulation, and, in a few cases, probable errors in the exptl. detd. structures.  When these obvious problems in the data sets are filtered out, av. RMSDs to the native structures improve to 0.43 Ã for 5 residue loops, 0.84 Ã for 8 residue loops, and 1.63 Ã for 11 residue loops.  In the vast majority of cases, the method locates energy min. that are lower than or equal to that of the minimized native loop, thus indicating that sampling rarely limits prediction accuracy.  The overall results are, to the authors' knowledge, the best reported to date, and the authors attribute this success to the combination of an accurate all-atom energy function, efficient methods for loop buildup and side-chain optimization, and, esp. for the longer loops, the hierarchical refinement protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqYMnqaWXvLVg90H21EOLACvtfcHk0lhi2aYaXTlhlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D&md5=e0eff655eeefb30ea00ae041ea9099c8</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1002%2Fprot.10613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10613%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPincus%26aufirst%3DD.%2BL.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26aulast%3DDay%26aufirst%3DT.%2BJ.%2BF.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520Hierarchical%2520approach%2520to%2520all-atom%2520protein%2520loop%2520prediction%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2004%26volume%3D55%26spage%3D351%26epage%3D367%26doi%3D10.1002%2Fprot.10613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span>Prime, version 3.8, <span class="NLM_publisher-name">SchrÃ¶dinger, LLC</span>, <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%2C+version+3.8%2C+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Protective role of 1,25(OH)2vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice</span> <span class="citation_source-journal">BMC Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="refDoi">Â DOI: 10.1186/1471-230X-12-57</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1186%2F1471-230X-12-57" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=22647055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCqu7rJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=57&author=H.+Zhaoauthor=H.+Zhangauthor=H.+Wuauthor=H.+Liauthor=L.+Liuauthor=J.+Guoauthor=C.+Liauthor=D.+Shihauthor=X.+Zhang&title=Protective+role+of+1%2C25%28OH%292vitamin+D3+in+the+mucosal+injury+and+epithelial+barrier+disruption+in+DSS-induced+acute+colitis+in+mice&doi=10.1186%2F1471-230X-12-57"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice</span></div><div class="casAuthors">Zhao, Hongwei; Zhang, Hong; Wu, Hui; Li, Hui; Liu, Lei; Guo, Jian; Li, Chenyang; Shih, David Q.; Zhang, Xiaolan</div><div class="citationInfo"><span class="NLM_cas:title">BMC Gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57</span>CODEN:
                <span class="NLM_cas:coden">BGMABE</span>;
        ISSN:<span class="NLM_cas:issn">1471-230X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Intestinal hyper-permeability plays a crit. role in the etiopathogenesis of inflammatory bowel disease (IBD) by affecting the penetration of pathogens, toxic compds. and macromols.  1,25-Dihydroxyvitamin D3 [1,25(OH)2D3], the active form of vitamin D, has been shown to be an important regulator of IBD and recent epidemiol. suggests that patients with IBD have an impaired vitamin D status.  The purpose of this study is to investigate the possible protective effects of 1,25(OH)2D3 on mucosal injury and epithelial barrier disruption on dextran sulfate sodium (DSS)-induced acute colitis model.  Methods: We used DSS-induced acute colitis model to investigate the protective effects of 1,25(OH)2D3 on mucosal injury and epithelial barrier integrity.  Severity of colitis was evaluated by disease activity index (DAI), body wt. (BW) change, colon length, histol., myeloperoxidase (MPO) activity, and proinflammatory cytokine prodn. including tumor necrosis factor-Î± (TNF-Î±) and interferon-Î³ (IFN-Î³).  In vitro the protective role of 1,25(OH)2D3 was assessed by incubating Caco-2 cells with or without DSS and measuring transepithelial elec. resistance (TEER) and fluorescein isothiocyanate dextran (FITC-D).  The intestinal permeability was analyzed by FITC-D, bacterial translocation and measurement of lipopolysaccharide (LPS).  Ultrastructural features of the colon tissue and Caco-2 cell monolayer were obsd. by electron microscopy.  Expressions of tight junction (TJ) proteins in the colon mucosa and Caco-2 cells were detected by immunohistochem., immunofluorescence, Western blot and real-time fluorescent quant. PCR, resp.  Results: DSS-induced acute colitis model was characterized by a reduced BW, AUC of BW, serum calcium, higher DAI, AUC of DAI, shortened colon length, elevated MPO activity, worsened histol. inflammation, increased mononuclear cell nos. in mesenteric lymph nodes (MLNs) and colonic lamina propria (LP), and enhanced proteins and mRNA levels of TNF-Î± and IFN-Î³.  1,25(OH)2D3 markedly increased expressions of TJ proteins and mRNA and decreased the FITC-D permeability and the level of LPS.  Furthermore, 1,25(OH)2D3 abrogated bacterial translocation to MLNs and ameliorated ultrastructural features of the colon epithelium by SEM (SEM).  In vitro, 1,25(OH)2D3 increased TEER, TJ proteins and mRNA expressions, decreased the FITC-D permeability, and preserved structural integrity of the TJ in Caco-2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopDKMwnFVPKbVg90H21EOLACvtfcHk0lhi2aYaXTlhlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCqu7rJ&md5=79efb9224c5915441cdda4e24b2ab8fd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2F1471-230X-12-57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-230X-12-57%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DShih%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DProtective%2520role%2520of%25201%252C25%2528OH%25292vitamin%2520D3%2520in%2520the%2520mucosal%2520injury%2520and%2520epithelial%2520barrier%2520disruption%2520in%2520DSS-induced%2520acute%2520colitis%2520in%2520mice%26jtitle%3DBMC%2520Gastroenterol.%26date%3D2012%26volume%3D12%26spage%3D57%26doi%3D10.1186%2F1471-230X-12-57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e','cit9f'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Arimont</span>, <span class="hlFld-ContribAuthor ">Shan-Liang  Sun</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Martine  Smit</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Analysis of Chemokine ReceptorâLigand Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 4735-4779. <a href="https://doi.org/10.1021/acs.jmedchem.6b01309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BAnalysis%252Bof%252BChemokine%252BReceptor%2525E2%252580%252593Ligand%252BInteractions%26aulast%3DArimont%26aufirst%3DMarta%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D31082016%26date%3D10032017%26date%3D22062017%26date%3D06022017%26volume%3D60%26issue%3D12%26spage%3D4735%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aymen M.  El-Saka</span>, <span class="hlFld-ContribAuthor ">Yomna A.  Zamzam</span>, <span class="hlFld-ContribAuthor ">Tamer  Haydara</span>, <span class="hlFld-ContribAuthor ">Sherief  Abd-Elsalam</span>. </span><span class="cited-content_cbyCitation_article-title">Immunohistochemical staining with chemokine panel of non-specific colitis predicts future IBD diagnosis. </span><span class="cited-content_cbyCitation_journal-name">Cytokine</span><span> <strong>2020,</strong> <em>127 </em>, 154935. <a href="https://doi.org/10.1016/j.cyto.2019.154935" title="DOI URL">https://doi.org/10.1016/j.cyto.2019.154935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cyto.2019.154935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cyto.2019.154935%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%26atitle%3DImmunohistochemical%252Bstaining%252Bwith%252Bchemokine%252Bpanel%252Bof%252Bnon-specific%252Bcolitis%252Bpredicts%252Bfuture%252BIBD%252Bdiagnosis%26aulast%3DEl-Saka%26aufirst%3DAymen%2BM.%26date%3D2020%26volume%3D127%26spage%3D154935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Signe Dille  LÃ¸vmo</span>, <span class="hlFld-ContribAuthor ">Angelico  Madaro</span>, <span class="hlFld-ContribAuthor ">Paul  Whatmore</span>, <span class="hlFld-ContribAuthor ">Tora  Bardal</span>, <span class="hlFld-ContribAuthor ">Mari-Ann  Ostensen</span>, <span class="hlFld-ContribAuthor ">Simen R.  Sandve</span>, <span class="hlFld-ContribAuthor ">Rolf Erik  Olsen</span>. </span><span class="cited-content_cbyCitation_article-title">Mid and hindgut transcriptome profiling analysis of Atlantic salmon (
              Salmon salar
              ) under unpredictable chronic stress. </span><span class="cited-content_cbyCitation_journal-name">Royal Society Open Science</span><span> <strong>2020,</strong> <em>7 </em>
                                    (2)
                                     , 191480. <a href="https://doi.org/10.1098/rsos.191480" title="DOI URL">https://doi.org/10.1098/rsos.191480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rsos.191480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frsos.191480%26sid%3Dliteratum%253Aachs%26jtitle%3DRoyal%2520Society%2520Open%2520Science%26atitle%3DMid%252Band%252Bhindgut%252Btranscriptome%252Bprofiling%252Banalysis%252Bof%252BAtlantic%252Bsalmon%252B%252528%252BSalmon%252Bsalar%252B%252529%252Bunder%252Bunpredictable%252Bchronic%252Bstress%26aulast%3DL%25C3%25B8vmo%26aufirst%3DSigne%2BDille%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D2%26spage%3D191480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renren  Bai</span>, <span class="hlFld-ContribAuthor ">Xiaokang  Jie</span>, <span class="hlFld-ContribAuthor ">Chuansheng  Yao</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of small-molecule candidates against inflammatory bowel disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111805. <a href="https://doi.org/10.1016/j.ejmech.2019.111805" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111805%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bsmall-molecule%252Bcandidates%252Bagainst%252Binflammatory%252Bbowel%252Bdisease%26aulast%3DBai%26aufirst%3DRenren%26date%3D2020%26volume%3D185%26spage%3D111805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin S.  Currie</span>, <span class="hlFld-ContribAuthor ">Leena  Patel</span>, <span class="hlFld-ContribAuthor ">Kassandra F.  Sedillo</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule agents for the treatment of inflammatory bowel disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2034-2041. <a href="https://doi.org/10.1016/j.bmcl.2019.06.042" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall-molecule%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bbowel%252Bdisease%26aulast%3DCurrie%26aufirst%3DKevin%2BS.%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2034%26epage%3D2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peijian  He</span>, <span class="hlFld-ContribAuthor ">Abedul  Haque</span>, <span class="hlFld-ContribAuthor ">Songbai  Lin</span>, <span class="hlFld-ContribAuthor ">Fabio  Cominelli</span>, <span class="hlFld-ContribAuthor ">C. Chris  Yun</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na
              +
              /H
              +
              exchanger 3 in SAMP1/Fc mice. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Gastrointestinal and Liver Physiology</span><span> <strong>2018,</strong> <em>315 </em>
                                    (5)
                                     , G762-G771. <a href="https://doi.org/10.1152/ajpgi.00215.2018" title="DOI URL">https://doi.org/10.1152/ajpgi.00215.2018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpgi.00215.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpgi.00215.2018%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Gastrointestinal%2520and%2520Liver%2520Physiology%26atitle%3DInhibition%252Bof%252Bautotaxin%252Balleviates%252Binflammation%252Band%252Bincreases%252Bthe%252Bexpression%252Bof%252Bsodium-dependent%252Bglucose%252Bcotransporter%252B1%252Band%252BNa%252B%25252B%252B%25252FH%252B%25252B%252Bexchanger%252B3%252Bin%252BSAMP1%25252FFc%252Bmice%26aulast%3DHe%26aufirst%3DPeijian%26date%3D2018%26volume%3D315%26issue%3D5%26spage%3DG762%26epage%3DG771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Palak J  Trivedi</span>, <span class="hlFld-ContribAuthor ">David H  Adams</span>. </span><span class="cited-content_cbyCitation_article-title">Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise. </span><span class="cited-content_cbyCitation_journal-name">Journal of Crohn's and Colitis</span><span> <strong>2018,</strong> <em>12 </em>
                                    (suppl_2)
                                     , S641-S652. <a href="https://doi.org/10.1093/ecco-jcc/jjx145" title="DOI URL">https://doi.org/10.1093/ecco-jcc/jjx145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ecco-jcc/jjx145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fecco-jcc%2Fjjx145%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Crohn%2527s%2520and%2520Colitis%26atitle%3DChemokines%252Band%252BChemokine%252BReceptors%252Bas%252BTherapeutic%252BTargets%252Bin%252BInflammatory%252BBowel%252BDisease%25253B%252BPitfalls%252Band%252BPromise%26aulast%3DTrivedi%26aufirst%3DPalak%2BJ%26date%3D2018%26date%3D2018%26volume%3D12%26issue%3Dsuppl_2%26spage%3DS641%26epage%3DS652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of vercirnon, compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-Chloro-6-nitrophthalic Anhydride (<b>4</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HNO<sub>3</sub>/H<sub>2</sub>SO<sub>4</sub>, rt, 12 h, 74%. (b) Ac<sub>2</sub>O, 120 Â°C, 18 h, 99%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Reaction Scheme for the Synthesis of Compounds <b>5</b>â<b>71</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOAc, reflux, 18 h. (b) 10% Pd/C/H<sub>2</sub>, MeOH. (c) Fe, HOAc, 6 h or H<sub>2</sub>/Raney Ni, ethanol, 6 h. (d) Pyridine, rt, 24 h. (e) cat DMAP, pyridine 125 Â°C, 24 h or (1) Pyridine, 90 Â°C, 8 h; (2) 1 M TBAF in THF, rt, 3 h. (f) mCPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8 h. (g) Zn(CN)<sub>2</sub>, dppf, Pd<sub>2</sub>(dba)<sub>3</sub>, Zn dust, N<sub>2</sub>, DMA, 120 Â°C, 2 h, microwave.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Overlay of two CCR9 antagonists, compounds <b>5</b> (pink) and <b>11</b> (cyan) docked into the binding pocket of a model of the CCR9 receptor. (b) Detail of the interactions of the chloro atom in compound <b>11</b> with residues in the binding pocket responsible for the enhanced affinity of this molecule. All distances quoted are in angstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Alternate views of the overlay of two CCR9 antagonists, compounds <b>12</b> (cyan) and <b>14</b> (green) docked into the binding pocket of a model of the CCR9 receptor. All distances quoted are in angstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/medium/jm-2015-01840j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Behavior of compounds <b>14</b>, <b>24</b>, <b>56</b> in the chronic DSS-induced colitis mouse model showing: (a) change in body weight with time; composite changes in (b) disease activity index (DAI); (c) fecal consistency; and (d) hemoccult score.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01840/20160414/images/large/jm-2015-01840j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01840&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i100">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bouma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strober, W.</span><span> </span><span class="NLM_article-title">The immunological and genetic basis of inflammatory bowel disease</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">â</span> <span class="NLM_lpage">533</span><span class="refDoi">Â DOI: 10.1038/nri1132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1038%2Fnri1132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=12876555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Smtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=521-533&author=G.+Boumaauthor=W.+Strober&title=The+immunological+and+genetic+basis+of+inflammatory+bowel+disease&doi=10.1038%2Fnri1132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The immunological and genetic basis of inflammatory bowel disease</span></div><div class="casAuthors">Bouma, Gerd; Strober, Warren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">521-533</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract.  Enormous progress has been made recently in understanding the pathogenesis of these diseases.  Through the study of patients and mouse models, it has emerged that Crohn's disease is driven by the prodn. of interleukin-12 (IL-12) and interferon-Î³ (IFN-Î³), whereas ulcerative colitis is probably driven by the prodn. of IL-13.  A second area of progress is in the identification of specific genetic abnormalities that are responsible for disease.  The most important finding is the identification of mutations in the gene that encodes NOD2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.  Here, the authors discuss these recent findings and the implications for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP2kHY2gtjPrVg90H21EOLACvtfcHk0liewL9t0AHORw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Smtr4%253D&md5=3cff8673e11d7751397eb6e91c465658</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnri1132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1132%26sid%3Dliteratum%253Aachs%26aulast%3DBouma%26aufirst%3DG.%26aulast%3DStrober%26aufirst%3DW.%26atitle%3DThe%2520immunological%2520and%2520genetic%2520basis%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D521%26epage%3D533%26doi%3D10.1038%2Fnri1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Vinader, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afarinkia, K.</span><span> </span><span class="NLM_article-title">A beginnerâs guide to chemokines</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">â</span> <span class="NLM_lpage">852</span><span class="refDoi">Â DOI: 10.4155/fmc.12.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.4155%2Ffmc.12.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=22571610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms12iu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=845-852&author=V.+Vinaderauthor=K.+Afarinkia&title=A+beginner%E2%80%99s+guide+to+chemokines&doi=10.4155%2Ffmc.12.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A beginner's guide to chemokines</span></div><div class="casAuthors">Vinader, Victoria; Afarinkia, Kamyar</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">845-852</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">This review provides an overview of chemokines and their receptors, with an emphasis on general features and nomenclature along with a short summary of their properties and functions.  It is intended as an introduction to the subject and a ref. point for those wishing to learn key facts about chemokines and their role in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-o0O4DbOtaLVg90H21EOLACvtfcHk0liewL9t0AHORw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms12iu7s%253D&md5=2ce32997d86223951812525e0558c5db</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.49%26sid%3Dliteratum%253Aachs%26aulast%3DVinader%26aufirst%3DV.%26aulast%3DAfarinkia%26aufirst%3DK.%26atitle%3DA%2520beginner%25E2%2580%2599s%2520guide%2520to%2520chemokines%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D845%26epage%3D852%26doi%3D10.4155%2Ffmc.12.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zabel, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agace, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassam, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zovko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponath, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, D. P.</span><span> </span><span class="NLM_article-title">Human G protein-coupled receptor GPR-9â6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine mediated chemotaxis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">â</span> <span class="NLM_lpage">1256</span><span class="refDoi">Â DOI: 10.1084/jem.190.9.1241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1084%2Fjem.190.9.1241" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1999&pages=1241-1256&author=B.+A.+Zabelauthor=W.+W.+Agaceauthor=J.+J.+Campbellauthor=H.+M.+Heathauthor=D.+Parentauthor=A.+I.+Robertsauthor=E.+C.+Ebertauthor=N.+Kassamauthor=S.+Qinauthor=M.+Zovkoauthor=G.+J.+La+Rosaauthor=L.+L.+Yangauthor=D.+Solerauthor=E.+C.+Butcherauthor=P.+D.+Ponathauthor=C.+M.+Parkerauthor=D.+P.+Andrew&title=Human+G+protein-coupled+receptor+GPR-9%E2%80%936%2FCC+chemokine+receptor+9+is+selectively+expressed+on+intestinal+homing+T+lymphocytes%2C+mucosal+lymphocytes%2C+and+thymocytes+and+is+required+for+thymus-expressed+chemokine+mediated+chemotaxis&doi=10.1084%2Fjem.190.9.1241"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1084%2Fjem.190.9.1241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.190.9.1241%26sid%3Dliteratum%253Aachs%26aulast%3DZabel%26aufirst%3DB.%2BA.%26aulast%3DAgace%26aufirst%3DW.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BJ.%26aulast%3DHeath%26aufirst%3DH.%2BM.%26aulast%3DParent%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DA.%2BI.%26aulast%3DEbert%26aufirst%3DE.%2BC.%26aulast%3DKassam%26aufirst%3DN.%26aulast%3DQin%26aufirst%3DS.%26aulast%3DZovko%26aufirst%3DM.%26aulast%3DLa%2BRosa%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DL.%2BL.%26aulast%3DSoler%26aufirst%3DD.%26aulast%3DButcher%26aufirst%3DE.%2BC.%26aulast%3DPonath%26aufirst%3DP.%2BD.%26aulast%3DParker%26aufirst%3DC.%2BM.%26aulast%3DAndrew%26aufirst%3DD.%2BP.%26atitle%3DHuman%2520G%2520protein-coupled%2520receptor%2520GPR-9%25E2%2580%25936%252FCC%2520chemokine%2520receptor%25209%2520is%2520selectively%2520expressed%2520on%2520intestinal%2520homing%2520T%2520lymphocytes%252C%2520mucosal%2520lymphocytes%252C%2520and%2520thymocytes%2520and%2520is%2520required%2520for%2520thymus-expressed%2520chemokine%2520mediated%2520chemotaxis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1999%26volume%3D190%26spage%3D1241%26epage%3D1256%26doi%3D10.1084%2Fjem.190.9.1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zaballos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GutiÃ©rrez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ArdavÃ­n, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¡rquez, G.</span><span> </span><span class="NLM_article-title">Cutting edge: Identification of the orphan chemokine receptor GPR-9â6 as CCR9, the receptor for the chemokine CCL25</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">5671</span><span class="NLM_x">â</span> <span class="NLM_lpage">5675</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=5671-5675&author=A.+Zaballosauthor=J.+Guti%C3%A9rrezauthor=R.+Varonaauthor=C.+Ardav%C3%ADnauthor=G.+M%C3%A1rquez&title=Cutting+edge%3A+Identification+of+the+orphan+chemokine+receptor+GPR-9%E2%80%936+as+CCR9%2C+the+receptor+for+the+chemokine+CCL25"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZaballos%26aufirst%3DA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DJ.%26aulast%3DVarona%26aufirst%3DR.%26aulast%3DArdav%25C3%25ADn%26aufirst%3DC.%26aulast%3DM%25C3%25A1rquez%26aufirst%3DG.%26atitle%3DCutting%2520edge%253A%2520Identification%2520of%2520the%2520orphan%2520chemokine%2520receptor%2520GPR-9%25E2%2580%25936%2520as%2520CCR9%252C%2520the%2520receptor%2520for%2520the%2520chemokine%2520CCL25%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D5671%26epage%3D5675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kunkel, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haraldsen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisvert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vierra, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardlaw, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agace, W. W.</span><span> </span><span class="NLM_article-title">Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of the tissue-specific chemokines as an organizing principle in regional immunity</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">761</span><span class="NLM_x">â</span> <span class="NLM_lpage">768</span><span class="refDoi">Â DOI: 10.1084/jem.192.5.761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1084%2Fjem.192.5.761" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2000&pages=761-768&issue=5&author=E.+J.+Kunkelauthor=J.+J.+Campbellauthor=G.+Haraldsenauthor=J.+Panauthor=J.+Boisvertauthor=A.+I.+Robertsauthor=E.+C.+Ebertauthor=M.+A.+Vierraauthor=S.+B.+Goodmanauthor=M.+C.+Genoveseauthor=A.+J.+Wardlawauthor=H.+B.+Greenbergauthor=C.+M.+Parkerauthor=E.+C.+Butcherauthor=D.+P.+Andrewauthor=W.+W.+Agace&title=Lymphocyte+CC+chemokine+receptor+9+and+epithelial+thymus-expressed+chemokine+%28TECK%29+expression+distinguish+the+small+intestinal+immune+compartment%3A+Epithelial+expression+of+the+tissue-specific+chemokines+as+an+organizing+principle+in+regional+immunity&doi=10.1084%2Fjem.192.5.761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1084%2Fjem.192.5.761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.192.5.761%26sid%3Dliteratum%253Aachs%26aulast%3DKunkel%26aufirst%3DE.%2BJ.%26aulast%3DCampbell%26aufirst%3DJ.%2BJ.%26aulast%3DHaraldsen%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DBoisvert%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DA.%2BI.%26aulast%3DEbert%26aufirst%3DE.%2BC.%26aulast%3DVierra%26aufirst%3DM.%2BA.%26aulast%3DGoodman%26aufirst%3DS.%2BB.%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DWardlaw%26aufirst%3DA.%2BJ.%26aulast%3DGreenberg%26aufirst%3DH.%2BB.%26aulast%3DParker%26aufirst%3DC.%2BM.%26aulast%3DButcher%26aufirst%3DE.%2BC.%26aulast%3DAndrew%26aufirst%3DD.%2BP.%26aulast%3DAgace%26aufirst%3DW.%2BW.%26atitle%3DLymphocyte%2520CC%2520chemokine%2520receptor%25209%2520and%2520epithelial%2520thymus-expressed%2520chemokine%2520%2528TECK%2529%2520expression%2520distinguish%2520the%2520small%2520intestinal%2520immune%2520compartment%253A%2520Epithelial%2520expression%2520of%2520the%2520tissue-specific%2520chemokines%2520as%2520an%2520organizing%2520principle%2520in%2520regional%2520immunity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D192%26issue%3D5%26spage%3D761%26epage%3D768%26doi%3D10.1084%2Fjem.192.5.761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Papadakis, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prehn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouroumalis, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deem, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breaverman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponath, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodge, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targan, S. R.</span><span> </span><span class="NLM_article-title">CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohnâs disease</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">â</span> <span class="NLM_lpage">254</span><span class="refDoi">Â DOI: 10.1053/gast.2001.27154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1053%2Fgast.2001.27154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=11487533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVymsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2001&pages=246-254&author=K.+A.+Papadakisauthor=J.+Prehnauthor=S.+T.+Morenoauthor=L.+Chengauthor=E.+A.+Kouroumalisauthor=R.+Deemauthor=T.+Breavermanauthor=P.+D.+Ponathauthor=D.+P.+Andrewauthor=P.+H.+Greenauthor=M.+R.+Hodgeauthor=S.+W.+Binderauthor=S.+R.+Targan&title=CCR9-positive+lymphocytes+and+thymus-expressed+chemokine+distinguish+small+bowel+from+colonic+Crohn%E2%80%99s+disease&doi=10.1053%2Fgast.2001.27154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic crohn's disease</span></div><div class="casAuthors">Papadakis, Konstantinos A.; Prehn, John; Moreno, Sofia T.; Cheng, Lorna; Kouroumalis, Elias A.; Deem, Richard; Breaverman, Tim; Ponath, Paul D.; Andrew, David P.; Green, Peter H. R.; Hodge, Martin R.; Binder, Scott W.; Targan, Stephan R.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-254</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">Thymus-expressed chemokine (TECK or CCL25) is selectively expressed in the small bowel (SB), where lamina propria lymphocytes (LPL) and intraepithelial leukocyte expressing the cognate chemokine receptor CCR9 predominate.  The authors characterize the role of TECK and CCR9-expressing lymphocytes in small intestinal Crohn's disease.  CCR9 expression on lymphocytes from lamina propria, mesenteric lymph node, and peripheral blood was analyzed by flow cytometry and by Northern blotting for LPL.  TECK expression was analyzed in inflamed SB and colon by reverse-transcription polymerase chain reaction and immunohistochem.  The fraction of CCR9+ T cells in inflamed SB was significantly lower than in uninvolved SB mucosa.  In contrast, in peripheral blood lymphocytes, CCR9+ lymphocytes were markedly elevated in patients with small bowel Crohn's or celiac disease, but not in patients with purely colonic Crohn's.  Also, TECK expression is altered in inflamed small bowel, being intensely expressed in a patchy distribution in crypt epithelial cells in proximity to lymphocytic infiltrates.  TECK is not expressed in either normal or inflamed colon.  In SB immune-mediated diseases, there is repartitioning of CCR9+ lymphocytes between SB and blood and an altered pattern of TECK expression in SB Crohn's.  The TECK/CCR9 ligand/receptor pair may play an important role in the pathogenesis of SB Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou0eBnCrPhEbVg90H21EOLACvtfcHk0liqKCARP2IzlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVymsrk%253D&md5=4ee10b0d66c39b9df5f8659349309da4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1053%2Fgast.2001.27154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fgast.2001.27154%26sid%3Dliteratum%253Aachs%26aulast%3DPapadakis%26aufirst%3DK.%2BA.%26aulast%3DPrehn%26aufirst%3DJ.%26aulast%3DMoreno%26aufirst%3DS.%2BT.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DKouroumalis%26aufirst%3DE.%2BA.%26aulast%3DDeem%26aufirst%3DR.%26aulast%3DBreaverman%26aufirst%3DT.%26aulast%3DPonath%26aufirst%3DP.%2BD.%26aulast%3DAndrew%26aufirst%3DD.%2BP.%26aulast%3DGreen%26aufirst%3DP.%2BH.%26aulast%3DHodge%26aufirst%3DM.%2BR.%26aulast%3DBinder%26aufirst%3DS.%2BW.%26aulast%3DTargan%26aufirst%3DS.%2BR.%26atitle%3DCCR9-positive%2520lymphocytes%2520and%2520thymus-expressed%2520chemokine%2520distinguish%2520small%2520bowel%2520from%2520colonic%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DGastroenterology%26date%3D2001%26volume%3D121%26spage%3D246%26epage%3D254%26doi%3D10.1053%2Fgast.2001.27154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Rivera-Nieves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivashkina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cominelli, F.</span><span> </span><span class="NLM_article-title">Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">1518</span><span class="NLM_x">â</span> <span class="NLM_lpage">1529</span><span class="refDoi">Â DOI: 10.1053/j.gastro.2006.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1053%2Fj.gastro.2006.08.031" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=1518-1529&author=J.+Rivera-Nievesauthor=J.+Hoauthor=G.+Bamiasauthor=N.+Ivashkinaauthor=K.+Leyauthor=M.+Oppermannauthor=F.+Cominelli&title=Antibody+blockade+of+CCL25%2FCCR9+ameliorates+early+but+not+late+chronic+murine+ileitis&doi=10.1053%2Fj.gastro.2006.08.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2006.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2006.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DRivera-Nieves%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DJ.%26aulast%3DBamias%26aufirst%3DG.%26aulast%3DIvashkina%26aufirst%3DN.%26aulast%3DLey%26aufirst%3DK.%26aulast%3DOppermann%26aufirst%3DM.%26aulast%3DCominelli%26aufirst%3DF.%26atitle%3DAntibody%2520blockade%2520of%2520CCL25%252FCCR9%2520ameliorates%2520early%2520but%2520not%2520late%2520chronic%2520murine%2520ileitis%26jtitle%3DGastroenterology%26date%3D2006%26volume%3D131%26spage%3D1518%26epage%3D1529%26doi%3D10.1053%2Fj.gastro.2006.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Walters, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumgart, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairaghi, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertl, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penfold, M. E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungashe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schall, T. J.</span><span> </span><span class="NLM_article-title">Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for the treatment of inflammatory bowel disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">â</span> <span class="NLM_lpage">69</span><span class="refDoi">Â DOI: 10.1124/jpet.110.169714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1124%2Fjpet.110.169714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=20660125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gisr3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=61-69&author=M.+J.+Waltersauthor=Y.+Wangauthor=N.+Laiauthor=T.+Baumgartauthor=B.+N.+Zhaoauthor=D.+J.+Dairaghiauthor=P.+Bekkerauthor=L.+S.+Ertlauthor=M.+E.+T.+Penfoldauthor=J.+C.+Jaenauthor=S.+Keshavauthor=E.+Wendtauthor=A.+Pennellauthor=S.+Ungasheauthor=Z.+Weiauthor=J.+K.+Wrightauthor=T.+J.+Schall&title=Characterization+of+CCX282-B%2C+an+orally+bioavailable+antagonist+of+the+CCR9+chemokine+receptor%2C+for+the+treatment+of+inflammatory+bowel+disease&doi=10.1124%2Fjpet.110.169714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease</span></div><div class="casAuthors">Walters, Matthew J.; Wang, Yu; Lai, Nu; Baumgart, Trageen; Zhao, Bin N.; Dairaghi, Daniel J.; Bekker, Pirow; Ertl, Linda S.; Penfold, Mark E. T.; Jaen, Juan C.; Keshav, Satish; Wendt, Emily; Pennell, Andrew; Ungashe, Solomon; Wei, Zheng; Wright, J. J. Kim; Schall, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-69</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The chemokine system represents a diverse group of G protein-coupled receptors responsible for orchestrating cell recruitment under both homeostatic and inflammatory conditions.  Chemokine receptor 9 (CCR9) is a chemokine receptor known to be central for migration of immune cells into the intestine.  Its only ligand, CCL25, is expressed at the mucosal surface of the intestine and is known to be elevated in intestinal inflammation.  To date, there are no reports of small-mol. antagonists targeting CCR9.  We report, for the first time, the discovery of a small mol., CCX282-B, which is an orally bioavailable, selective, and potent antagonist of human CCR9.  CCX282-B inhibited CCR9-mediated Ca2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, resp.  In the presence of 100% human serum, CCX282-B inhibited CCR9-mediated chemotaxis with an IC50 of 33 nM, and the addn. of Î±1-acid glycoprotein did not affect its potency.  CCX282-B inhibited chemotaxis of primary CCR9-expressing cells to CCL25 with an IC50 of 6.8 nM.  CCX282-B was an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, resp.  CCX282-B also inhibited mouse and rat CCR9-mediated chemotaxis.  Inhibition of CCR9 with CCX282-B results in normalization of Crohn's disease such as histopathol. assocd. with the TNFÎARE mice.  Anal. of the plasma level of drug assocd. with this improvement provides an understanding of the pharmacokinetic/pharmacodynamic relationship for CCR9 antagonists in the treatment of intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAvKRxhmslqLVg90H21EOLACvtfcHk0lh-XSAuCvo40w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gisr3I&md5=0d7903a7e25721ede33196f8e32f0e87</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.169714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.169714%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DN.%26aulast%3DBaumgart%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DB.%2BN.%26aulast%3DDairaghi%26aufirst%3DD.%2BJ.%26aulast%3DBekker%26aufirst%3DP.%26aulast%3DErtl%26aufirst%3DL.%2BS.%26aulast%3DPenfold%26aufirst%3DM.%2BE.%2BT.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DKeshav%26aufirst%3DS.%26aulast%3DWendt%26aufirst%3DE.%26aulast%3DPennell%26aufirst%3DA.%26aulast%3DUngashe%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DWright%26aufirst%3DJ.%2BK.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26atitle%3DCharacterization%2520of%2520CCX282-B%252C%2520an%2520orally%2520bioavailable%2520antagonist%2520of%2520the%2520CCR9%2520chemokine%2520receptor%252C%2520for%2520the%2520treatment%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D61%26epage%3D69%26doi%3D10.1124%2Fjpet.110.169714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Carballido Herrera, J. M.; Jaksche, H.; Lehr, P.; Werner, G.; Winiski, A.</span><span> </span><span class="NLM_article-title">Inhibitors of CCR9 activity</span>. Patent WO 2007/071441, June 28,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+M.+Carballido+Herrera&author=H.+Jaksche&author=P.+Lehr&author=G.+Werner&author=A.+Winiski&title=Inhibitors+of+CCR9+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarballido%2BHerrera%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520CCR9%2520activity%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ungashe, S.; Wei, Z.; Wright, J. J.; Pennell, A.</span><span> </span><span class="NLM_article-title">Aryl sulfonamides</span>. Patent WO 2004/046092, July 15,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Ungashe&author=Z.+Wei&author=J.+J.+Wright&author=A.+Pennell&title=Aryl+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUngashe%26aufirst%3DS.%26atitle%3DAryl%2520sulfonamides%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Charvat, T. T.; Hu, C.; Melikian, A.; Novack, A.; Pennell, A. M. K.; Powers, J.; Punna, S.; Sullivan, E. J.; Thomas, W. D.; Ungashe, S.; Zhang, P.</span><span> </span><span class="NLM_article-title"><i>N</i>-(2-(Hetaryl)aryl)arylsulfonamides and <i>N</i>-(2-(Hetaryl)hetaryl)arylsulfonamides</span>. Patent WO 2009/038847, March 26,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+T.+Charvat&author=C.+Hu&author=A.+Melikian&author=A.+Novack&author=A.+M.+K.+Pennell&author=J.+Powers&author=S.+Punna&author=E.+J.+Sullivan&author=W.+D.+Thomas&author=S.+Ungashe&author=P.+Zhang&title=N-%282-%28Hetaryl%29aryl%29arylsulfonamides+and+N-%282-%28Hetaryl%29hetaryl%29arylsulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCharvat%26aufirst%3DT.%2BT.%26atitle%3DN-%25282-%2528Hetaryl%2529aryl%2529arylsulfonamides%2520and%2520N-%25282-%2528Hetaryl%2529hetaryl%2529arylsulfonamides%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ugashe, S.; Wei, Z.; Wright, J. J.; Pennell, A.</span><span> </span><span class="NLM_article-title">Aryl sulfonamides</span>. US Patent US 2004/0171654, September 2,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Ugashe&author=Z.+Wei&author=J.+J.+Wright&author=A.+Pennell&title=Aryl+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUgashe%26aufirst%3DS.%26atitle%3DAryl%2520sulfonamides%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Fleming, P.; Harriman, G. C. B.; Shi, Z.; Chen, S.</span><span> </span><span class="NLM_article-title">CCR9 inhibitors and methods of use thereof</span>. Patent WO2003/099773, December 4,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=P.+Fleming&author=G.+C.+B.+Harriman&author=Z.+Shi&author=S.+Chen&title=CCR9+inhibitors+and+methods+of+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DP.%26atitle%3DCCR9%2520inhibitors%2520and%2520methods%2520of%2520use%2520thereof%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Anderson, E. C.; Biediger, R. J.; Chen, J.; Dupre, B.; Lory, P.; Market, R. V.; Monk, K. A.; Savage, M. M.; Tennyson, R.; Young, B. M.</span><span> </span><span class="NLM_article-title">Modulators of CCR9 receptor and methods of use thereof</span>. US Patent US 2010/0029753, February 4,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+C.+Anderson&author=R.+J.+Biediger&author=J.+Chen&author=B.+Dupre&author=P.+Lory&author=R.+V.+Market&author=K.+A.+Monk&author=M.+M.+Savage&author=R.+Tennyson&author=B.+M.+Young&title=Modulators+of+CCR9+receptor+and+methods+of+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DE.%2BC.%26atitle%3DModulators%2520of%2520CCR9%2520receptor%2520and%2520methods%2520of%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Koenecke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FÃ¶rster, R.</span><span> </span><span class="NLM_article-title">CCR9 and inflammatory bowel disease</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">306</span><span class="refDoi">Â DOI: 10.1517/14728220902762928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1517%2F14728220902762928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=19236152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFKnu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=297-306&author=C.+Koeneckeauthor=R.+F%C3%B6rster&title=CCR9+and+inflammatory+bowel+disease&doi=10.1517%2F14728220902762928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">CCR9 and inflammatory bowel disease</span></div><div class="casAuthors">Koenecke, Christian; Foerster, Reinhold</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-306</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The pathol. features of inflammatory bowel disease (IBD) are assocd. with leukocyte cell infiltrates, which contribute to disease progression and persistence by prodn. of proinflammatory mediators.  Recruiting leukocytes to the gut involves local expression of chemokines that interact with receptors on the leukocytes' surface.  Specific antagonists may interfere with leukocyte recruitment to the intestine.  The chemokine receptor CCR9 is one of the key mols. in leukocyte homing to gut mucosa.  CCR9 antagonists have been shown to retard progression in patients with IBD.  Objective: To discuss CCR9 as a potential target for the treatment of IBD.  Methods: A literature review.  Results/conclusions: The therapeutic effects of CCR9 antagonists, in combination with established therapies, should be evaluated in an attempt to slow down leukocyte recruitment at early stages of IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0aD_iKz66KLVg90H21EOLACvtfcHk0lh-XSAuCvo40w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFKnu78%253D&md5=2ccb6dbb178cdfb68badf503a7f1dc8f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F14728220902762928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902762928%26sid%3Dliteratum%253Aachs%26aulast%3DKoenecke%26aufirst%3DC.%26aulast%3DF%25C3%25B6rster%26aufirst%3DR.%26atitle%3DCCR9%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D297%26epage%3D306%26doi%3D10.1517%2F14728220902762928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Proudfoot, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span> </span><span class="NLM_article-title">Anti-chemokine small molecule drugs: a promising future?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">â</span> <span class="NLM_lpage">355</span><span class="refDoi">Â DOI: 10.1517/13543780903535867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1517%2F13543780903535867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=20113217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFKmsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=345-355&author=A.+E.+Proudfootauthor=C.+A.+Powerauthor=M.+K.+Schwarz&title=Anti-chemokine+small+molecule+drugs%3A+a+promising+future%3F&doi=10.1517%2F13543780903535867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-chemokine small molecule drugs: a promising future?</span></div><div class="casAuthors">Proudfoot, Amanda E. I.; Power, Christine A.; Schwarz, Matthias K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-355</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Chemokines have principally been assocd. with inflammation due to their role in the control of leukocyte migration, but just over a decade ago chemokine receptors were also identified as playing a pivotal role in the entry of the HIV virus into cells.  Chemokines activate seven transmembrane G protein-coupled receptors, making them extremely attractive therapeutic targets for the pharmaceutical industry.Areas covered in this review: Although there are now a large no. of mols. targeting chemokines and chemokine receptors including neutralizing antibodies in clin. trials for inflammatory diseases, the results to date have not always been pos., which has been disappointing for the field.  These failures have often been attributed to redundancy in the chemokine system.  However, other difficulties have been encountered in drug discovery processes targeting the chemokine system, and these will be addressed in this review.What the reader will gain: In this review, the reader will get an insight into the hurdles that have to be overcome, learn about some of the pitfalls that may explain the lack of success, and get a glimpse of the outlook for the future.Take home message: In 2007, the FDA approved maraviroc, an inhibitor of CCR5 for the prevention of HIV infection, the first triumph for a small-mol. drug acting on the chemokine system.  The time to market, 11 years from discovery of CCR5, was fast by industry stds.  A second small-mol. drug, a CXCR4 antagonist for hematopoietic stem cell mobilization, was approved by the FDA at the end of 2008.  The results of a Phase III trial with a CCR9 inhibitor for Crohn's disease are also promising.  This could herald the first success for a chemokine receptor antagonist as an anti-inflammatory therapeutic and confirms the importance of chemokine receptors as a target class for anti-inflammatory and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotTjTl2LXpmrVg90H21EOLACvtfcHk0liLwcphGP1V7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFKmsrw%253D&md5=1e9fcb9e17420219e301a0308e92c133</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543780903535867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780903535867%26sid%3Dliteratum%253Aachs%26aulast%3DProudfoot%26aufirst%3DA.%2BE.%26aulast%3DPower%26aufirst%3DC.%2BA.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26atitle%3DAnti-chemokine%2520small%2520molecule%2520drugs%253A%2520a%2520promising%2520future%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D345%26epage%3D355%26doi%3D10.1517%2F13543780903535867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Keshav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VaÅÃ¡sek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niv, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petryka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howaldt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bafutto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¡cz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetzel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinisch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">KarlÃ©n, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schall, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker, P.</span><span> </span><span class="NLM_article-title">Prospective randomized oral-therapy evaluation in Crohnâs disease trial-1 PROTECT-1 study group</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">e60094</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0060094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1371%2Fjournal.pone.0060094" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e60094&issue=3&author=S.+Keshavauthor=T.+Va%C5%88%C3%A1sekauthor=Y.+Nivauthor=R.+Petrykaauthor=S.+Howaldtauthor=M.+Bafuttoauthor=I.+R%C3%A1czauthor=D.+Hetzelauthor=O.+H.+Nielsenauthor=S.+Vermeireauthor=W.+Reinischauthor=P.+Karl%C3%A9nauthor=S.+Schreiberauthor=T.+J.+Schallauthor=P.+Bekker&title=Prospective+randomized+oral-therapy+evaluation+in+Crohn%E2%80%99s+disease+trial-1+PROTECT-1+study+group&doi=10.1371%2Fjournal.pone.0060094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0060094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0060094%26sid%3Dliteratum%253Aachs%26aulast%3DKeshav%26aufirst%3DS.%26aulast%3DVa%25C5%2588%25C3%25A1sek%26aufirst%3DT.%26aulast%3DNiv%26aufirst%3DY.%26aulast%3DPetryka%26aufirst%3DR.%26aulast%3DHowaldt%26aufirst%3DS.%26aulast%3DBafutto%26aufirst%3DM.%26aulast%3DR%25C3%25A1cz%26aufirst%3DI.%26aulast%3DHetzel%26aufirst%3DD.%26aulast%3DNielsen%26aufirst%3DO.%2BH.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DReinisch%26aufirst%3DW.%26aulast%3DKarl%25C3%25A9n%26aufirst%3DP.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26aulast%3DBekker%26aufirst%3DP.%26atitle%3DProspective%2520randomized%2520oral-therapy%2520evaluation%2520in%2520Crohn%25E2%2580%2599s%2520disease%2520trial-1%2520PROTECT-1%2520study%2520group%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D3%26spage%3De60094%26doi%3D10.1371%2Fjournal.pone.0060094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wendt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshav, S.</span><span> </span><span class="NLM_article-title">CCR9 antagonism: potential in the treatment of inflammatory bowel disease</span> <span class="citation_source-journal">Clin. Exp. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">130</span><span class="refDoi">Â DOI: 10.2147/CEG.S48305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.2147%2FCEG.S48305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=25897254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A280%3ADC%252BC2MjmsFyjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=119-130&author=E.+Wendtauthor=S.+Keshav&title=CCR9+antagonism%3A+potential+in+the+treatment+of+inflammatory+bowel+disease&doi=10.2147%2FCEG.S48305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease</span></div><div class="casAuthors">Wendt Emily; Keshav Satish</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental gastroenterology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammatory Bowel Disease (IBD), mainly comprising Crohn's disease (CD) and ulcerative colitis (UC), is a chronic condition that primarily affects the intestine and is characterized by leukocytic infiltration.  Blocking the migration of leukocytes from the circulation is therefore a reasonable therapeutic goal.  Recent clinical trials using this approach have shown promise, with the monoclonal antibody to Î±4Î²7 integrin, vedolizumab, and previously with the monoclonal antibody to the Î±4 subunit, natalizumab.  Directly targeting the subset of Î±4Î²7 expressing cells that co-express CC chemokine receptor 9 (CCR9), using the orally administered antagonist, CCX282-B, also known as vercirnon, has also been evaluated in Phase II and III trials that have produced mixed results.  Although CCX282-B showed efficacy in inducing response in active CD in early studies, this was not confirmed in a Phase III study.  CCX282-B was also more effective than placebo in maintaining remission, and this result has yet to be confirmed in Phase III.  The efficacy of blocking CCR9 in UC, where vedolizumab was effective, has not been tested.  The prospect of targeting CCR9 in IBD remains attractive.  Much of the local accumulation of inflammatory cells in the intestine arises from migration rather than local proliferation and genetic and pharmacological targeting of CCR9 or its ligand in preclinical models that mimic UC and CD ameliorate inflammation in some cases.  Furthermore, binding of chemokine ligands to receptor is a critical step in activating integrin binding, so there is a potential for synergistic action between integrin and chemokine antagonists.  CCR9 is expressed on a smaller proportion of circulating cells than Î±4Î²7 integrin, which may offer greater specificity of effect, particularly in long term use.  Furthermore, while Î±4Î²7 is widely expressed on T and B cell subsets, CCR9 is mainly expressed on effector memory Th1 cells.  Indications for the use of intestine-specific integrin and chemokine receptor targeting may also extend beyond IBD, to include, for example, postoperative ileus, and primary sclerosing cholangitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzG8G4Bs2UKUEgZCMqtRBifW6udTcc2ebEUFaMPjMW67ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjmsFyjsQ%253D%253D&md5=96b5219e57fb1e39a99c06030b042fa9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2147%2FCEG.S48305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCEG.S48305%26sid%3Dliteratum%253Aachs%26aulast%3DWendt%26aufirst%3DE.%26aulast%3DKeshav%26aufirst%3DS.%26atitle%3DCCR9%2520antagonism%253A%2520potential%2520in%2520the%2520treatment%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DClin.%2520Exp.%2520Gastroenterol.%26date%3D2015%26volume%3D8%26spage%3D119%26epage%3D130%26doi%3D10.2147%2FCEG.S48305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Feagan, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandborn, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâHaens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorak, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrance, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurgensen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. J.</span><span> </span><span class="NLM_article-title">Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohnâs disease</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span><span class="NLM_x">â</span> <span class="NLM_lpage">1181</span><span class="refDoi">Â DOI: 10.1111/apt.13398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1111%2Fapt.13398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=26400458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Ohu73J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=1170-1181&author=B.+G.+Feaganauthor=W.+J.+Sandbornauthor=G.+D%E2%80%99Haensauthor=S.+D.+Leeauthor=M.+Allezauthor=R.+N.+Fedorakauthor=U.+Seidlerauthor=S.+Vermeireauthor=I.+C.+Lawranceauthor=A.+C.+Maroneyauthor=C.+H.+Jurgensenauthor=A.+Heathauthor=D.+J.+Chang&title=Randomised+clinical+trial%3A+vercirnon%2C+an+oral+CCR9+antagonist%2C+vs.+placebo+as+induction+therapy+in+active+Crohn%E2%80%99s+disease&doi=10.1111%2Fapt.13398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease</span></div><div class="casAuthors">Feagan, B. G.; Sandborn, W. J.; D'Haens, G.; Lee, S. D.; Allez, M.; Fedorak, R. N.; Seidler, U.; Vermeire, S.; Lawrance, I. C.; Maroney, A. C.; Jurgensen, C. H.; Heath, A.; Chang, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1170-1181</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Background : Many patients with active Crohn's disease do not adequately respond to therapies, highlighting the need for new treatments.  Aims : To conduct a randomised, double-blind, placebo-controlled phase 3 study to assess the efficacy and safety of vercirnon, an oral inhibitor of CC chemokine receptor-9, for the treatment of patients with moderately-to-severely active Crohn's disease.  Methods : Patients with a Crohn's Disease Activity Index (CDAI) of 220-450, plus evidence of active disease (endoscopically confirmed or elevation of both C-reactive protein and faecal calprotectin), who had failed corticosteroid or immunosuppressant therapy were enrolled.  Patients were equally randomised to receive placebo, vercirnon 500 mg once daily or vercirnon 500 mg twice daily.  The primary endpoint was clin. response, defined as a 100-point decrease in CDAI from baseline to week 12.  Results : Six hundred and eight patients were randomised.  Patient characteristics and baseline demographics were similar among the groups.  The proportions of patients achieving a clin. response were 25.1%, 27.6% and 27.2% for placebo, once daily and twice daily resp.; treatment differences were not significant (2.5%; 95% confidence interval, CI -6.1% to 11.0%, P = 0.546 for once daily vs. placebo, and 2.1%; 95% CI -6.5% to 10.7%, P = 0.648 for twice daily vs. placebo).  Adverse events were reported in 69.8%, 73.3% and 78.1% with serious adverse events in 8.9%, 5.9%, and 6.0% of patients in the placebo, once-daily and twice-daily groups, resp.  Conclusions : We did not demonstrate efficacy of vercirnon as an induction therapy in patients with moderately-to-severely active Crohn's disease; its effect in maintenance therapy was not addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDpjdHoZsB-rVg90H21EOLACvtfcHk0lh4hqfsXOtQyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Ohu73J&md5=d7fbb83bdae34f08d4fa289646efc7d0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fapt.13398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fapt.13398%26sid%3Dliteratum%253Aachs%26aulast%3DFeagan%26aufirst%3DB.%2BG.%26aulast%3DSandborn%26aufirst%3DW.%2BJ.%26aulast%3DD%25E2%2580%2599Haens%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DS.%2BD.%26aulast%3DAllez%26aufirst%3DM.%26aulast%3DFedorak%26aufirst%3DR.%2BN.%26aulast%3DSeidler%26aufirst%3DU.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DLawrance%26aufirst%3DI.%2BC.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DJurgensen%26aufirst%3DC.%2BH.%26aulast%3DHeath%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DD.%2BJ.%26atitle%3DRandomised%2520clinical%2520trial%253A%2520vercirnon%252C%2520an%2520oral%2520CCR9%2520antagonist%252C%2520vs.%2520placebo%2520as%2520induction%2520therapy%2520in%2520active%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2015%26volume%3D42%26spage%3D1170%26epage%3D1181%26doi%3D10.1111%2Fapt.13398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stucka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varoglu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandonnet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, B.</span><span> </span><span class="NLM_article-title">Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3661</span><span class="NLM_x">â</span> <span class="NLM_lpage">3664</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.06.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1016%2Fj.bmcl.2015.06.046" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3661-3664&author=J.+Zhangauthor=J.+Romeroauthor=A.+Chanauthor=J.+Gossauthor=S.+Stuckaauthor=J.+Crossauthor=B.+Chamberlainauthor=M.+Varogluauthor=H.+Chandonnetauthor=D.+Ryanauthor=B.+Lippa&title=Biarylsulfonamide+CCR9+inhibitors+for+inflammatory+bowel+disease&doi=10.1016%2Fj.bmcl.2015.06.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.046%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DGoss%26aufirst%3DJ.%26aulast%3DStucka%26aufirst%3DS.%26aulast%3DCross%26aufirst%3DJ.%26aulast%3DChamberlain%26aufirst%3DB.%26aulast%3DVaroglu%26aufirst%3DM.%26aulast%3DChandonnet%26aufirst%3DH.%26aulast%3DRyan%26aufirst%3DD.%26aulast%3DLippa%26aufirst%3DB.%26atitle%3DBiarylsulfonamide%2520CCR9%2520inhibitors%2520for%2520inflammatory%2520bowel%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3661%26epage%3D3664%26doi%3D10.1016%2Fj.bmcl.2015.06.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitter, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotti, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerino, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirshfield, J.</span><span> </span><span class="NLM_article-title">Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2235</span><span class="NLM_x">â</span> <span class="NLM_lpage">2246</span><span class="refDoi">Â DOI: 10.1021/jm00120a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00120a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADyaL1cXmtVCgurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=2235-2246&author=B.+E.+Evansauthor=K.+E.+Rittleauthor=M.+G.+Bockauthor=R.+M.+DiPardoauthor=R.+M.+Freidingerauthor=W.+L.+Whitterauthor=G.+F.+Lundellauthor=D.+F.+Veberauthor=P.+S.+Andersonauthor=R.+S.+L.+Changauthor=V.+J.+Lottiauthor=D.+J.+Cerinoauthor=T.+B.+Chenauthor=P.+J.+Klingauthor=K.+A.+Kunkelauthor=J.+P.+Springerauthor=J.+Hirshfield&title=Methods+for+drug+discovery%3A+development+of+potent%2C+selective%2C+orally+effective+cholecystokinin+antagonists&doi=10.1021%2Fjm00120a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for drug discovery:  development of potent, selective, orally effective cholecystokinin antagonists</span></div><div class="casAuthors">Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2235-46</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">3-(Acylamino)-5-phenyl-2H-1,4-benzodiazepines) (I, X = H or F; R1 = H, Me, CH2CO2Et, CH2CO2H; R2 = acylamino, indolylalkyl, heterocyclic contg. groups, substituted benzoyl, etc.), antagonists of the peptide hormone cholecystokinin (CCK), are described.  Developed by reasoned modification of the known anxiolytic benzodiazepines, these compds. provide highly potent, orally effective ligands selective for peripheral (CCK-A) receptors, with binding affinities approaching or equaling that of the natural ligand CCK-8.  The distinction between CCK-A receptors on the one hand and CNS (CCK-B), gastrin, and central benzodiazepine receptors on the other is demonstrated by using the structure-activity profiles of the new compds.  Details of the binding of these agents to CCK-A receptors are examd., and the method of development of these compds. is discussed in terms of its relevance to the general problem of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF3uSMSNckhrVg90H21EOLACvtfcHk0lh4hqfsXOtQyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmtVCgurs%253D&md5=783be926d2512ab8f67c8786afcf0276</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm00120a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00120a002%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DWhitter%26aufirst%3DW.%2BL.%26aulast%3DLundell%26aufirst%3DG.%2BF.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DLotti%26aufirst%3DV.%2BJ.%26aulast%3DCerino%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DKling%26aufirst%3DP.%2BJ.%26aulast%3DKunkel%26aufirst%3DK.%2BA.%26aulast%3DSpringer%26aufirst%3DJ.%2BP.%26aulast%3DHirshfield%26aufirst%3DJ.%26atitle%3DMethods%2520for%2520drug%2520discovery%253A%2520development%2520of%2520potent%252C%2520selective%252C%2520orally%2520effective%2520cholecystokinin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D2235%26epage%3D2246%26doi%3D10.1021%2Fjm00120a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peden, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaitseva, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, J. M.</span><span> </span><span class="NLM_article-title">CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">â</span> <span class="NLM_lpage">1305</span><span class="refDoi">Â DOI: 10.4049/jimmunol.164.3.1293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.4049%2Fjimmunol.164.3.1293" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=1293-1305&author=C.+R.+Yuauthor=K.+W.+Pedenauthor=M.+B.+Zaitsevaauthor=H.+Goldingauthor=J.+M.+Farber&title=CCR9A+and+CCR9B%3A+two+receptors+for+the+chemokine+CCL25%2FTECK%2FCk+beta-15+that+differ+in+their+sensitivities+to+ligand&doi=10.4049%2Fjimmunol.164.3.1293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.164.3.1293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.164.3.1293%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.%2BR.%26aulast%3DPeden%26aufirst%3DK.%2BW.%26aulast%3DZaitseva%26aufirst%3DM.%2BB.%26aulast%3DGolding%26aufirst%3DH.%26aulast%3DFarber%26aufirst%3DJ.%2BM.%26atitle%3DCCR9A%2520and%2520CCR9B%253A%2520two%2520receptors%2520for%2520the%2520chemokine%2520CCL25%252FTECK%252FCk%2520beta-15%2520that%2520differ%2520in%2520their%2520sensitivities%2520to%2520ligand%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D1293%26epage%3D1305%26doi%3D10.4049%2Fjimmunol.164.3.1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Altschul, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipman, D. J.</span><span> </span><span class="NLM_article-title">Basic local alignment search tool</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">â</span> <span class="NLM_lpage">410</span><span class="refDoi">Â DOI: 10.1016/S0022-2836(05)80360-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1016%2FS0022-2836%2805%2980360-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=2231712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=1990&pages=403-410&author=S.+F.+Altschulauthor=W.+Gishauthor=W.+Millerauthor=E.+W.+Myersauthor=D.+J.+Lipman&title=Basic+local+alignment+search+tool&doi=10.1016%2FS0022-2836%2805%2980360-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Basic local alignment search tool</span></div><div class="casAuthors">Altschul, Stephen F.; Gish, Warren; Miller, Webb; Myers, Eugene W.; Lipman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">403-10</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">A new approach to rapid sequence comparison, basic local alignment search tool (BLAST), directly approximates alignments that optimize a measure of local similarity, the maximal segment pair (MSP) score.  Recent math. results on the stochastic properties of MSP scores allow an anal. of the performance of this method as well as the statistical significance of alignments it generates.  The basic algorithm is simple and robust; it can be implemented in a no. of ways and applied in a variety of contexts including straightforward DNA and protein sequence database searches, motif searches, gene identification searches, and in the anal. of multiple regions of similarity in long DNA sequences.  In addn. to its flexibility and tractability to math. anal., BLAST is an order of magnitude faster than existing sequence comparison tools of comparable sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEHw-q53MfLVg90H21EOLACvtfcHk0li_iyBxOSCCeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVGmsA%253D%253D&md5=009d2323eb82f0549356880e1101db16</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2805%2980360-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252805%252980360-2%26sid%3Dliteratum%253Aachs%26aulast%3DAltschul%26aufirst%3DS.%2BF.%26aulast%3DGish%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DMyers%26aufirst%3DE.%2BW.%26aulast%3DLipman%26aufirst%3DD.%2BJ.%26atitle%3DBasic%2520local%2520alignment%2520search%2520tool%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1990%26volume%3D215%26spage%3D403%26epage%3D410%26doi%3D10.1016%2FS0022-2836%2805%2980360-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jaroszewski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychlewski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godzik, A.</span><span> </span><span class="NLM_article-title">FFAS03: a server for profile-profile sequence alignments</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">W284</span><span class="NLM_x">â</span> <span class="NLM_lpage">W288</span><span class="refDoi">Â DOI: 10.1093/nar/gki418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1093%2Fnar%2Fgki418" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=W284-W288&author=L.+Jaroszewskiauthor=L.+Rychlewskiauthor=Z.+Liauthor=W.+Liauthor=A.+Godzik&title=FFAS03%3A+a+server+for+profile-profile+sequence+alignments&doi=10.1093%2Fnar%2Fgki418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgki418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgki418%26sid%3Dliteratum%253Aachs%26aulast%3DJaroszewski%26aufirst%3DL.%26aulast%3DRychlewski%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGodzik%26aufirst%3DA.%26atitle%3DFFAS03%253A%2520a%2520server%2520for%2520profile-profile%2520sequence%2520alignments%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3DW284%26epage%3DW288%26doi%3D10.1093%2Fnar%2Fgki418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span> </span><span class="NLM_article-title">Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">1387</span><span class="NLM_x">â</span> <span class="NLM_lpage">1390</span><span class="refDoi">Â DOI: 10.1126/science.1241475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1126%2Fscience.1241475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=24030490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=1387-1390&author=Q.+Tanauthor=Y.+Zhuauthor=J.+Liauthor=Z.+Chenauthor=G.+W.+Hanauthor=I.+Kufarevaauthor=T.+Liauthor=L.+Maauthor=G.+Fenaltiauthor=J.+Liauthor=W.+Zhangauthor=X.+Xieauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=H.+Liuauthor=R.+C.+Stevensauthor=Q.+Zhaoauthor=B.+Wu&title=Structure+of+the+CCR5+chemokine+receptor-HIV+entry+inhibitor+maraviroc+complex&doi=10.1126%2Fscience.1241475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex</span></div><div class="casAuthors">Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">1387-1390</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry.  Here we report the 2.7 angstrom-resoln. crystal structure of human CCR5 bound to the marketed HIV drug maraviroc.  The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry.  A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity.  These high-resoln. insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5VKeO5Hmb7Vg90H21EOLACvtfcHk0li_iyBxOSCCeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ&md5=730ee5644a2a144cd49cd0e9a15eba2e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241475%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure%2520of%2520the%2520CCR5%2520chemokine%2520receptor-HIV%2520entry%2520inhibitor%2520maraviroc%2520complex%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D1387%26epage%3D1390%26doi%3D10.1126%2Fscience.1241475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grishin, N. V.</span><span> </span><span class="NLM_article-title">PROMALS3D: a tool for multiple sequence and structure alignment</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2295</span><span class="NLM_x">â</span> <span class="NLM_lpage">2300</span><span class="refDoi">Â DOI: 10.1093/nar/gkn072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1093%2Fnar%2Fgkn072" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2295-2300&author=J.+Peiauthor=B.+H.+Kimauthor=N.+V.+Grishin&title=PROMALS3D%3A+a+tool+for+multiple+sequence+and+structure+alignment&doi=10.1093%2Fnar%2Fgkn072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkn072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkn072%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26atitle%3DPROMALS3D%253A%2520a%2520tool%2520for%2520multiple%2520sequence%2520and%2520structure%2520alignment%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3D2295%26epage%3D2300%26doi%3D10.1093%2Fnar%2Fgkn072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span> </span><span class="NLM_article-title">Force field validation using protein side chain prediction</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">11673</span><span class="NLM_x">â</span> <span class="NLM_lpage">11680</span><span class="refDoi">Â DOI: 10.1021/jp021564n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp021564n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVOisrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2002&pages=11673-11680&author=M.+P.+Jacobsonauthor=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=C.+S.+Rapp&title=Force+field+validation+using+protein+side+chain+prediction&doi=10.1021%2Fjp021564n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Force Field Validation Using Protein Side Chain Prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Kaminski, George A.; Friesner, Richard A.; Rapp, Chaya S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11673-11680</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-6106</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prediction of protein side chain conformations is used to evaluate the accuracy of force field parameters.  Specifically, new torsional parameters have recently been reported for the OPLS-AA force field, which achieved substantially better accuracy with respect to high level gas-phase quantum chem. calcns. [J. Phys. Chem. B 2001, 105, 6474].  Here we demonstrate that these new parameters also lead to qual. improved side chain prediction accuracy.  The primary emphasis is on the prediction of single side chain conformations, with the rest of the protein held fixed at the native configuration.  Errors due to incomplete sampling can thus be essentially eliminated, using a combination of rotamer search and energy minimization.  In addn., the protein environment is modeled realistically using implicit solvation and an explicit representation of crystal packing effects.  Aided by the development of new algorithms, these calcns. have been performed with modest computational requirements (a cluster of PCs) on a database of 36 proteins (â¼5000 total residues).  The side chain prediction tests that we employ are quite general and can be used to evaluate nonbonded or solvation parameters as well.  As such, they provide a useful complement to decoy studies for force field validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJvh-DVauJrVg90H21EOLACvtfcHk0li_iyBxOSCCeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVOisrw%253D&md5=1cc23c97485ac031d3f2524f672370a4</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjp021564n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp021564n%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26atitle%3DForce%2520field%2520validation%2520using%2520protein%2520side%2520chain%2520prediction%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2002%26volume%3D106%26spage%3D11673%26epage%3D11680%26doi%3D10.1021%2Fjp021564n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pincus, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">A Hierarchical approach to all-atom protein loop prediction</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">â</span> <span class="NLM_lpage">367</span><span class="refDoi">Â DOI: 10.1002/prot.10613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1002%2Fprot.10613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=15048827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=351-367&author=M.+P.+Jacobsonauthor=D.+L.+Pincusauthor=C.+S.+Rappauthor=T.+J.+F.+Dayauthor=B.+Honigauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=A+Hierarchical+approach+to+all-atom+protein+loop+prediction&doi=10.1002%2Fprot.10613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">A hierarchical approach to all-atom protein loop prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Pincus, David L.; Rapp, Chaya S.; Day, Tyler J. F.; Honig, Barry; Shaw, David E.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The application of all-atom force fields (and explicit or implicit solvent models) to protein homol.-modeling tasks such as side-chain and loop prediction remains challenging both because of the expense of the individual energy calcns. and because of the difficulty of sampling the rugged all-atom energy surface.  Here the authors address this challenge for the problem of loop prediction through the development of numerous new algorithms, with an emphasis on multiscale and hierarchical techniques.  As a first step in evaluating the performance of the authors' loop prediction algorithm, the authors have applied it to the problem of reconstructing loops in native structures; the authors also explicitly include crystal packing to provide a fair comparison with crystal structures.  In brief, large nos. of loops are generated by using a dihedral angle-based buildup procedure followed by iterative cycles of clustering, side-chain optimization, and complete energy minimization of selected loop structures.  The authors evaluate this method by the largest test set yet used for validation of a loop prediction method, with a total of 833 loops ranging from 4 to 12 residues in length.  Av./median backbone root-mean-square deviations (RMSDs) to the native structures (superimposing the body of the protein, not the loop itself) are 0.42/0.24 Ã for 5 residue loops, 1.00/0.44 Ã for 8 residue loops, and 2.47/1.83 Ã for 11 residue loops.  Median RMSDs are substantially lower than the avs. because of a small no. of outliers; the causes of these failures are examd. in some detail, and many can be attributed to errors in assignment of protonation states of titratable residues, omission of ligands from the simulation, and, in a few cases, probable errors in the exptl. detd. structures.  When these obvious problems in the data sets are filtered out, av. RMSDs to the native structures improve to 0.43 Ã for 5 residue loops, 0.84 Ã for 8 residue loops, and 1.63 Ã for 11 residue loops.  In the vast majority of cases, the method locates energy min. that are lower than or equal to that of the minimized native loop, thus indicating that sampling rarely limits prediction accuracy.  The overall results are, to the authors' knowledge, the best reported to date, and the authors attribute this success to the combination of an accurate all-atom energy function, efficient methods for loop buildup and side-chain optimization, and, esp. for the longer loops, the hierarchical refinement protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqYMnqaWXvLVg90H21EOLACvtfcHk0ljrjYnA8coNLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D&md5=e0eff655eeefb30ea00ae041ea9099c8</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1002%2Fprot.10613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10613%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPincus%26aufirst%3DD.%2BL.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26aulast%3DDay%26aufirst%3DT.%2BJ.%2BF.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520Hierarchical%2520approach%2520to%2520all-atom%2520protein%2520loop%2520prediction%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2004%26volume%3D55%26spage%3D351%26epage%3D367%26doi%3D10.1002%2Fprot.10613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span>Prime, version 3.8, <span class="NLM_publisher-name">SchrÃ¶dinger, LLC</span>, <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%2C+version+3.8%2C+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Protective role of 1,25(OH)2vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice</span> <span class="citation_source-journal">BMC Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="refDoi">Â DOI: 10.1186/1471-230X-12-57</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=10.1186%2F1471-230X-12-57" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=22647055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCqu7rJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=57&author=H.+Zhaoauthor=H.+Zhangauthor=H.+Wuauthor=H.+Liauthor=L.+Liuauthor=J.+Guoauthor=C.+Liauthor=D.+Shihauthor=X.+Zhang&title=Protective+role+of+1%2C25%28OH%292vitamin+D3+in+the+mucosal+injury+and+epithelial+barrier+disruption+in+DSS-induced+acute+colitis+in+mice&doi=10.1186%2F1471-230X-12-57"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice</span></div><div class="casAuthors">Zhao, Hongwei; Zhang, Hong; Wu, Hui; Li, Hui; Liu, Lei; Guo, Jian; Li, Chenyang; Shih, David Q.; Zhang, Xiaolan</div><div class="citationInfo"><span class="NLM_cas:title">BMC Gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57</span>CODEN:
                <span class="NLM_cas:coden">BGMABE</span>;
        ISSN:<span class="NLM_cas:issn">1471-230X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Intestinal hyper-permeability plays a crit. role in the etiopathogenesis of inflammatory bowel disease (IBD) by affecting the penetration of pathogens, toxic compds. and macromols.  1,25-Dihydroxyvitamin D3 [1,25(OH)2D3], the active form of vitamin D, has been shown to be an important regulator of IBD and recent epidemiol. suggests that patients with IBD have an impaired vitamin D status.  The purpose of this study is to investigate the possible protective effects of 1,25(OH)2D3 on mucosal injury and epithelial barrier disruption on dextran sulfate sodium (DSS)-induced acute colitis model.  Methods: We used DSS-induced acute colitis model to investigate the protective effects of 1,25(OH)2D3 on mucosal injury and epithelial barrier integrity.  Severity of colitis was evaluated by disease activity index (DAI), body wt. (BW) change, colon length, histol., myeloperoxidase (MPO) activity, and proinflammatory cytokine prodn. including tumor necrosis factor-Î± (TNF-Î±) and interferon-Î³ (IFN-Î³).  In vitro the protective role of 1,25(OH)2D3 was assessed by incubating Caco-2 cells with or without DSS and measuring transepithelial elec. resistance (TEER) and fluorescein isothiocyanate dextran (FITC-D).  The intestinal permeability was analyzed by FITC-D, bacterial translocation and measurement of lipopolysaccharide (LPS).  Ultrastructural features of the colon tissue and Caco-2 cell monolayer were obsd. by electron microscopy.  Expressions of tight junction (TJ) proteins in the colon mucosa and Caco-2 cells were detected by immunohistochem., immunofluorescence, Western blot and real-time fluorescent quant. PCR, resp.  Results: DSS-induced acute colitis model was characterized by a reduced BW, AUC of BW, serum calcium, higher DAI, AUC of DAI, shortened colon length, elevated MPO activity, worsened histol. inflammation, increased mononuclear cell nos. in mesenteric lymph nodes (MLNs) and colonic lamina propria (LP), and enhanced proteins and mRNA levels of TNF-Î± and IFN-Î³.  1,25(OH)2D3 markedly increased expressions of TJ proteins and mRNA and decreased the FITC-D permeability and the level of LPS.  Furthermore, 1,25(OH)2D3 abrogated bacterial translocation to MLNs and ameliorated ultrastructural features of the colon epithelium by SEM (SEM).  In vitro, 1,25(OH)2D3 increased TEER, TJ proteins and mRNA expressions, decreased the FITC-D permeability, and preserved structural integrity of the TJ in Caco-2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopDKMwnFVPKbVg90H21EOLACvtfcHk0ljrjYnA8coNLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCqu7rJ&md5=79efb9224c5915441cdda4e24b2ab8fd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2F1471-230X-12-57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-230X-12-57%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DShih%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DProtective%2520role%2520of%25201%252C25%2528OH%25292vitamin%2520D3%2520in%2520the%2520mucosal%2520injury%2520and%2520epithelial%2520barrier%2520disruption%2520in%2520DSS-induced%2520acute%2520colitis%2520in%2520mice%26jtitle%3DBMC%2520Gastroenterol.%26date%3D2012%26volume%3D12%26spage%3D57%26doi%3D10.1186%2F1471-230X-12-57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS','PDB','4MBS'); return false;">PDB: 4MBS</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d39e5977-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i95"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01840">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_03151"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01840">10.1021/acs.jmedchem.5b01840</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental details and data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01840/suppl_file/jm5b01840_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Compound data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01840/suppl_file/jm5b01840_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01840/suppl_file/jm5b01840_si_001.pdf">jm5b01840_si_001.pdf (877.91 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01840/suppl_file/jm5b01840_si_002.csv">jm5b01840_si_002.csv (5.93 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01840&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01840%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01840" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a4124c262308","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
